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Proton and ion beams produced during ultra-intense laser interactions with thin foils have
very different properties compared to beams of comparable energy produced by conven-
tional accelerators. As a result they have the potential to be used for a wide range of inno-
vative applications, particularly in the areas of science, technology and medicine [1]. The
properties of interest include high brightness of ∼ 1012 ions in picosecond-scale bunches
[2], high laminarity and energy cut-off, ultra-short pulse durations [3], high intensity, ultra-
low emittance, good collimation which increases with proton energy [4] and a high field
acceleration gradient [5]. Current interest in laser-driven ion sources for medicinal pur-
poses such as hadron therapy stems from factors such as the ease of beam production and
the reduction in the facility scale required for their acceleration and delivery. Convention-
ally, large magnetic steering systems, called Gantries, have to be employed to enable to the
irradiation of a lying position from any direction. The creation of a specialised, relatively
small medical laser proton accelerator would reduce the size of the accelerator gantry set-up
to approximately 2 - 3 m and a few tons, compared to existing conventional systems which
are approximately 6 - 8 m in diameter, 10 - 12 m in length and weigh more than 100 tons
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Fig. 1.1 The difference of dose distribution by one port between carbon ion beams and
X-rays [7].
[6].
One of the greatest challenges of cancer radiation therapy using X-rays is the lack of
contrast between normal healthy cells and the cancerous cells of the tumour. The dose
delivered to a patient in a single X-ray treatment is limited and the full curative dose may be
delivered over a number of treatments in a process called fractionation. The advantageous
energy deposition properties of ions compared with X-rays can be exploited in radiation
therapy, as ions are able to deliver a lethal amount of dose into the target tumour whilst
limiting harm to the surrounding healthy tissue [5], owing to their inherent Bragg peak.
Laser-driven ion beams which are currently available have not yet sufficiently fulfilled
the requirements for many of the envisaged applications, particularly in terms of the energy
required for medical applications. For proton therapy for cancer treatment, beams in the
energy range of 60 - 250 MeV [8] and with a bandwidth of a few per cent of the central
energy are required, but the highest published laser-driven proton energy reported to date is
85 MeV [9]. The energies required for the treatment of deep seated tumours are in excess
of 250 MeV, which is well beyond the capabilities of current systems. Determining the
feasibility of using future high power lasers as drivers of proton acceleration for oncology
still requires investigation of the scaling of laser-accelerated proton energies and yields as a
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function of laser parameters such as intensity, energy and pulse duration [2].
One of the main differences between laser-driven ion beams and their conventionally
produced counterparts is their ultra-short pulse length, as the ions are emitted in bursts
of picosecond duration at the source. From here, the beam pulse will lengthen in time
corresponding to the spread of energies and distance over which the protons travel from the
source to the target, typically resulting in a pulse with duration in the range of nanoseconds.
A proton pulse depositing energy on this very short time frame coupled with the inherent
high flux of proton beams correlates into an ultra-high dose rate of > 109 Gys−1 [10].Their
therapeutic use may result in dose rates as many as 8 orders of magnitude higher than those
normally used with conventionally accelerated protons. The biological effects of ions at
these ultra-high dose rates are virtually unknown and cannot be put to any medical use until
they have been carefully assessed [11].
1.2 Thesis Aims
Currently, one of the most important challenges facing radiotherapy is tumour hypoxia. Tu-
mour hypoxia occurs in nearly all human solid tumours and ionising radiation depends heav-
ily on the presence of molecular oxygen to produce cytotoxic effects [12]. The treatment of
hypoxic tumours is challenging even with the most advanced X-ray based therapies, often
leading to the failure of such treatments. Ion beam therapy has gained momentum as an
effective modality for combating this challenge, employing protons and high LET charged
particles, with several investigations reporting success in inducing cell death in cancer cells
under hypoxia [13–16]. The prospect of employing laser accelerated ions as a cost effec-
tive alternative to protons and ions from conventional acceleration sources has also become
more realistic with significant advances in laser technologies. In recent years the capability
of high-energy lasers to generate suitable ion beams for cancer therapy has been demon-
strated [17–19].
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The dose rates achieved by employing laser driven ion sources may impact the oxy-
gen dependency of the radiation response, thus it is imperative to gain an understanding
and characterise the radiobiological effects at the ultra-high dose rates delivered by these
short ion pulses on human cells under hypoxic conditions if the technology is to develop
and advance towards clinical applications. The effectiveness of laser accelerated protons
and carbon ions in the induction of DNA double strand breaks in AG01522 normal human
fibroblast cells has already been shown (see Section 6.1.). Here we aim to demonstrate
for the first time laser accelerated proton induced double strand breaks in human cells un-
der physically induced hypoxia, chemically induced hypoxia and a free radical scavenging
environment, as well as in an oxic environment for comparison.
What we want to know is do laser accelerated protons deposited at ultra-high dose rates
produce different biological effects under oxic, physically hypoxic, chemically hypoxic and
free radical scavenged conditions, as compared to X-rays and conventionally accelerated
protons?
To fully understand the relationship between laser accelerated ion induced DNA dam-
age and oxygen dependency it is necessary to have a compact and reliable device capable of
maintaining hypoxia for the duration of the radiation exposure and the subsequent twenty
four hours over which the DNA double strand break kinetics are observed. Several devices
exist, discussed in more detail in Section 5.5, however a device compatible with the irradia-
tion procedures and set-up required for laser accelerated ion beams did not exist. Therefore,
a portable and compact hypoxia chamber was developed, suitable for characterising the
biological effects of laser accelerated beams under a range of oxygen concentrations.
Experiments have been carried out employing three high-power laser systems: TARA-
NIS at Queen’s University Belfast, LULI2000 at Ecole Polytechnique Paris and the Vulcan
Petawatt system at the Rutherford Appleton laboratory. Comparison X-ray experiments
were carried out in the Centre for Cancer Research and Cell Biology at Queen’s University
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Belfast, and data from conventional proton sources was provided by colleagues from ex-
perimental campaigns at Clatterbirdge Cancer Centre, Birkenhead England and the Istituto
Nazionale di Fisica Nucleare-Laboratori Nazionali del Sud (INFN-LNS), Catania Italy.
The main aim of the TARANIS experiment were to test the newly designed hypoxia
chamber with laser accelerated protons as a proof of principle to develop the cell handling
procedure and irradiation methods for the TAP Vulcan experiment. The effect of hypoxia on
DNA double strand break induction and repair was studied by irradiating AG01522 normal
human fibroblast cells inside the hypoxia chamber in hypoxic and oxic conditions for a
direct comparison.
The main aim of the LULI experiment was to use the unique capabilities of the laser
system carry out single shot investigations of the cellular response to proton irradiation,
through ultra-fast proton dose deposition in normal cell models. The DNA double strand
break formation and repair were monitored as a function of dose and time post irradiation
by means of immunofluorescence.
The main aim of the TAP Vulcan experiment was demonstrate for the first time laser
accelerated proton induced double strand breaks in AG01522 normal human fibroblast cells
under physically induced hypoxia, chemically induced hypoxia and a free radical scaveng-
ing environment, whilst overcoming limitations in terms of the dose available in a single
shot, and a need to relax the energy selection and pulse duration, highlighted by the previ-
ous Gemini (Section 6.1.1) and TARANIS (Section 6.2) campaigns. This experiment was
performed using the new compact hypoxia chamber designed specifically for this experi-
ment and tested previously employing he TARANIS laser.
Therefore the main aims of thesis can be summarised as follows:
• Demonstrate laser accelerated proton induced DNA DSB under physically induced
hypoxia, chemically induced hypoxia and free radical scavenging environments for
the first time
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• Develop and characterise a new compact hypoxia chamber for use with laser driven
ion sources
• Develop the cell handling procedure and irradiation methods associated with the use
of the new hypoxia chamber
• Repeat laser accelerated proton experiments in an oxic environment for comparison
• Discover if there are different biological effects produced under the four irradiation
environments as compared to X-ray and conventionally accelerated proton irradiations
where data exists
• Develop a robust immunofluorescence protocol
1.3 Thesis Overview
There are two main areas of investigation presented in this thesis: the generation of laser-
accelerated ion beams produced from thin foil interactions and their scaling dependence on
pulse duration; and the biological effects of such laser-driven ion beams at ultra-high dose
rates on normal human cells. The results presented are from four different experimental
campaigns carried out at three different high power laser facilities: the TARANIS system
at Queen’s University Belfast, the LULI2000 system at École Polytechnique Paris and the
Vulcan Petawatt system at the Rutherford Appleton Laboratory Oxford. Some results from
previous experiments, carried out employing the Gemini laser system at the Rutherford
Appleton Laboratory, are also presented as motivation for continued work in this field.
The structure of the thesis is as follows:
Chapter 2 provides an overview of the physical processes relevant to laser solid inter-
actions, as all the experiments involved the irradiation of thin or ultra-thin foils with high
intensity laser beams. The laser ion acceleration methods at work are also discussed.
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Chapter 3 explains the different laser systems, diagnostics and detectors employed
throughout the experimental campaigns. A brief description of the four high power laser
systems mentioned above is followed by a description of the working principles of the three
main diagnostics used: the Thomson Parabola Spectrometer (TPS), Image Plates (IP) and
Radiochromic Films (RCF). A brief explanation of improvements to the standard TPS and
an introduction to experimental results from ion acceleration investigation into energy scal-
ing are also discussed.
Chapter 4 gives an introduction to the relevant aspects of radiobiology. How radia-
tion effects human tissue including DNA damage and repair mechanisms, reactive oxygen
species, influence of the cell cycle, the role of hypoxia and the rationale for using laser-
driven ion beams for next generation Cancer therapy.
Chapter 5 explains the different biological tools and techniques employed through-
out the experimental campaigns, including the design, development and validation of a new
compact hypoxia chamber and the biological protocols used for cell culture and Immunoflu-
orescence.
Chapter 6 presents the results of three experimental campaigns carried out to investi-
gate the biological effects of laser-driven ions at ultra-high dose rates in oxic and hypoxic
conditions employing Vulcan, TARANIS and LULI2000. Previous results from the first ra-
diobiology experiment employing the Gemini laser are also presented. These experiments
focused on the induction and repair kinetics of DNA DSB damage in a variety of irradiation
conditions: oxia, physical hypoxia, chemical hypoxia and free radical scavenging.
Chapter 7 presents any conclusions derived from the experimental work and any con-
siderations relevant for future work in the fields discussed.
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1.4 Role of the Author
The experimental results presented in Chapter 3 regarding benchmarking the modified TPS
design and ion acceleration, and the radiobiological experimental results presented in Chap-
ter 6 were the result of collaborations with several research groups at the various different
European laser facilities. The experiments carried out employing Vulcan and Astra-Gemini
required essential planning and support from the staff of the Central Laser Facility, espe-
cially the Link Scientists, Target Fabrication, Engineering staff and staff members of the
Research Complex at Harwell. Members of the research team at Public Health England
Harwell also provided invaluable support. Experiments carried out at TARANIS and the
Centre for Cancer Research and Cell Biology (CCRCB) at Queen’s University Belfast ben-
efited from expertise from the Borghesi Plasma Physics Group in the Centre for Plasma
Physics, and the Prise Radiobiology Group, with special mention to Dr. Domenico Doria
and Dr. Pankaj Chaudhary. Essential support was also provided by Dr. Gagik Nersissyan
and Dr. Dan Marlow, and the Mechanical Workshop staff who manufactured the new hy-
poxia chambers. At École Polytechnique, the staff of LULI2000 and Laboratoire d’Optique
et Biosciences (LOB) were extremely accommodating and helpful during the experimental
run, especially Dr. Lorenzo Romagnani and Marianne Grognot.
The author has actively participated in the three main experimental campaigns presented
in Chapter 6 of this thesis: the TARANIS, LULI and Vulcan radiobiology experiments, as
well as the previous work carried out on Astra-Gemini and the comparison X-ray experi-
ments carried out in the CCRCB. The author did not actively participate in the experiments
which culminated in the results shown in Chapters 3, but instead carried out data analysis
and simulations pre and post experiments. A more detailed account is given below.
The two separate investigations described in Section 3.3.1 of Chapter 3 were carried
employing the Petawatt arm of the Vulcan laser at the Rutherford Appleton Laboratory. The
author did not actively participate in either of these investigations, but instead prepared and
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ran the PTRACE simulations used to design the modified Thomson Parabola Spectrometer
(PTRACE written by Dr. Angelo Schiavi [20]). The first experiment verified the use of
longer electric plates, the second the altered shape of the electrodes (described in more
detail in Section 3.3.1 of Chapter 3). The author also carried out analysis of the image
plates used in the first experiment, more detail of which is given in Section 3.3.4 of Chapter
3.
The results presented in Section 3.3.4 of Chapter 3 were obtained from the first inves-
tigation described in Section 3.3.1 of Chapter 3. The author modified an existing Matlab
GUI called TPSpec (written by Dr. Satya Kar and Dr. Domenico Doria), which was used
to analyse the digitised image plate scans. The GUI was then used by the author to extract
the ion spectra of the species detected to determine the scaling dependence of the peak ion
energy on pulse duration (more detail is given in Section 3.3.4 of Chapter 3). The author
also analysed images of the laser focal spot to determine the focal spot size and thus the
intensity of the laser pulse.
The author was involved in the design, development and validation of the new hypoxia
chamber described in Section 5.5 of Chapter 5. The initial design was created by the author
and Dr. Domenico Doria, and fine tuned by Dr. Doria. The author carried out the validation
of the hypoxia chamber by physically and biologically measuring the oxygen concentration
and induction of hypoxia inside the chamber in collaboration with Dr. Pankaj Chaudhary
and Carla Maiorino. The author also validated the dose received inside and outside the
chamber by means of a calibration produced by irradiating RCF films.
The author was actively involved in all the experiments presented in Chapter 6. The
author was involved in maintaining the AG01522 cell line and preparing samples for irra-
diation during the Astra-Gemini experiment, and heavily involved in the subsequent data
acquisition through the taking of images of the samples under the microscope and counting
the number of induced DNA DSBs (more details given in Chapter 6 Section 6.1.1). The au-
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thor was involved in the planning and conduction of the three main experiments employing
the TARANIS laser at Queen’s University Belfast, LULI2000 (pico) at École Polytechnique
Paris, and Vulcan Petawatt at RAL Oxford, presented in Sections 6.2, 6.3 and 6.4 respec-
tively of Chapter 6. The author provided minor assistance in the setting up of the laser
interaction chambers, with the main focus being the maintenance of the AG01522 cell line
and the preparation of samples for irradiations. The author carried out biological analysis of
the samples through several permutations of the immunofluorescence technique (described
in Section 5.3.1 of Chapter 5), and acquired the biological data through fluorescence mi-
croscopy and the Cell Counter application of ImageJ. The author was also responsible for
building and scanning RCF stacks at Vulcan, and used the Epson Perfection V750 Pro QUB
program (written by Dr. Doria) to convert the raw RCF scans to dose for all three experi-
ments, as well as for the calibration mentioned above.
Chapter 2
Physical Concepts of Laser Interactions
This chapter presents a brief overview of the physics of intense laser interactions with solid
targets. The different absorption mechanisms which transfer the laser energy into the target,
generation and transport of hot electrons, and ion acceleration during interactions with thin
foils are described.
2.1 Laser-Matter Interactions
When an intense laser pulse is focused onto a solid target, a sudden ionisation of the tar-
get material occurs producing a front surface plasma. Ionisation of all target materials is
guaranteed when the intensity of the laser is greater than the atomic intensity of the target
material, which is when the binding strength of the electron to the atom is matched to the





where Ea is the electric field strength at the Bohr radius. The target is ionised by different
processes, dependent upon the laser intensity and energy, with ionisation possible below
this threshold via multiphoton effects. The two main regimes of ionisation are multiphoton
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which is the ponderomotive potential of the laser field and Eion is the ionsiation potential of
the ion or atom with charge (Z−1). When the laser wavelength is shorter and the intensity
lower, γ > 1, and ionisation of the target occurs via multiphoton ionisation. In this regime
an electron is excited from its bound state into the free continuum by simultaneously ab-
sorbing several low frequency photons or a single high frequency photon. When the laser
wavelength is longer and has higher intensity, γ < 1, the laser field is strong enough to
distort the Coulomb field which holds the electrons in their orbit and the target is ionised
by tunnelling/barrier suppression ionisation [22, 23]. Tunnelling ionisation is the domi-
nant ionisation mechanism in intense laser interactions with solids, where the intensities are
≥ 1014 Wcm−2.
Fig. 2.1 (a) Schematic of multiphoton ionisation, (b) schematic of tunnelling ionisation. In
multiphoton ionisation the electron escapes into the free continuum, in tunnelling
ionisation the electron tunnels through the potential barrier.
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Once this ionisation of the target surface has occurred, a plasma with ionisation state Z∗
and electron density ne = Z∗ni will be formed on the front surface of the target, which starts







where kB is the Boltzmann constant, Te is the electron temperature and mi is the ion mass
[23]. As the plasma expands, it creates large density and temperature gradients. Assuming
that this expansion is isothermal (when the isothermal equation of state pe = neTe is satisfied
[24]), the electron density variation in the direction of the expansion can be approximated
by an exponential decay:






where n0 is the initial electron density in the target and x is the distance the plasma has
expanded [24]. This produces a well defined scale length of L = csτL during a laser pulse of
length τL [25, 26].
The propagation of laser radiation at a frequency of ωL through a cold collision-less











is the plasma frequency and k is the wave number. From the dispersion relation, as the
laser frequency approaches the plasma frequency the wave number approaches zero, thus
the laser can only propagate up to a critical density defined by the condition ωp =ωL. When
the wave number is equal to zero, the plasma appears opaque to the laser and it is reflected.
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where λLµ is the laser wavelength in microns. This critical density is used to classify the
plasma as either over-dense ne > nc or under-dense, ne < nc, which supports the propagation
of the laser through the plasma [26].
When chirped pulse amplification is used to produce an intense laser pulse, the main
pulse is usually preceded by a pedestral or pre-pulse which in general is intense enough to
ionise the target surface before the arrival of the main pulse. This means the main pulse
interacts predominantly with the preformed plasma rather than the target surface, and the
laser energy is transferred to the electrons in the pre-plasma. It is thus important to discuss
the motion of these electrons in high intensity laser fields.
2.2 Electron Motion and the Ponderomotive Force
2.2.1 Electron Motion
The equation of motion for an electron in the electric (E) and magnetic (B) fields of an
















=−e(v . E) (2.10)
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where v, me and p = γmv are the electron velocity, mass and momentum, and γ = (1+
p2/m2ec2)1/2 is the relativistic factor. In the non-relativistic case where v≪ c, the magnetic
term in the equation becomes negligible and the electron will oscillate in the direction of the




where EL and ωL are the electric field and frequency of the laser. This allows the definition








which can be used to distinguish if the interaction is in the relativistic or non-relativistic
regime [27]. If a0 < 1 the motion of the electron is non-relativistic, however if the laser field
strength is such that a0 ≥ 1 the relativistic effect becomes important as the electrons are now
oscillating at velocities comparable to the speed of light. This occurs when λ ∼ 1µm and
I ∼ 1018 Wcm−2.







2.2.2 The Ponderomotive Force
The ponderomotive force is a pressure exerted on the plasma by the electromagnetic field
of the laser, which arises because of the spatial variations in the intensity of the wave [28].
The electric and magnetic fields of the laser which act on the electrons contained in the
plasma are oscillatory, but can still exert a time-averaged force on the electrons if the wave
amplitude varies in space. If a0 ≪ 1, the motion of the electrons is purely an oscillation
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along E, but if the amplitude of the field is spatially dependent and the electron reaches a
region where the amplitude is smaller within a half cycle of the laser, the second half of the
cycle will have a smaller amplitude and the electron will not return to its original position.
The overall consequence is that the electrons will drift towards regions of the field which
are less intense [24, 28], i.e. away from the center of a focused laser beam [23].
For the non-relativistic case, the time-averaged ponderomotive force can be calculated
as follows using a perturbation method. If the electrons respond to a field of the form:
E = E0(r)cos(ωt) (2.14)







neglecting the v×B term in the first order, and v and r are:





where E has been evaluated at the initial position r0. The v1×B1 term has to be considered
when going to the second order. B1 is given by Maxwell’s equation:
∇×E0 =−∂B∂ t (2.18)
B1 =− 1ω∇×E0 |r=r0 sinωt (2.19)
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Expanding E(r) about r0 gives:
E(r) = E(r0)+(r1 ·∇)E |r=r0 +... (2.20)





















Taking the cycle average of this expression yields the following expression, as the cosωt






[(E0 ·∇)E0+E0× (∇×E0)] (2.22)
































where A is the vector potential. In an oscillating, quasimonochromatic electromagnetic field
described by a dimensionless vector potential a(r,t) whose envelope is sufficiently smooth
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where a = eA/mc2.
In a typical laser pulse, the intensity profile in non-uniform such that Fp ̸= 0 and the
electrons will be accelerated away from the laser axis creating a space charge field. Because
of this charge separation between the electrons and the ions, a mechanical equilibrium be-
tween the electrostatic and ponderomotive forces on the electron will be established, and
the whole material will experience a ponderomotive pressure, which will accelerate the ions
[26].
2.3 Absorption Mechanisms
Laser energy can be transferred to solid targets by a variety of different mechanisms which
depend on both the target parameters, such as shape, material and temperature, and laser pa-
rameters, such as wavelength, intensity and pulse duration. A selection of these mechanism
will be briefly described in the following Sections.
2.3.1 Inverse Bremsstrahlung
Inverse Bremsstrahlung is a collisional absorption mechanism which transfers energy from
the laser to the under-dense region of the plasma via electron-ion collisions. This absorption
mechanism dominates at laser intensities of 1012 - 1014 Wcm−2.
The electrons first gain energy by oscillating in the electric field of the laser, then lose
part of this energy via the collisions with the ions. As a result of these interactions, the
laser energy is damped and the plasma is heated. This requires the addition of a collisional
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≃ 2.91×10−6ZneT−3/2e ln Λ s−1 (2.29)
where Z is the ionisation state, ne is the electron density in cm−3, Te is the electron
temperature in eV and Λ is the plasma parameter.
Assuming the electrons have a Maxwellian distribution and approximately linear scal-
ing, the fraction of energy absorbed by this mechanism is given by [24, 29]:








where v∗ei is the collision frequency at critical density, as given by Equation 2.29, and Ln
is the scale length of the plasma.
Longer pulses (ns) produce longer scale lengths and thus lower electron temperatures
[23]. The temperature of the distribution can be estimated from classical heat transport
models and is given by:






where the intensity is expressed as IN = I(Wcm−2)/10N and τ is the pulse length in units
of 100 fs. Equation 2.31 shows that the temperature will increase with the intensity, there-
fore at intensities of approximately 1015 Wcm−2 the electron-ion collisions become ineffec-
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tive as the effective collision frequency becomes negligible [26]. The electron distribution
can no longer be assumed to be Maxwellian at these intensities and the precise electron-ion
frequency should be calculated from kinetic equations such as the Vlasov–Fokker–Planck
equation [29]. Other collision-less absorption mechanisms start to play their role at these
intensities.
2.3.2 Resonance Absorption
Laser light can excite resonant plasma oscillations at the critical density surface when
obliquely incident on the plasma density gradient. An incident light wave at angle θ will be
refracted by the density gradient and reflected at a density lower than the critcal density, with
the turning point occurring at ne(θ) = nccos2θ [24, 28]. If the laser is p-polarised, a com-
ponent of the electric vector oscillates electrons along the direction of the density gradient
(E is parallel to ∇n), generating fluctuations in the charge density which can be resonantly
enhanced by the plasma. The light wave will tunnel through to the critical surface of the
target, where it transfers some of its energy to an electrostatic oscillation, or plasma wave
at frequency ω = ωp, in a phenomenon termed resonance absorption [30]. This wave will
eventually be damped either by collisions at low intensities or by particle trapping and wave
breaking at high intensities [23]. If the laser is s-polarised, there is no component of E along
∇n so no plasma wave can be driven.
Even though the light wave itself reflects at a density lower then the critical density, the
fields tunnel to the critical density region to excite the resonance. The amount of energy
transferred to the plasma wave depends on the amplitude of the field that can tunnel from
the turning point to the critical surface and drive the plasma wave. The field driving the
resonance, Ed , is the component of the electric field of the light wave which oscillates the
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where EFS is the value of the electric field of the light wave in free space, τ is a parameter
which relates the scale length L and the angle of incidence θ , equal to (ωL/c)1/3sinθ , and
the Denisov function φ(τ) ≃ 2.3τ exp(−2τ3/3) describes the angular dependence of the
driving field as a function of τ [23]. Since the component of the electric field along the
density gradient varies as sinθ , the driving field will vanish as τ → 0. The driving field
becomes very small for large angles of incidence as the distance between the critical surface
and reflection surface is too large to tunnel. If θ is too small, the component of the electric
field along the gradient will also be small and the electron oscillations will not be driven
effectively [24, 28].
By integrating the energy lost by the light wave over the density profile, the absorption





Resonance absorption is therefore most efficient at the angle of incidence which max-






At higher laser intensities, the angular dependence of of the absorption may be altered by
the ponderomotive steepening of the density profile near the critical density. If the density
profile is steeper the distance the field is required to tunnel to reach the critical surface is
shortened and the resonance absorption is less sensitive to θ . Effects such as rippling of the
critical surface can enhance the amount of resonance absorption, by providing additional
regions of the plasma where E ·∇n ̸= 0, which can lead to resonance absorption for s-
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polarised light as well as p-polarised light [28].
2.3.3 Vacuum Heating - Brunel Absorption
In resonance absorption, a smooth density profile allows coupling between the incident
laser pulse and the plasma wave, but when the density gradient of the plasma is very steep,
resonance absorption ceases to work as these plasma waves cannot be initiated. This is
because the field amplitude Ep of the plasma wave at critical density is enhanced very little
and is roughly equal to the incident laser field EL. Therefore the electrons will oscillate along
the density gradient with an amplitude of xp ≃ εEL/meω2 = vosc/ω , thus the resonance
breaks down when xp exceeds the density scale length L [23]. The collisional absorption
process of vacuum heating comes into play at short scale lengths and moderate intensities
[31].
The electrons near the edge of the abrupt plasma-vacuum interface are now directly
exposed to the laser field. Thus at high enough intensities, thermal electrons will be dragged
out of the target surface into the vacuum by the electric field, and accelerated back into
the plasma when the field changes sign [32, 33]. As the plasma is highly over-dense, the
electric field will only penetrate to a skin depth of approximately c/ωp allowing the electron
to travel unhindered into the target where it will be absorbed by collisions. Instead of the
energy imparted to the electrons being transferred to the plasma wave, it is now directly
imparted to the target [34].
This mechanism was first modelled by Brunel using a capacitor approximation, in which
the magnetic field of the wave is ignored and the laser electric field EL has a component Ed
normal to the target surface which pulls the electrons back and forth across their equilibrium
positions [23], thus the laser must again be p-polarised as in resonance absorption. Initially
the target has a smooth mirror-like surface on which the laser light wave is incident at an
angle θ , producing a standing wave with a driving electric field. This driving field will pull
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a layer of electrons out of the target, creating an electric field between the target and the
position of this electron layer, which can be equated to the driving field. On returning to its
original position, this electron layer will acquire a velocity of vd ≃ 2voscsinθ , where vosc is
the electron quiver velocity. The reflectivity of the surface will not be perfect, therefore the
driving field will have amplitude:
Ed = [(1−ηa)1/2]ELsinθ (2.35)










where f = 1+(1−ηa)1/2 is the field amplification factor and a0 = vosc/c [23, 29].
For short scale lengths and high intensities, this type of absorption saturates at around 10
- 15%, but for moderate intensities, around those at which resonance absorption also occurs,
the absorption can be as high as 70% [23].
2.3.4 j X B Heating
J x B heating is the absorption mechanism that dominates in the relativistic regime at in-
tensities ≥ 1018 Wcm−2. At these intensities the contribution of the Lorentz force becomes
important and vosc will have a component along the k-vector of the radiation. As with the
Brunel mechanism, the electrons are directly accelerated by the laser field incident on a
step-like density profile, however the driving term is now the high frequency v×B compo-
nent of the Lorentz force rather than the electric field. This component of the Lorentz force
oscillates at twice the laser frequency [23, 28].
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the first term is the usual ponderomotive force which pushes the electron density profile in-
wards, the second term is the high-frequency oscillating component which leads to heating
of the electrons owing to the magnetic field of the laser and the transverse quivering of the
electrons in the laser electric field [26]. This j×B term works for both s- and p- polarisations
and is most efficient for normal incidence, as the laser electric field vector is perpendicular
to the plasma density gradient and the electrons gain most of their energy by being acceler-
ated across this gradient in the laser propagation direction [26]. This term does not work for
circular polaristation at normal incidence as the oscillating term vanishes. j×B heating be-
comes significant with sufficiently high intensities at oblique incidence, even in addition to
resonance absorption. Vacuum heating is however more important than j×B heating when
the driving field is greater than the magnitude of the j×B field (when sinθ > voscω0/cωpe)
[28].
2.3.5 Hot Electron Transport
In intense laser-plasma interactions large numbers of hot electrons are generated which are
crucial for laser-driven ion acceleration. This results in a large electron current trying to
propagate through the target and the plasma. There is however a limit, known as the Alfvén
limit, on the maximum current which can propagate through a plasma without generating a




≃ 17βγ kA (2.38)
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where β = v/c and (γ − 1)mc2 is the kinetic energy of the electron [23]. This limit is
exceeded in typical laser interactions, and the current of fast electrons flowing into the target
will rapidly heat and ionise the target creating a plasma [36]. For this fast electron current,
j f , to be able to propagate, local charge neutrality needs to exist in the form of a return
current, jr, which is both spatially coincident with the fast electron current density and
nearly cancels the fast electron current to a good approximation [37], thus:
j f + jr ≈ 0 (2.39)
where j f ≈−enhvh and jr ≈−encvc are the charge densities for the hot electrons and return
current respectively, and nh,c and vh,c are the respective electron densities and velocities of
the hot and cold electrons. In a hot plasma equation 2.39 is easily satisfied, since it acts like
a superconductor with almost zero resistivity. In a cold solid, or cold solid density plasma,
jr is very much less than j f in general owing to the finite resistivity of the material. This
rapidly induces an electric field which effectively inhibits the penetration of any further hot
electrons. Instead of the hot electrons freely streaming into the target, there is an electro-
static equilibrium in which the electrons are reflected back from the solid region of the target
out towards the surface by the potential barrier associated with the field [23].
The return current produced may not entirely balance the hot electron current, inducing
a magnetic field which will also inhibit the penetration of the hot electrons into the target.














µm ·4 MG (2.40)
where τL is the pulse duration, I17 is the intensity of the laser in units of 1017 Wcm−2, σe
is the conductivity of the target, ηa is the resistivity and λL is the wavelength of the laser in
microns [26].
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In thin foil interactions, a fraction of the most energetic hot electrons will escape from
the target and establish a quasi-electrostatic sheath field in the order of 1012 Vm−1 on the
rear surface of the target. This field is responsible for ion acceleration in the Target Normal
Sheath Acceleration mechanism which will be described in Section 2.4.1. This field is
strong enough to re-inject the majority of the escaped electrons back into the target, where
they travel back to the front surface where a similar sheath potential has formed. This field
will then reflect the returning electrons in a process known as electron reflux or electron
recirculation [38]. This occurs several times, resulting in an increase in the electron density
at the rear surface of the target, as the recirculated electrons combine with the electrons
reaching the target rear surface for the first time. The effect of this process increases with
decreasing target thickness, thus the efficiency of the ion acceleration is also increased.
2.4 Laser-Driven Ion Acceleration
An important factor which influences the beams produced by laser-foil interactions is the
particle acceleration mechanism at work.
2.4.1 Target Normal Sheath Acceleration
When a laser interacts with a thin foil, proton and ion beams will form from the layer of
hydrocarbon contaminants on the target. As hydrogen atoms have a low ionisation poten-
tial and high charge to mass ratio [39], they tend to ionise first and the protons will react
more quickly to the accelerating fields than the other ion species as they also have a high
charge to mass ratio [40]. The protons undergo the strongest acceleration, travelling ahead
of the other species, thus shielding them from the space charge field [41]. Heavier ions
will not be accelerated to as high energies as the protons, as the protons deplete most of
the energy provided by the accelerating mechanism. However, if the layer of hydrocarbon
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contaminants on the target is removed, the signal from the protons will be suppressed and
ions from the target constituents will be accelerated to higher energies. Although ions are
accelerated from both the rear and front surfaces of the target, the sharp density interface at
the rear causes the acceleration to be much stronger at this surface than at the front [42]. The
photon pressure of the laser accelerates the electrons into the target. The electrons ionise
the molecules on the back of the target, resulting in the most energetic ions emerging from
the rear surface. As the cloud of electrons is emitted from the back surface they produce
an electrostatic field which accelerates the protons and the ions [5]. The electrostatic field
produced is typically 1012 - 1013 Vm−1 [41, 43] and accelerates the ions perpendicular to
the rear surface of the target in the direction of the laser beam [42].
Typically the front surface of the target foil irradiated by the laser will become ionised
ahead of the peak of the irradiating pulse. During the interaction of a high energy laser
pulse (up to 1021 Wcm−2 in the laser focus, achieved by chirped pulse amplification [44],
although ∼ 1019 Wcm−2 is more routinely realised [43]) with a solid target, the prepulse is
sufficiently intense to transform the matter into the plasma state, thus the main pulse will
interact with a highly ionised hot plasma [40].
During the high-intensity laser-plasma interaction which takes place at the peak of the
pulse, the electrons will be accelerated forward into the target, owing to a number of mech-
anisms depending on the conditions of the target and the interaction. The typical energies
of the fast electrons accelerated at the front of the target are such that their mean free path is
much larger than the thickness of the targets used in this type of experiment, thus allowing
the electrons to freely propagate to the rear of the target [4]. The atoms are ionised and the
ions are rapidly accelerated normal to the initially unperturbed surface, as the electrostat-
ically confined electrons on the rear surface set up a charge separation field over a Debye
length λD inducing strong electric fields. The accelerated ions form a dense bunch of short
duration that is charge neutralised by co-moving electrons. The space-charge field produced
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As the rear of the target is initially a cold surface and the duration of the acceleration is
extremely short, there are excellent emission properties [4].
Fig. 2.2 Target Normal Sheath Acceleration reproduced from [45].
After this initial phase the ions stream into the vacuum, preceded by a Debye sheath of
hot electrons. This form of acceleration is normally referred to as Target Normal Sheath
Acceleration, or TNSA, and is shown in Figure 2.2.
The scaling of the maximum proton energy, Eproton, achievable with peak laser intensity,
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Fig. 2.3 Model profiles of the ion density ni (blue), electron density ne (green) and
electrostatic field Ex (red) at three different stages of RPA [27].
Unfortunately, TNSA beams are characterised by large divergence, low particle density and
almost 100% energy spread which poses significant limitations for many of the envisaged
applications [46, 47].
2.4.2 Radiation Pressure Acceleration
By contrast, ion production by the radiation pressure of intense lasers has been predicted to
be a more promising route for accelerating large numbers of ions quasi-monoenergetically
to the range of GeV’s per nucleon in a more efficient manner than TNSA [43].
In the Radiation Pressure Acceleration (RPA) regime a superior scaling in terms of laser-
ion conversion efficiency and ion energy is predicted, with similarly efficient acceleration
for both protons and ions of higher mass.
In RPA the ions are accelerated by directional momentum transfer from the laser to the
target via the ponderomotive force of the laser. In a plasma the electrons feel the effect of
the ponderomotive force, which is then transferred to the ions via a space-charge field. The
ponderomotive force acts as a snowplough on the front surface of the target and a dense ion
bunch is launched into the target. Experimental evidence for RPA is scarce (some results are
discussed in Section 2.5) as TNSA dominates for typical interaction conditions, but there
are two known regimes; hole-boring and light-sail.
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Hole-Boring
In the hole-boring mechanism the radiation pressure instantly pushes the electrons in the
skin depth and sets up a strong accelerating field for the ions to promptly follow the elec-
trons, allowing the laser to bore through the target [47]. The hole-boring velocity is depen-
dent on the laser intensity and the mass density of the target [47, 48]. A very high intensity
laser is required to achieve high energy ion beams as the ion velocity does not increase with
time after hole-boring has saturated. The maximum energy of the ions scales linearly with
the intensity of the laser.
If the laser and target parameters do not vary considerably over an acceleration cycle,
all ions will be accelerated up to a maximum energy and the hole-boring process, although
of non-stationary nature, may be described on the average by a quasi-stationary model. The
situation changes when a target is thin enough that all the ions are accelerated before the
end of the laser pulse and a complete hole-boring cannot occur [49].
Light-Sail
The term "light-sail" is appropriate to refer to a thin object of finite inertia, having low mass
and large surface so that it can receive a significant boost from radiation pressure. If a target
is thin enough, the hole-boring phase will cease well before the end of the laser pulse. If
the target thickness is less than the product of the hole-boring velocity and the laser pulse
duration, the ions will pile up at the rear surface of the target before the end of the laser
pulse. As the thickness of the compressed layer becomes comparable to or less than the
evanescence length of the ponderomotive force, the whole layer is cyclically accelerated
[47] with high efficiency for the rest of the duration of the laser pulse, as shown in Figure
2.4.
The LS regime can be simplistically modelled as totally reflecting, perfectly rigid plane
mirror boosted by a light wave which is perpendicular to its surface. As the laser follows the
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ion bunch, the acceleration stage will be repeated. This model predicts that the efficiency η
of the acceleration regime , defined as the ratio between the mechanical energy of the mirror





where β = V/c and V is the mirror velocity, hence RPA becomes more and more effi-
cient (η -> 1) as β -> 1 [50]. The assumption of the LS model that the target is a perfect
mirror implies that all the ions will be accelerated to the same velocity producing a perfectly
monoenergetic spectrum. This is not the case as in reality only a thin layer of the rear side of
the foil is accelerated by RPA. The electrostatic pressure pushing the ions in the accelerated
layer is modelled such that the equation of motion for the thin layer is the same as if the en-
tire foil were accelerated, thus maintaining a mechanical quasi-equilibrium of the electrons.
This simplistic view therefore can predict the energy of the accelerated ions, but will over
estimate the fraction of the laser pulse energy transferred to the quasi-monoenergetic ions
(the conversion efficiency).
As the ions become relativistic, the energy momentum transfer is very efficient. The
scaling of the ion bunch energy, Ebunch, with dimensionless laser amplitude, a0, pulse dura-







where α = 2 for the non-relativistic case, and α = 1 for the ultra-relativistic case. A full
description of the parameters a0, τp and χ will be given in Section 3.3.4. Another consid-
eration for the ultrarelativistic case, is the impact on the surface’s reflective quality. As the
threshold for critical density increases it causes the laser to propagate further into the target
with increasing momentum, thus decreasing the reflectivity non-linearly [51]. The laser’s
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Fig. 2.4 Light-Sail Acceleration.
amplitude will also have a limit above which there will be the inception of relativistic trans-
parency. If this limit is breached the energy attainable via RPA will be limited, with the
onset of relativistically transparent effects.
Higher energies are expected from this light-sail regime as the ions are no longer screened
by the background plasma. The light-sail regime is particularly promising for producing
higher energy beams suitable for oncology, as they possess narrow energy spectra, reduced
divergence, similarly efficient acceleration for both protons and higher mass ions, and there
is a favourable dependence on fluence in the scaling of the ion energy. Although they are
currently barely competitive in terms of average flux, the density of such laser accelerated
ion bunches can reach almost solid density, exceeding conventional sources by many orders
of magnitude [43].
2.5 Research
Research in the area of laser-driven ion sources has grown at a phenomenal rate, with most
of the present research being motivated by the exceptional spatial and temporal qualities
of the beams, the high energy and high particle numbers achievable and the application of
these properties to Plasma Physics, Medicine, Technology and many other interdisciplinary
areas. Research groups worldwide are striving to optimize the control of the acceleration
mechanism and the beam properties [52].
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There are a wide range of proposed potential applications including tumour therapy,
ultra-fast radiography, isotope production and fast ignition inertial confinement fusion, which
rely on a monoenergetic high-energy, large particle number ion beam with a small angular
divergence. Along with TNSA, RPA using circularly polarised lasers has been regarded as
the most promising and efficient route to achieving these desirable ion beams. The majority
of studies have been focused on proton and light ion beams, while using RPA to produce
heavy ion beams has been largely unexplored [44, 53–55]. Heavy ion beams have a much
broader appeal for medical, material, nuclear fission/fusion, quantum electrodynamics and
high energy density plasma applications.
Proton energies up to 85 MeV [9] and heavier ions with up to 7 MeV per nucleon have
been have been measured [39]. These proton beams have a number of unique properties
such as high brightness and ultra-low emittance, and a possible application of these laser-
based ion beams is the production of medical isotopes for positron emission tomography
(PET). To produce these intense radioisotope sources a large number of protons at ∼ 10
MeV is required. Normally > 109 Bq of C11 or F18 are commonly used per patient dose
[2]. Up to 107 Bq of C11 and 105 Bq of F18 produced by laser accelerated protons were
measured by Ledingham et al. [56]. Further investigation is required to determine if this
is a feasible option of high-power lasers as drivers of proton acceleration for PET isotope
production.
Several experimental investigations have been carried out to investigate the maximum
achievable proton energy as a function of laser parameters. Fuchs et al. investigated laser-
driven proton production and scaling employing aluminium targets, laser pulse durations of
0.15 - 10 ps and laser intensities from 1018 to 6 x 1019 Wcm−2 [57]. They measured the
proton beam maximum energy and energy conversion efficiency as a function of varying
laser and target parameters. The scaling laws achieved were favourably compared with
predictions from a simple fluid based model of proton acceleration and supported by 2D
34 Physical Concepts of Laser Interactions
PIC simulations, with the fluid model emerging as a helpful predictive tool for high-energy
and high-quality proton beams [57]. This model, Mora’s plasma-explosion model, was used
to predict that a proton energy of 200 MeV could be achieved with a ps laser pulse at an
intensity of about 5 x 1020 Wcm−2.
Robson et al. extended the experimental energy and intensity range over which proton
scaling is parametrically investigated up to 400 J and 6 x 10 20 Wcm−2 [2]. They found
their results for the higher energy and intensity regimes and pulse durations of up to 10 ps
were not consistent with previous predictions, with the increase in maximum proton energy
being much slower than previously thought. They compared their results to the same model
as Fuchs, and introduced a revised form of the model, which involved two phases of electron
temperature, and mimicked three-dimensional effects, and found their experimental results
were in much better agreement with this revised model. At the lower end of the intensity
range investigated by Robson, the measurements were in good agreement with the results
reported by Fuchs, with a maximum proton energy of 20 MeV for a laser intensity of around
6 x 10 19 to 8 x 1019 Wcm−2, however Robson found the scaling relations for proton energy
and conversion efficiency reported by Fuchs to not be valid at the higher intensity regime
[2].
The two main acceleration mechanisms identified as the promising routes to achieving
high energy, high particle number ion beams are TNSA and RPA. Most experimental re-
search to date has been focused on the TNSA mechanism, producing ion beams typically
characterised by a broad energy spectrum, a modest conversion efficiency at high energies,
a large divergence and scaling of maximum proton energy E proportional to the peak laser
intensity I1/20 . The RPA mechanism has since attracted a substantial amount of theoretical
and experimental attention owing to the superior scaling of the peak ion energy and conver-
sion efficiency predicted for this regime. The most promising sub regime of RPA is the LS
regime as the beams produced by the scheme have natively narrow energy spectrum, low
2.5 Research 35
divergence and a favourable dependence on fluence. This scheme also results in similarly
efficient acceleration of both protons and higher mass ions. It is generally accepted that an
effective implementation of the RPA scheme at relativistic irradiances is facilitated by the
implementation of circularly polarised laser pulses, as this provides a constant poderomo-
tive drive [58]. Conversely for linearly polarised lasers, the oscillating j×B term causes
the re-circulation of the hot electrons, creating the large sheath field on the rear side of the
target which accelerates the ions via TNSA, as the rapid decompression of the foil breaks
the equilibrium conditions required for LS acceleration [58], thus experimental evidence of
the of the LS regime is scarce as TNSA is the dominant mechanism of ion acceleration in
typical interaction conditions.
Schreiber et al. [59] presented a general expression for the maximum ion energy ob-
served in experiments with thin foils irradiated by high intensity laser pulses. Their ana-
lytical model was based on a radially confined surface charge set up by laser accelerated
electrons on the rear side of the target. The only input parameters required for the model
are the target thickness and the laser pulse properties. The model explains, and predicted,
to good agreement the optimal laser pulse duration and maximum ion energies observed in
a variety of existing experiments as well as dedicated studies where either the laser pulse
duration or the charge-to-mass ratio of the ions was varied. They found that the highest
intensity was not necessarily suitable for reaching maximum energies.
Esikepov et al. [60] identified a RPA dominated laser-piston regime at extremely high
intensities of > 1023 Wcm−2. This regime produces a high density ultra-short relativistic
ion beam from a thin foil by an ultra-intense EM wave, with the ion beam generation in
this scheme being highly efficient and the ion energy per nucleon being proportional to the
laser pulse energy. The results obtained conformed to the results of 3D PIC simulations
and promote the advantage of using exawatt lasers. They distinguished two distinct stages
in the laser-piston regime (i) a relativistically strong laser pulse with a significantly wide
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waist to promote quasi-one-dimensional geometry irradiates a thin foil, quickly accelerat-
ing electrons via the transverse electric field pushing all the electrons forward creating a
charge separation field between the electrons and ions, which accelerates the ions to rel-
ativistic energies, and (ii) the accelerated foil is regarded as a relativistic plasma mirror
which co-propagates with the laser, perfectly reflecting the laser pulse, hence the plasma
mirror acquires energy from the laser pulse and is accelerated by the radiation pressure. The
radiation momentum is transferred to the ions through the charge separation field, providing
them with a greater forward kinetic energy than the electrons [60]. The main principle of
this method is that the ultra-strong radiation pressure produced is used to accelerate the ions
to relativistic energies within a few cycles of the laser before the rear sheath field rapidly
grows and decompresses the foil, allowing the ions and protons to catch the accelerated
electrons in the accelerated plasma slab.
Zhuo et al. [61] also presented a dual-peaked electrostatic field acceleration using lin-
early polarised pulses for the production of quasi-monoenergetic ion beams, which in reality
was qualitatively the same as the laser-piston regime, as they also employed a very high laser
intensity of 5.5 x 1022 Wcm−2, with the proton energy reaching relativistic levels within 2
cycles of the laser. There is also a clear interest in the identification of regimes where
the RPA mechanism can dominate the particle acceleration at intensities which are more
easily obtainable with the currently available linearly polarised laser systems. Qiao et al.
[58] identified a new RPA dominated regime where quasi-monoenergetic ion beams were
generated by linearly polarised laser pulses at the more moderate intensities of 1020 - 1021
Wcm−2. With an appropriate coupling condition between the laser pulse duration, intensity
and target foil thickness, the RPA mechanism can win the competition between the RPA and
TNSA mechanisms in the hybrid acceleration stage. Qiao analytically derived and verified
this coupling condition using 2D PIC simulations, showing 1.26 GeV quasi-monoenergetic
C6+ ion beams with an angular divergence of < 5◦ and an energy spread of ∼ 0.1 GeV ob-
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tained through irradiation of 80 nm ultra-thin foils with linearly polarised laser pulses at an
intensity of 1021 Wcm−2. The simulations also showed that a multi-species foil contributed
to the stabilisation of the LS RPA component in the hybrid acceleration of lighter ions. This
resulted in more pronounced spectral peaks, similar to those observed from ’pure’ RPA
using circularly polarised lasers.
Henig et al. [62] have also reported RPA effect associated spectral peaks. They pre-
formed experimental studies using ultra-thin diamond like carbon foils irradiated with 0.7 J
laser pulses of ultra-high contrast and peak intensities of 5 x 1019 Wcm−2. These features
were attributed to polarisation dependent modifications of the ion spectral profile at moder-
ate ion energies, as a reduction in the electron heating was observed when the polarisation
of the laser was switched from linear to circular, resulting in pronounced peaks in the C6+
spectrum at an optimal target thickness of 5.3 nm. 2D PIC simulations revealed the C6+
ions were dominantly accelerated in a phase-stable way by the laser radiation pressure for
the first time [62].
Kar et al. also presented experimental evidence of narrow-band features in the ion spec-
tra produced by thin foil irradiations with sub petawatt laser pulses. They presented carbon
ion peaks centred at up to 7 MeV per nucleon for the first time, with a flux of nearly an order
of magnitude higher than previously reported [62–64]. The scaling of the ion energy Eion
was proportional to (a20τp/χ)
α with α equal to 2 when the dimensionless fluence parameter
ε « 1 and α equal to 1 when ε » 1 in the ultra relativistic case (τp = ctp/λ , χ = ρ ′l/λ and
ρ ′ = ρ/mpnc ). The spectral features and their scaling with the target and laser parameters
points to the multispecies scenario of LS acceleration. The possibility of achieving spectral
peaks beyond 100 MeV per nucleon, a key requirement for hadron therapy, could become
a reality by tuning currently achievable laser and target parameters as predicted by 2D PIC
simulations [65].
Most current experiments rely on TNSA, which allows the production of very energetic
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ion populations, although the exploration of other mechanisms has resulted from the charac-
teristic drawbacks of TNSA beams such as the low conversion efficiency and the difficulty
of obtaining a mono chromatic spectrum. This mechanism does however continue to play a
fundamental role as a new generation of laser facilities come online. This will pave the way
for exploring the TNSA mechanism with a new set of parameters so far unobtainable, and
an extensive parametric investigation based on satisfactory theory will be required, together
with detailed comparisons with experimental evidence [66], the main focus of which will be
the maximum ion energy achievable. With the recent development of 100 TW Ti:sapphire,
ultra-short pulse laser systems with pulse lenths around 30 fs, the hope will be to bridge
the gap between the maximum achievable ion energies between table-top and single shot
laser systems. Systematic studies can be performed and scaling laws for TNSA deduced
with ultra-short pulses for the identification of feasible routes toward high proton energies
at reasonable repetition rates [67]. Zeil et al. [67] presented a systematic investigation of
an ultra-short pulse laser acceleration of protons that yielded a maximum proton energy of
17 MeV employing a table-top 100 TW Ti:sapphire laser. They used plain few µm thick
foil targets, observing a linear scaling of the maximum proton energy with laser power, at-
tributed to the short acceleration period close to the rear surface of the target [67]. Slight
deformations in the target rear surface were found to lead to a shift in the direction of the
energetic proton emission away from the target normal that could be used for better discrim-
ination of the low energy part of the proton spectrum [67].
In the TNSA scheme the most efficient acceleration is of the hydrocarbon contaminant
layer on the rear of the surface, which impedes the acceleration of the heavier target mate-
rial ions. In the idealistic RPA scheme, all species would be co-accelerated with the lighter
ions not impeding the heavier ions, thus efficiently accelerating the heavier ions to much
higher energies. However, in a more realistic multi-dimensional view of the RPA scheme,
the heavier ions have a very broad spectrum resultant from rapid Coulomb explosion, de-
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ficiency of co-moving electrons and transverse instabilities [68]. Wu et al. proposed and
demonstrated a novel RPA regime for the generation of monoenergetic, high-energy heavy
ion beams by irradiation of ultrathin foils with intense laser pulses. An appropriate match-
ing condition between the target thickness, laser intensity and the ionisation energy gap
produced by the successive ionisation of high-Z atoms passing the noble gas configuration,
was used to create a self-organised stable RPA regime of highly charged heavy ions close
to the laser central axis [68]. A large number of electrons are also produced during the
ionisation, which stabilises the beam by keeping the accelerating plasma non-transparent
and suppressing the transverse instabilities. They analytically established and verified the
regime using a 2D PIC simulation, which produced a 1 GeV peak energy highly charged
monoenergetic Al13+ beam with total charge above 2 nC and 5% energy spread employing
a 7 x 1020 Wcm−2 circularly polarised laser, and a 16.8 GeV peak energy Fe26+ monoener-
getic beam was obtained by increasing the laser intensity to 4 x 1022 Wcm−2 [68].
Chapter 3
Experimental Tools and Techniques
This chapter describes the laser systems and detectors implemented in the experimental
work presented in this thesis. Four laser systems are described; Vulcan Petawatt, LULI2000,
TARANIS and Astra-Gemini. All four systems were employed for radiobiological studies
of the effect of ultra-high dose rate protons on AG01522 human fibroblast cells under dif-
ferent irradiation conditions, and Vulcan Petawatt was also employed for laser-driven ion
acceleration investigations. Details of the three different detectors used (Thomson Parabola
spectrometer, image plates and radiochromic films) are given, as is a short description of
how a Thomson Parabola Spectrometer was modified to enhance its functionality.
3.1 Chirped Pulse Amplification
Femtosecond laser pulses are prone to inducing beam distortions, non-linear effects and
optical dmage to the optical components through which they propagate, owing to high peak
powers and associated electric fields even in modest pulses. These effects include self-
focusing and its temporal counterpart self phase modulation. In order to amplify short
pulses to efficiently extract stored energy from the laser amplifier, the amplifying medium
must be operated at fluences close to the saturation fluence of the material, which is not
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possible with ultra-short pulses without the induction of significant self focusing and self
phase modulation, resulting in significant optical damage. To overcome these non-linear
limits associated with high intensity, yet still efficiently extract energy from high energy
storage materials by short pulses, more complex amplification schemes must be employed
which reduce the non-linearity of the gain medium and control the temporal stretching of the
pulse during amplification. This can be achieved by using the Chirped Pulse Amplification
(CPA) technique, which by producing short pulses only after amplification increases the
extractable energy achievable from broadband materials to a level comparable to that from
long pulses [69–72]. Keeping the pulse length at least at 40 ps throughout the amplifier chain
allows the components time to cool through thermal conduction, thus avioding damage [23].
As laser pulse lengths become shorter, it becomes increasingly difficult to efficiently
extract energy from the laser amplifier without incurring detrimental non-linear effects. This






where h is Planck’s constant, v is the laser frequency and σ is the emission cross section [70,
73]. The saturation fluence for most solid laser materials is between 1 J/cm2 (Ti:Sapphire)
and 6 J/cm2 (Nd:glass). It is not possible to amplify ps pulses to this level because of the
index of refraction;
n = n0+n2I (3.2)
which is dependent on the intensity of the pulse I [70]. This intensity-dependent refrac-
tive index produces a non-linear phase retardation given by the B integral which represents
the amount of wave-front distortion owing to the intensity dependent index of refraction,
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which results in eventual catastrophic filamentation which causes damage to the amplifier.






Small scale self focusing represents the most severe problem in the amplifier system [74,



















with the exponential growth rate Gm over gain length l being exactly equal to B. For laser
fusion systems, the beam has to be ‘cleaned ’with spatial filters every time B reaches 3,
and for high-field experiments where the temporal and spatial quality of the beam are much
more important, B has to be kept below 0.3 [75]. The intensity in the amplifier must remain
below the critical level at which the non-linear effects become significant and distort the
temporal and spatial profile of the pulse [73].
Amplifier materials which have lower cross sections, such as Nd:glass, can store up to
10,000 times more energy than dyes or excimers. However, to extract this increased amount
of stored energy in a ps pulse requires a beam of intensity∼1012 Wcm−2, corresponding to a
B value of a few thousand which is not possible. Therefore in order to utilise these materials
with superior energy storage, the input energy needed for extraction must be increased whilst
keeping the input intensity at an acceptable level, which is achieved through the process of
CPA [69, 74, 75].
In CPA the pulse is primarily stretched by a factor of 1000 to 100,000 by introducing
a large well characterised dispersion, or time delay, of the different spectral components
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Fig. 3.1 Schematic diagram of a CPA laser [72].
of the ultra-short pulse to produce a long chirped optical pulse, without changing the input
pulse energy (input fluence) or the energy extraction capability. The stretching of the pulse
allows more energy to be extracted from the amplifier system than would be from a short
pulse. It does however lower the input intensity by the stretching ratio and hence keeps
B at a reasonable level, reducing the peak power in the amplifier below the threshold for
non-linear pulse distortion. The pulse is then amplified by 6 to 12 orders of magnitude
from the nJ to the mJ/kJ level and is finally recompressed by the same stretching ratio back
to a duration close to its initial value, via a dispersion that closely matches the stretching
dispersion but has the opposite sign [71, 72, 75, 76].
A significant portion of the energy in the pulse remains uncompressed, forming the
pedestral. This pedestral originates from the non-linear chirp, the non-Gaussian pulse shape
and non-linearities in the amplification process [76]. Optical recompression of the laser
pulse can also be prevented through amplitude and phase distortions resultant from the CPA
process [72].
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Since the advent of chirped pulse amplification in 1985 by Mourou, Strickland, Maine
and colleagues at the University of Rochester [69, 73], it is exploited by nearly all existing
high power femtosecond laser systems. To further increase the power of these laser systems
without destroying the laser components is possible through the further reduction of the
pulse length employing the OPCPA, optical parametric chirped pulse amplification, tech-
nique proposed by Ross et al [77]. This technique takes a conventional laser pump beam
of any wavelength and amplifies a large bandwidth of the chirped pulse and recompresses
it to short pulses 10 - 20 times shorter than those produced by CPA. This would allow cur-
rent PW class lasers to be upgraded to the 10 PW level without too much additional cost or
reconsruction [23].
3.1.1 Laser Contrast
As the intensities produced by high power CPA laser systems have increased greatly over
the past number of years to 1019 - 1022 Wcm−2, the importance of good laser contrast has
become increasingly evident. The laser pulse contrast ratio (LPCR) is defined as the ratio R






A reduction in the LPCR is caused by different mechanisms dependent on the timescale
of the intensity temporal profile. On the ns timescale (up to 20 ns), prepulses result form
insufficient contrast between the amplified laser pulse and neighbouring pulses produced
in the oscillator. Below a few ns, amplification of spontaneous emission (ASE - amplified
fluorescence produced by the pumped crystal during amplification of the laser pulse which
propagates along the same axis as the main pulse), results in a ns plateau shaped pedestral.
In the ps timescale (below a few 10’s of ps), deficient manipulations of the laser spectrum
resulting in imperfect pulse compression degrade the LPCR close to the peak intensity [78,
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79].
When considering the effect of a low LPCR on a laser solid interaction, there are two
target parameters of great importance; the ionisation threshold and the damage (ablation)
threshold. An intensity of ∼ 1013 Wcm−2 will ionise all known target materials to form a
plasma even in the shortest pulses. The presence of this pre-plasma near the target surface
before the arrival of the pulse peak intensity modifies the electron gradient density and the
nature of the mechanisms leading to the absorption of the laser energy in the target. The
damage threshold corresponds to the onset of a fluence dependent phase transition following
energy deposition in the solid target resulting in a morphology change. This change affects
the energy absorption process and may damage or even destroy the target [78–80].
At intensities in excess of 1021 Wcm−2, a peak intensity to prepulse intensity contrast of
greater than 1:1:10−9 (contrast of greater than 1010) is required [? ? ], to prevent the change
in the physical properties of the target before the arrival of the main pulse. This is very hard
to achieve directly from the laser amplifier itself, for example, the inherent contrast of Astra-
Gemini is 106 - 107, with typical sources being prepulses leaked by the Pockels cells, ASE
and spectral bandwidth limitations of the main pulse itself [80, 81]. Several techniques are
available to enhance the LPCR in CPA systems such as saturable absorbers, cross polarised
wave generation and plasma mirrors. Incorporating a plasma mirror into the experimental
set-up can increase the contrast by more than two orders of magnitude [82].
Plasma Mirror
One method of enhancing the contrast of the laser pulse is self-induced plasma shuttering,
more commonly known as a plasma mirror (PM). If a sufficiently intense laser pulse is
focused onto a dielectric material, rapid ionisation takes place releasing electrons which
gives rise to an overdense plasma with reflectivity close to unity. If the dielectric material is
a glass slab coated with a tailored anti-reflection coating, ionisation will only occur on the
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Fig. 3.2 A schematic of the operating principle of a plasma mirror. A laser pulse with a
preceding prepulse and pedestral is incident on a AR coated glass slab. The low intensity
prepulse and pedestral are transmitted until the laser intensity become sufficiently large at
the leading edge of the pulse to form a plasma. Once the critical density of the plasma is
reached, the laser pulse is reflected.
rising edge of the main pulse and the pulse peak will interact with the dense plasma. Given
the rapid change in reflectivity which occurs with the rapid ionisation, the PM can be used as
a laser-triggered ultrafast optical switch. The intensity of the incident laser beam is chosen
such that the intensity of any prepulse energy is below the ionisation/damage threshold of
the glass and experiences the cold reflectivity, while the main pulse easily ionises the target
and reflects off the plasma. The majority of the prepulse and pedestral energy are transmitted
through the plasma mirror [80, 81, 83, 84].
The reflectivity of a PM is maximised by operation at high intensities, as an earlier
"switch on" time allows more of the main pulse to be reflected, however the prepulse and
the pedestral may also be partially reflected if the switch-on is too early. Also the plasma
surface will have longer to expand, thus disturbing the initial flatness and causing the beam
to scatter and not be perfectly specularly reflected. To prevent the laser beam from resolving
any modulations in the plasma surface, the optimum operation condition of the PM with
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negligible distortion of the reflected beam is when,
cs∆t < λlaser (3.8)
where cs is the sound speed and ∆t is the time from ionisation to the peak of the main pulse.
If the intensity is too low, triggering may occur late or not at all [81, 83].
Use of double plasma mirror on the Astra Gemini laser system (described in Section
3.2.4) can increase the contrast between the pulse peak intensity and the ASE pedestral
intensity by a factor of ∼ 1000 [85]. However, the laser contrast is enhanced at the expense
of the energy delivered to the target. The reduction in energy is typically in the region of 15
- 30 % per PM interaction and consequently a reduction in the interaction intensity [82].
3.2 High Power CPA Laser Systems
The experiments described in this thesis were carried out employing three high power laser
systems: Vulcan Petawatt, LULI2000 and TARANIS. Previous experimental work which
contributed to this thesis was also carried out at the Astra-Gemini facility. These four sys-
tems will be described in the following Sections.
3.2.1 Vulcan
The Vulcan laser is a versatile high power laser system located at the Central Laser Facility,
Rutherford Appleton Laboratory, Oxford, UK. It is comprised of Nd:glass amplifier chains,
which can deliver up to 2.6 kJ of laser energy in long (ns range) pulses and up to 1 PW (1015
W) in a short (500 fs) pulse at a wavelength of 1053 nm [86].
Vulcan currently has eight beamlines; six of these beamlines operate only in long pulse
mode, the other two can operate in both long and short pulse modes. There are two different
target areas supported by Vulcan; Target Area Petawatt (TAP) and Target Area West (TAW).
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Fig. 3.3 Building blocks of the Vulcan Petawatt facility reproduced from [88].
The short- and long-pulse systems can be operated jointly and directed to the two different
target areas, enabling sophisticated interaction and probing experiments. The seed sources
for each target area are different; TAP is seeded by a commercial Ti:Sapphire laser and TAW
is seeded by a commercial Nd:glass laser, mode locked using a saturable absorber [87].
Vulcan is capable of delivering ultra-high focused intensities greater than 1021 Wcm−2
in its short pulse mode, achieved by amplifying a sub-picosecond pulse to hundreds of Joules
and then focusing it close to its diffraction limit. This amplification is achieved by CPA. The
low intensity pulse is stretched from a few femtoseconds to nanoseconds, amplified, then
recompressed and focussed onto the target, producing the high intensities [86].
Vulcan Petawatt
The CPA technique employs a pulse stretcher, amplifier and a compressor before delivery
to a target. The stretcher of Vulcan is based on a double Offner triplet arrangement, which
comprises two confocal equal positive lenses and one negative lens at the common focus,
which has half the focal length of the positive lenses eliminating aberrations. The beam
passes through one Offner then the other, being vertically displaced on each pass of the
stretcher using retro-reflectors [89].
The pre-amplification of the beam employs OPCPA (optical parametric chirped pulse
amplification), which generates∼ 10 mJ pulses at large bandwidth (1 mJ nm−1) for injection
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into the rod and disc amplifier chain. The amplifier chain is optimised for bandwidth using
a combination of Nd:silicate and Nd:phosphate amplifying media. The pre-amplifier uses
a 10 Hz, 2 J, 1053 nm YAG laser to generate a frequency doubled pump pulse of 4.5 ns
and 200-300 mJ. This pumps a three stage optical parametric amplifier that is seeded by the
stretched oscillator pulse [89].
The amplification stage comprises three ex-Nova 208 mm aperture disc amplifiers with
gain isolation provided by a 208 mm aperture Faraday rotator and a single polariser at the
stage input [89]. When this additional amplifier stage was added, one of the apertures was
modified in order to be able to operate with Vulcan’s existing pulse power system. Under
the narrow bandwidth 1053 nm operation conditions, the small signal gain was measured
as 2.23, falling to ∼ 2.0 under saturation conditions for 670 J total output, indicating a
saturation fluence of 4 Jcm−2 [89].
The use of a large 120 mm aperture adaptive optics module is essential for the Vulcan
facility, as it is required to improve the wave-front quality to produce an optimum on target
focal spot, and also to achieve the best possible re-compression of the stretched pulse.
The compressor (operational frequency 170 mJ cm−2) uses a pair of gold-coated holo-
graphic 1480 line mm−1 gratings, 940 mm in diameter, separated by 13 m with an opera-
tional angle of 48◦, inside a large vacuum chamber. The compressed pulse is focused down
to a 5 µm (FWHM) focal spot using an f/3 OAP, delivering 500 J in ∼ 500 fs and peak
intensity of 1021 Wcm−2. Measured 60 ps ahead of the main pulse, the pulse peak to ASE
contrast ratio was found to be 106 [88].
Target Area Petawatt (TAP) is configured for delivering the highest intensity of up to
1021 Wcm−2 using the F3 focusing optic. The length and energies of the pulses are config-
urable on request from sub-ps to tens of ps. A single standard long pulse beam of length 0.5
ns to 8 ns and energy 50 J to 300 J depending on the operational pulse length is available
in addition to the standard short pulse beamline. The beam can also be converted to the
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second harmonic and the temporal shape of the beam can also be modified. The standard
jitter between the two beams is 150 ps [90].
3.2.2 LULI2000
LULI (Laboratoire d’Utilisation des Lasers Intenses) is a large scale facility and research
laboratory founded in 1988 and supported by CNRS (Centre National de la Recherche Sci-
entifique), CEA (Commissariat à l’Énergie Atomique), Université Pierre et Marie Curie and
École Polytechnique where it is located (Palaiseau, Paris, France). The LULI2000 system
is unique to European academia in the field of high-energy density physics owing to the
coupling of short (ps) and long (ns) high energy laser beams and the availability of auxiliary
beams for pump-probe experiments [91].
Two high-power single pulse neodymium glass laser chains (NORTH and SOUTH) are
contained within the laser hall. In the nano2000 configuration, each beam can deliver up to
∼ 0.8 kJ at ω (wavelength 1053 nm) in 1.5 ns. A delay line allows the delay to be adjusted
by ± 10 ns between the two chains [92]. A 10 Hz laser allows fast diagnostic alignment,
but the repetition rate is limited to 1 shot every 90 minutes, equating to 4 to 6 full energy
shots per day.
A second configuration, pico2000, implements CPA on the SOUTH laser chain to com-
press the beam in time by a factor of 1000, allowing that chain to operate in the ps regime
[93]. However, the energy delivered is then limited to ∼ 100 J in 1 ps (100 TW) to avoid
any damage to the grating.
There are two additional moderately energetic beams, the blue and black chains, which
are fully synchronised and available for laser-based diagnostics such as Thomson scattering
and off- or on-axis radiography. The blue chain delivers 50 J ns pulses while the black chain
delivers a few J in 1 ps [92]. The NORTH, SOUTH and blue chains are also able to deliver
frequency-doubled pulses (2ω).
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Fig. 3.4 The MILKA interaction chamber in LULI2000 target area room 1 [94].
It is possible to have on target pulses with different temporal shapes as there are three
independent laser oscillators. One is for the NORTH and SOUTH chains when they are
operated in the ns regime, 1 is for the SOUTH and black chains when they are operated in
the ps regime, and the third is for the blue chain. The pulses may be shaped over a total
duration of ∼ 1 to ∼ 10 ns when operated in the ns regime.
There are two target areas at the LULI2000 facility, each dedicated to either the nano2000
configuration (room 2) or the pico2000 configuration (room 1).
Three laser beams are available in target area room 1; the NORTH beam, the SOUTH
beam and the blue beam. The NORTH beam offers 800 J in 1.5 ns at ω , the SOUTH beam
offers 100 J in 1 ps at ω in the pico2000 configuration and the blue beam offers 50 J in 1.5
ns at ω [94]. The spherical MILKA target chamber has an approximate diameter of 2 m,
with an internal vacuum of 10−2 mbar (10−4 Pa) achievable after 30 minutes of pumping.
When the SOUTH beam is being operated in the ps regime, the room is radio-protected and
radiologically controlled through the implementation of strategically placed dosimeters.
Four laser beams are available in target area room 2; the NORTH and SOUTH laser
beams, the blue beam and the black beam. The NORTH and SOUTH beams are both op-
erated at 800 J in 1.5 ns at ω in the nano2000 configuration, the blue beam offers the same
specifications as those it operates at in room 1, and the black beam offers a few J in 1 ps at
ω [94].
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3.2.3 TARANIS
The Terawatt Apparatus for Relativistic And Non-linear Interdisciplinary Science (TARA-
NIS) is located in the Centre for Plasma Physics at Queen’s University Belfast. TARANIS
is a hybrid Ti:Sapphire-Nd:glass system opperating in the CPA mode [95]. The front end
of the laser system comprises a Ti:Sapphire oscillator, followed by a folded all reflective
stretcher and a Ti:Sapphire regenerative amplifier (RA). The oscillator is a commercial Co-
herent Mira mode-locked system, which provides a train of 120 fs transform limited pulses
at 1053 nm, with a repetition frequency of 76 MHz [96]. The wavelength is chosen to match
the peak of the Nd:glass amplifiers gain curve, although the oscillator still delivers an aver-
age power of 400 mW even though the Ti:Sapphire crystal is not peaked at this wavelength.
The pulse is stretched by a factor of ∼ 104 within the double-pass stretcher equipped with
a 1740 lines/mm diffraction grating and an f = 1524 mm spherical mirror arranged in an
inverting telescope configuration, producing optically chirped pulses of ∼ 1.2 ns [96]. The
pulse is pre-amplified in the Ti:Sapphire RA, pumped by a commercial Coherent Evolution
Q-switched Nd:YLF 527 nm laser. The RA delivers ∼ 0.6 mJ pulses, at a maximum fre-
quency rate of 500 Hz in a ∼ 300 mW average power beam [96]. Pre-pulse activity and
spontaneous amplified emission are controlled and limited by a double set of Pockels cells
and optimisation of the Ti:Sapphire RA for amplification at 1053 nm.
Amplification of the laser pulse to multi-TW levels is achieved by a three stage flash-
lamp pumped Nd:glass rod chain that amplifies two separate pulses up to ∼ 30 J per pulse
at a repetition rate of one shot every ten minutes in the full power mode. The two pulses
from the glass rod chain can be recompressed separately in two double-pass grating com-
pressors, each with two parallel gold-coated diffraction gratings. A minimum pulse duration
of 560 fs (typically 700 fs on average at high energy) can be achieved with ∼ 60% energy
transmission through the compressors [95], and longer pulses of ∼ 1 ns can be obtained by
by-passing the compressors.
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Fig. 3.5 Optical layout of the TARANIS laser. Image key: FI – Faraday isolator; VSF –
vacuum spatial filter; TA – Teflon aperture; TP – Teflon pinhole; SA – serrated aperture; 1,
2, 3 - laser heads with Nd:Glass rods of 9 mm, 25 mm, and 50 mm diameter, respectively;
L1L2, L3L4, L5L6, L7L9, L8L10 – relay imaging telescopes; VC1, VC2 – vacuum
compressors [96].
A pulse picking technique using three Pockels cells with crossed polarisers is employed
to reduce pre-pulse activity. One Pockels cell is before the RA, the other two are between
the RA and the Nd:glass amplifying chain. The intensity contrast ratio is measured at low
energy on a ns timescale, and the pre-pulse activity is recorded by a fast photodiode. The
measured intensity contrast ratio is ∼ 107 [96].
For experiments requiring two beams, different combinations of ns and ps pulse dura-
tions can be selected. A short pulse beam and an uncompressed long pulse beam can be
delivered into TA1 (target area 1), while a combination of a short pulse and a long pulse or
two short pulses can be delivered to TA2 (target area 2). A 180 mJ pulse can be extracted
after the second stage of the amplifying chain and separately recompressed down to 400
fs duration in a compact double diffraction grating compressor, and can be employed as a
probe pulse for time resolved optical probing measurements in either target area [96].
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Fig. 3.6 Schematic layout of the Gemini laser. Reproduced from [98].
3.2.4 Astra-Gemini
The Astra Gemini laser system is also located at the Central Laser Facility. Astra is a high-
repetition rate, ultra-short pulse, high power laser, which uses titanium-doped sapphire (TiS)
as its active material and opperates at 800 nm [97]. Astra Gemini is an extension of Astra
which transforms it from a single beam 10 TW system into a two beam Petawatt class laser,
that can deliver thirty times as much energy in each of its two beams at a peak power of 0.5
PW. It is one of the most intense lasers in the world with 30 J on target, a repetition rate of
three shots per minute and an intensity of greater than 1021 Wcm−2 [97].
The source beam of Gemini is the output from the third amplifier of Astra. The Gemini
system consists of a pair of TiS amplifiers, each with its own pulse compressor and pair of
pump lasers. Each pump laser will produce a 35 J, 10 ns optical pulses at 527 nm, with each
pair providing up to 70 J of pump energy to each amplifier seeded by the Astra system [98].
The two beam design of Gemini allows the possibility of a combination of long and short
pulses, different focal lengths, variations in relative timing and mixed polarisations as both
beams are independently configurable [99].
Through temporal compression each beam delivers 15 J on target in a pulse of 30 fem-
toseconds, with a maximum focused intensity of ∼ 1022 Wcm−2 from each beam. Gemini
3.3 Diagnostics and Detectors 55
has an inherent intensity contrast of ∼ 107 20 ps before the pulse peak, as measured by a
third-order scanning autocorrelator [85]. The laser system has a repetition rate of one shot
every 20 seconds, which is incredibly high for a facility of this type. The beams enter the
target chamber from above, providing 360◦ access around the chamber, and the beam po-
larisation can be controlled by the direction they are steered. The beams are focused onto
a double plasma mirror system using an off-axis parabola (OAP), with a second identical
OAP used to re-collimate the expanding beam. This arangement enhances the pulse peak to
ASE pedastal intensity ratio to ∼ 1010, a factor of ∼ 1000 improvement [85].
3.3 Diagnostics and Detectors
The high power laser systems described in the Section 3.2 are capable of accelerating pro-
tons and other heavier ions up to tens of MeV per nucleon via the acceleration mechanisms
described in Chapter 2. Evidently these ion sources are multi species as the accelerated
protons and ions originate from both the bulk target material and the contaminant layer
which is present on the target surface. Protons, several charge states of carbon, oxygen
and the bulk target elements, are all accelerated simultaneously, resulting in an essential
demand for spectrometers which adequately discriminate between these different species.
Diagnosis and characterisation of these ion beams is essential for understanding the un-
derlying acceleration mechanisms at work, and for tailoring the experimental set-up to the
beam characteristics required for specific investigations. Many diagnostics exist including
Radiochromic film detectors [100, 101], image plate detectors [102–104] (discussed in Sec-
tions 3.3.3 and 3.3.2 respectively), nuclear activation techniques [105, 106], nuclear track
detectors [107, 108], Faraday cups [109] and Thomson Parabola Spectrometers [110–113]
(discussed in Section 3.3.1). However the most convenient to use in terms of implementa-
tion and data analysis is the Thomson Parabola Spectrometer which disperses the ion species
in energy and mass-to-charge (A/Z) ratio by means of static magnetic and electric fields.
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Fig. 3.7 Schematic of a Thomson Parabola Spectrometer [110]. The TPS described here
has the electric and magnetic fields separated by a distance D, however there are variations
which have overlapping electric and magnetic fields [116].
3.3.1 Thomson Parabola Spectrometer
A Thomson Parabola Spectrometer (TPS) is the most convenient diagnostic to use in terms
of ease of implementation and data analysis when studying laser-driven ion beams. A
schematic of a traditional TPS used in laser plasma experiments is shown in Figure 3.7.
A TPS consists of a pair of rectangular permanent magnets and a pair of rectangular elec-
trodes, which produce uniform static magnetic and electric fields, and disperse the ions
according their mass-to-charge ratio and energy [114], resulting in a unique parabolic trace
on the detector plane for each mass-to-charge ratio.
It is used to measure the energy spectra of different ion species in a given solid angle,
and more than one TPS can be employed to gain information from different positions within
the interaction chamber. From a single shot, complete information about the energy distri-
butions of all ionisation states of the ion can be obtained for ions with charge states q < 20
[115].
The pinhole of the TPS selects a pencil beam of ions, which is transmitted through the
magnetic and electric field regions which are parallel to each other but perpendicular to the
ion’s initial momentum. High energy ions are deflected less than low energy ions, whilst
neutral particles will pass through un-deflected.
For uniform electric and magnetic fields, without considering fringe effects, the ion
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displacements at the detector plane along the Y, SB, owing to the magnetic field, and X, SE ,

















where α = q/mvz and vz is the longitudinal speed of the ion (of mass m and charge q) at the
pinhole [110], LB1, LB2, LE1 and LE2 correspond to the distances shown in Figure 3.7, and E
and B represent the electric and magnetic field strengths respectively. These displacements
are derived from the equations of motion and the Lorentz force, where the change in vz can
be neglected without any loss in generality. Equations 3.9 and 3.10 can be used to define












As can be seen from Equations 3.9 and 3.10, the deflection produced has a linear depen-
dence on the magnetic field strength and the electric field strength, but a stronger dependence
on the length of either the magnets or the electric plates.
The dimensions of the various elements of the TPS, such as the field regions and the dis-
tances from the electric and magnetic fields to the detector, and the strengths of the electric
and magnetic fields are what governs the dispersion of the ion species. The spectrometers
need to be compact in order to fit inside the interaction chamber, but still provide sufficient
A/Z resolution for heavy ions beyond several MeV/nucleon as the parabolic traces will start
to overlap, making it difficult to discriminate the individual ion species towards the high
energy end of the spectrum. Overlapping of the ion tracks occurs when the deflection owing
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to the electric field is insufficient, even if the dispersion by the magnetic field is adequate.
Species separation can primarily be improved by increasing the distance between the end of
the field region and the detector plane (LE2 and LB2), increasing the strength of the electric
field (E) or increasing the longitudinal extent of the electric field region (LE1). However,
increasing LE2 results in a loss of resolution at the detector plane, increasing E may result
in damage to the apparatus or the low energy ions being deflected away from the detector,
and increasing LE1 results in the low energy ions being deflected into the electric plate itself.
This compromises the ability of the detector to resolve the entire ion spectrum, however if
the electric plates are shaped the low energy ions could be retained whilst still preventing
the overlapping of the traces at the high energy end of the spectrum.
Modification of a TPS for use with high energy, multi-species ion sources
The 3D particle tracing code PTRACE [20] was used to study a suitable field configura-
tion for effective charge state separation, whilst retaining the low energy ions. PTRACE
is written in C++ object orientated methodology and computes the trajectory of the parti-
cle through a customised electromagnetic field region using a differential equation solver
at its core. The numerical algorithm is a fourth order Runge-Kutta solver coupled with an
adaptive step-size monitoring routine [110]. This approach is fast and reliable at solving
the equation of motion, and it is possible to prescribe the degree of precision to which the
trajectory is comptued [20].
The 3D setup of PTRACE is shown in Figure 3.7. The selected pencil beam of ions input
to the TPS is defined as a very low divergence point source with a multi-energy spectrum.
The magnetic field was defined as being the first field encountered by the ions. To include
any fringe field effects produced by the magnets, the magnetic field region was defined
according to the field profile in a conventional magnet-yoke configuration, as measured by
Carroll et al [116]. This magnetic field profile along the ion propagation axis (Z-axis) was
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Fig. 3.8 Schematic of the electric plate setup in PTRACE for calculation of the E-field
[110].
fitted with a super-Gaussian like function:








where Bpeak is the peak magnetic field, zcentre is the z coordinate of the centre of the magnets,
and BFWHM is the full width at half maximum of the field profile, which is approximately
equal to the length of the magnets.
A simple numerical approach was chosen for the electric field calculation in order to
study the effect of different electric plate geometries. The electric field at any given point in
space P(x,y,z) was numerically calculated by the superposition of the electric fields owing
to all points on the electrodes, shown by Figure 3.8. In the case of rectangular electrode
geometry, the electric field
−→














where K = 1/4πε0, the surface charge density σ = 2ε0 and the limits ymax, ymin, zmax, zmin
and xnegative refer to those shown in Figure 3.8. In order to simplify the calculation, the
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integration over z was substituted with a summation over z. During the transit of the ion
of a given charge, mass and energy, the main module of PTRACE accesses the electric
and magnetic field objects in order to obtain the fields values at the ion’s position. The
trajectory of the ion is subsequently simulated by the differential equation solver, producing
a two dimensional image of the simulated ion trace at the detector plane (a distance of LE2
from the end of the electric plate).
As mentioned earlier, the species separation can be increased by three possible methods:
(1) increase LE2, (2) increase the strength of the electric field, and (3) increase LE1. In terms
of the capability of discriminating ion traces at the detector plane, the resolution of the






where SE1 and SE2 stand for the electric field displacements of two ion species of charge
q1 and q2, and masses m1 and m2, respectively, at a given magnetic displacement (when
q1/m1v1z = q2/m2v2z), a stands for the size of the pinhole at the entrance of the TPS, which
typically defines the width of the ion traces at the detector (in a standard configuration, the
pinhole to detector distance is significantly less than the distance between the ion source and
the pinhole). Since R = 1 corresponds to the threshold for discriminating two neighbouring










where Ai, Zi and Wi represent the atomic mass, ionisation state, and energy per nucleon of
a given charge species. Equation 3.14 indicates that the resolution increases linearly with
E and LE2, whereas the dependence on electric plate length, LE1, is quadratic. Increasing
LE2, by a significant amount, in order to improve the resolution, is normally not a viable
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option as it is difficult to place a large spectrometer inside a small interaction chamber,
whilst still keeping the TPS a reasonable distance from the target. However, moving the
detector significantly further away from the end of the electric plates also increases the
magnetic field dispersion commensurately, as it entails an increase in LB2, which is not
always desired given the finite dimensions of the detector. There will also be a decrease
in the particle flux at the detector plane, as there would be with any alteration that would
increase the dispersion of the ions, giving rise to a lower signal to noise ratio. The strength
of the electric field can be increased by two different methods; decreasing the separation of,
or, increasing the voltage to the electrodes. These methods are both limited by the onset of
arcing or discharging between the electrodes, causing the elctric field to fluctuate or drop
instantaneously. Typically an experimental chamber has vacuum pressure of 10−4 to 10−5
mbar allowing up to ∼ 2 x 106 V/m to be applied to the electrodes without any significant
discharge [64, 113]. Increasing the length of the electrode however is not limited by any
fundamental constraints.
Equation 3.9 can be used to calculate the maximum energy Wi at which a particular
charge state of ion species can be resolved from adjacent traces. Figure 3.9 shows Wi for
A/Z = 2.0 (e.g. C6+), plotted against ∆(A/Z) for different configurations of a TPS, either
doubling the electric field strength or doubling the length of the electrode. For example, if
the neighbouring ion tracks of C6+ (A/Z = 2.00) and O7+ (A/Z = 2.29), corresponding to
∆(A/Z) = 0.29, using 100 mm electric plates will provide track separation at significantly
higher ion energies compared to using 50 mm electric plates with the same electric field or
50 mm plates with an electric field of double the strength [110].
The performance of a TPS with different electric plate lengths and the effect on the
separation of the different charge states was simulated using PTRACE. These simulations
assumed a point source of ions entering the TPS, when in reality the pinhole at the entrance
of the TPS will determine a finite track size at the detector, thus the highest energies resolv-
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Fig. 3.9 Comparison of the maximum energy of A/Z = 2.0 resolvable for different values
of ∆(A/Z) achieved with 50 x 50 mm plates at 1 x 106 V/m, 50 x50 mm plates at 2 x 106
V/m, and 50 x 100 mm plates at 1 x 106 V/m, assuming LE2 = 150 mm [110].
able by the TPS will be generally lower in reality than those predicted by the simulations.
The length of the electric plate, LE1, was increased, while keeping Bpeak, LB1 and LB2 con-
stant. There was a significant improvement in the track separation at high energies (around
100 MeV protons and 200 MeV C6+) for 150 mm electric plates, as compared to a standard
TPS with 50 mm electric plates, shown in Figure 3.10.
A benchmark experiment for the longer electric plates was carried out at the Vulcan
Petawatt laser facility of RAL-STFC, UK. A TPS with 150 mm electric plates and a Fuji
BAS-TR image plate detector were employed. The laser was focused on target using a f/3
OAP, delivering ∼ 250 J of energy on target in a pulse duration of 0.75 ps. The 10 nm gold
foil target was irradiated with an intensity of 3 x 1020 Wcm−2. The TPS was placed 1.7 m
from the laser irradiated target with a 100 µm pinhole at the front. The applied magnetic
and electric fields in this case were ∼ 1.0 T and 1.8 x 106 Vm−1 respectively. As shown
in the experimental data in Figure 3.11, the TPS was able to clearly resolve proton traces,
several charge states of carbon and oxygen ions, and gold ions with adjacent charge states
ranging from ∼ 30 to ∼ 50 [110].
The trapezoidal electric plate design was also benchmarked in a recent experiment car-
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Fig. 3.10 Comparison between the TPS traces of several ion species (from left to right; up
to 100 MeV p+, up to 200 MeV C6+, C5+ and C4+ ions, and up to 1000 MeV Au40+ and
Au45+ ions) obtained using the different TPS configurations shown in the schematics. The
red arrows show the ion beam direction, with the beam axis 10 mm above the bottom edge
of the electric plate. For all simulated configurations LE1 + LE2 = 300 mm, the B = 1.0 T
magnets were 50 mm in length (LB1), the distance between the magnets and electric plates
was 5 mm (D), the electric field strength E = 1.8 x 106 V/m, and the electric plates were 18
mm apart (d = 9 mm). The insets show a zoomed in view of the high energy portion of the
ion traces. There is improved trace separation in (b) as comapred to (a), and even better
A/Z resolution and trace separation is obtained in (c). Some clipping of the low energy
ions is observed in (b) and more seriously in (c) as shown by the dotted red line.
Trapezoidally shaped electric plates, as shown in (d), can be used in such high resolution
spectrometers allowing the lower energy ions to pass over the top of the plate, whilst
keeping the same trace separation for the high energy ions as obtained in (c) [110].
ried out employing Vulcan Petawatt. The laser was focused onto the 25 µm aluminium
targets in a ∼ 6 µm full width at half maximum spot using a f/3 OAP. This delivered a
peak intensity in excess of 1020 Wcm−2. The TPS employed in this experiment had 300
mm long trapezoidal electric plates (LE1), B = 0.972 T 50 mm magnets (LB1), the detector
was placed 118 mm from the end of the electric plate (LE2) and the electric field E was ∼
2.0 x 106 Vm−1. The experiment was interested in characterising proton and C(4−6)+ ions,
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Fig. 3.11 (a) 3D schematic view of the TPS employed in the experiment, (b) data obtained
by the TPS showing traces of different energy and mass-to-charge ratio ions produced by
the interaction of the Vulcan laser with a 10 nm gold foil. The low energy ions are clipped
by the electric plate as shown by the dotted line, (c) a zoomed in view of the enhanced
species separation produced by the 150 mm rectangular electric plates, where the numbers
represent A/Z values for the ion species, such as 1.0 - p+, 2.0 - C6+ and O8+, 2.29 - O7+,
2.4 - C5+, 2.67 - O6+, 3 - C4+, (d) a zoomed in view of the fine charge state separation of
Au ions, which are clipped by the longer electric plate [110].



















where γ is the Lorentz factor and (x, y, z) = (∆, yclipe , Lclipe ) is the clipping position for a
given separation (∆) between the beam axis and the electrode (a more complete explanation
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Fig. 3.12 Raw experimental data from the image plate scans employing different electric
plate designs, as shown by the inset at the bottom right corner. The white line in (a)
represents the clipping of the lower energy ion traces, which are not clipped when using
the plate geometry shown in (b). (c) shows a zoomed in view of the data shown in (b), as
marked by the orange square [112].
is available in reference [112]). The experimental results are shown in Figure 3.12, which
shows that the longer electric plate was clearly able to resolve all the ion species with the
significant clipping of the ion traces combated with the use of the trapezoidal plate.
3.3.2 Image Plate Detectors
Image plates (IPs) are widely used in laser plasma experiments for the detection of charged
particles and X-rays, with the most commonly used types being BAS-MS and BAS-TR.
Image plate detectors were developed by Fuji Photo Film Co. Ltd [117] in the early 1980s.
They are passive detectors based on the principle of photoluminescence (PL), where an atom
is excited to a higher energy state then returns to a lower state emitting a photon in the pro-
cess. They are made of phosphors with phosphorescent properties and store energy for long
periods of time, before being stimulated by photons of suitable wavelengths and releasing
the stored energy as a de-excitation [104, 118]. They have many attractive properties such
66 Experimental Tools and Techniques
as high spatial resolution of up to 10 µm, a high dynamic range of 4-5 orders of magnitude,
insensitivity to electromagnetic noise, a linearity in response (the fluorescence emission is
proportional to the radiation dose in the entire range) and they are reusable as the signal can
be erased after every use by exposure to an intense visible light source for 10 - 15 minutes
[102].
An IP has three main components; a protective layer, a photo-stimulable phosphor layer
and a support. The plastic protective layer is normally 0 - 10 µm thick and is used to pre-
serve the efficency of the phosphor by reducing the intensity of the radiation, with different
thicknesses suitable for different applications, and IPs with no protective layer (such as
BAS-TR mentioned above) used for low intensity radiation. The phosphor layer is 50 - 180
µm thick and is comprised of photo-stimuable crystal grains of BaFX:Eu2+ (X = Cl, Br or I,
typically X = Br0.85I0.5) [119] of an average density 5.2 gcm−3 and 5 µm size embedded in
a urethane resin [104]. The support material of the IP is usually flexible polyester for ease
of use in experimental set-ups.
The half-life for spontaneous decay from the metastable state of the phosphor layer is
typically a few days, following a much faster decay phase in the first thirty minutes post
exposure [102, 103, 111]. The energy stored in the IP is retrieved by stimulating the excited
metastable state, up to several hours post exposure, using optical photons in the red part of
the visible spectrum. The energy released is referred to as photo-stimulated luminescence
(PSL), and is released as UV light.
PSL is formed by duplicate stimulations. When the IP is exposed to ionising radiation,
electrons are liberated from the Eu2+ ions are promoted into the conduction band of the
phosphor. These electrons become trapped in the metastable lattice defects, called F-centres,
producing a latent image in the phosphor with a lifetime of several days. These defects are
intentionally introduced into the phosphor layer during the manufacturing process. The
latent image is retrieved by scanning the IP with a 632.8 nm red read-out laser, which
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Fig. 3.13 The PSL process. Reproduced from [119].
excites the trapped ions into the conduction band, where they recombine with the Eu3+
ions, emitting blue light at 400 nm that is detected with a photomultiplier tube. Some types
of photo-stimulable layers with blue dye absorb the 632.8 nm red read-out laser to avoid
the reduction of spatial resolution caused by the diffusion of the laser. The intensity of the
emitted light is proportional to the incident energy of the particles that initially struck the
IP. The laser and photomultiplier tube are housed in a complete reader (Fujifilm FLA-5000)
which has a mechanism to scan the laser across the entire plate. The signal is digitised by
an analogue to digital converter (ADC) and an algorithm in a 16 bit discrete number, thus
the image is stored in a 16 bit format where each pixel represents a scanned position on the
IP surface. The stored information in the IP is completely erased by returning the Eu2+ ions
to the ground state through exposure to a strong white light, allowing the IP to be reused
[103, 118, 120, 121]. A schematic of the PSL process is shown in Figure 3.13.
The PSL value stored in each pixel of the readout image can be obtained by converting its
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bit value, or quantum level (QL), using the following formula provided by the manufacturer
















where R is the resolution, L is the latitude or dynamic range, S is the sensitivity and G
is the bit depth [104, 111].
Some of the electrons which are trapped in the metastable state spontaneously recombine
with the Eu3+ ions before they are read-out by the laser, thus the recorded image is faded
[103, 119]. The rate at which the image fades varies from very fast in the first tens of minutes
post irradiation, to a significantly slower rate over the next few days. The fading rate close
to the time of irradiation is dependent on the PSL signal strength at the time of exposure, the
duration of the exposure and the type of IP [111]. A fading curve was obtained by Alejo et
al. [111] for BAS-TR IPs, and the following empirical formula was inferred from the curve
to determine the PSL signal at a reference time point of 30 minutes after exposure when the







The IPs used in the experiments described in this thesis were BAS-TR (Fuji Photo Film
Co. Ltd.), which do not have the protective layer covering the phosphor active layer, thus
allowing the detection of very low energy particles, making them the most sensitive IP
existing on the market [102].
3.3.3 Radiochromic Films
GafChromic radiochromic films (RCF) have been used extensively for dosimetry of ionis-
ing radiation in medical physics and more recently for the characterisation of protons beams
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from laser foil interactions. These films are self developing, consisting of an active mono-
layer which polymerises upon exposure to ionising radiation to form a darker dye. The dose
versus the optical density response of RCF is quasilinear over several orders of magnitude
in dose, is independent of the dose rate (Li et al. exposed films to X-rays, γ-rays and a
3.8 MeV electron beam over an absorbed dose rate range of 0.8 to 5 x 108 Gys−1, with the
films exhibiting equivalent responses [122]), low dependence on the energy of the ionising
particles and near water equivalence [100, 123, 124]. The films offer a superior spatial res-
olution compared to any other digital dosimetric 2D detector array (more than 104 dots per
inch (dpi) or less than 2.54 µm [106]), with the ability to detect steep dose gradients attrac-
tive for intensity-modulated radiation therapy (IMRT) with both photons and protons. The
dose rate independent response makes RCF ideal for the dose determination in cell irradi-
ation experiments employing laser driven ions, however the positioning of the samples and
the RCF must be carefully considered [125]. Many types of RCF are available such as MD-
V3, HD-V2, EBT-2 and EBT-3, each suited to a different purpose [126]. The films used in
the cell irradiation experiments described in this thesis were EBT-3 normal and customised
films designed by Ashland, International Speciality Products, Wayne, NJ, USA.
Care must be taken to reduce uncertainties associated with film dosimerty including film
batch and scan orientation consistency, post exposure time, scanner warm-up characteristics
and lateral film position on the scanner [101, 124]. Accurate film dosimetry guidelines
have been published many times in literature, most notably by the American Association of
Physicists in Medicine [127].
EBT-3 Normal and Customised Films
Gafchromic EBT (External Beam Therapy) films were designed as a substitute for silver
halide radiography films in IMRT quality assurance systems [128]. Normal EBT-3 films
are yellow tinted and comprise a 28 µm active layer sandwiched between two 125 µm
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Fig. 3.14 The structure of EBT-3 dosimetry film. The film has 28 µm active layer
sandwiched between two 125 µm matte-polyester substrates. The active layer contains the
active component, a marker dye, stabilisers and other components which give the film its
near energy-independent response [129].
matte surface clear polyester substrates, as shown in Figure 3.14. The symmetrical design
prevents probable errors in measurement of optical density and also prohibits fringe artefact
formation [123, 128]. Customised EBT-3 films have one of the protective layers removed.
EBT-3 is particularly suited to for high energy photons, with a dynamic dose range of 0.1
to 20 Gy, but an optimum dose range of 0.2 to 10 Gy [129].
The active layer of the RCF is composed of polycrsytalline diacetylene suspended in a
synthetic or natural polymer, the full chemical name of which is pentacosa-10,12-dyinoic
acid (PCDA). The lithium salt of PCDA, LiPCDA, is used in EBT-3 films, which has more
hair like crystals than PDCA. The addition of the lithium salt dopant provides the film with
a greater low energy sensitivity [130]. When exposed to ionising radiation, the active layer
undergoes polymerisation via a free-radical mechanism forming polydiacetylene chains.
These chains are blue in colour and and provide the change in colour and optical density
of the active layer. The number of chains formed is related to the dose deposited in the
active layer, and thus the change in the optical density [130, 131]. The optical density is the








where I0 is the maximum light intensity without the film and I is the light intensity transmit-
ted through the exposed film. The absorption spectrum typically has two peaks in the visible
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region at 583 and 635 nm for EBT-3 films, so highest sensitivity and contrast during digiti-
zation is achieved using red light [131]. Transmission densitometers, spectrophotometers or
film scanners can be used to digitise the RCFs, although attention must be paid to the time
at which the films are scanned, as nearly complete dyeing occurs within milliseconds but
increased dyeing can occur for the next 24 hours [106]. The pixel value for each particular
colour channel is used for I in equation 3.20.
The films used in the experiments described in this thesis were scanned with an Epson
Perfection V750 Pro calibrated flat-bed transmission scanner. The scanner settings used
were RGB 48 bit with resolution 300 dots per inch (dpi). To achieve accurate signal to
dose conversion, the EBT-3 customised and normal films were calibrated for protons and
X-rays. The calibrations were incorporated into a dose conversion Macro for ImageJ written
by Domenico Doria for protons and carbon ions, and adapted by the author for X-rays. This
Macro directly converts the raw signal from the scanned RCF image into dose. It takes each
colour channel separately and converts it from 16 bit colour to dose, and recombines the
three channels to produce a dose converted image. The dose is measured by selecting the
appropriate region of the image relating to the ion energy of interest using ImageJ.
3.3.4 Ion Detection
In reality, numerous ion detection methods are used simultaneously with custom analy-
sis packages to provide the best view of ion species and their properties produced in high
power laser experiments. For example, images plates used in conjunction with TPSs were
leveraged as part of a recent experiment employing the petawatt arm of the Vulcan laser
system at the Rutherford Appleton laboratory, investigating the scaling of ion energy in a
hybrid TNSA-RPA regime. The laser, focused by a f/3 off axis parabolic mirror, delivered
147 - 172 J at intensities of 2.2 - 9.7x1019 Wcm−2 to a variety of target materials (Ag, Al,
Au, Cu, Formvar and composite targets) and thickness (10-3000 µm) in 1.0 - 5.2 ps pulses.
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Three TPSs with BAS-TR image plates, TP-3, TP0 and TP3 were placed at -5.66, -0.59
and 9.24 degrees respectively from the laser axis. The image plates were analysed using a
specially designed MATLAB GUI called TPspec.
TPspec works by reading in PSL converted, background subtracted images scanned from
the Image plates placed at the exit of the TPS. The zero point of the image is manually
selected, and the required parameters of the TP including the field positions and widths,
solid angle, and the position of the image plate relative to the start of the magnet are read
from a configuration file. The atomic mass M and the charge Z of the desired species to be
traced are entered and the code generates a trace line on the image, according to the values
of the electric and magnetic fields chosen. The equation set used to calculate the magnetic,


















where rL = mv0/qB is the Larmour radius, LB1, LB2, LE1 and LE2 correspond to the
distances shown in Figure 3.7, m is the mass (in kg) and q is the charge (in C) of the species
being traced, v0 is the initial velocity of the ion, and E and B are the electric and magnetic
field strengths respectively. Both the rotation of the image and the field strengths can be
modified to exactly match the generated trace line to the experimental data.
Different species are traced by changing the values of M and Z, thus enabling the iden-
tification of all the M/Z ratios present. The data is obtained by selecting a region enclosing
the traced species, subtracting a background region of the same size, and then the signal
and the energy spectrum are calculated. To select the region, two points are chosen; one at
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Fig. 3.15 MATLAB GUI TPspec with an example of an image plate showing traced proton,
carbon and oxygen tracks.
the high energy end and the other at the low energy end of the trace line. The code stores
all the values of the y co-ordinates between these two points, which corresponds to the de-
flection owing to the magnetic field, calculates the energy of the particle that produced that
deflection and uses these values to calculate the corresponding x co-ordinates, or electric
field deflection. An analogous method is used to obtain the background region. The signal
and thus the energy per nucleon of the desired species is calculated by summing the sig-
nal from the region surrounding the trace line and subtracting the summed signal from the
background region. The distribution can be viewed immediately on linear or logarithmic
axes and exported to Excel for more detailed analysis.
Options are available to calibrate the data according to the species traced and to correct
the signal level for fading. The calibration function determines the energy of the entire ion
species, as well as calculating the energy per nucleon, and the fading function calculates
the signal that would have been present on the image plate directly after the shot was taken
according to how many minutes after the shot time the image plate was scanned.
Figures 3.16, 3.17 and 3.18 shows example proton, carbon and gold ion spectra obtained
using the TPspec code for three different laser shots, each on 10 nm Au targets, irradiated
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Fig. 3.16 Proton spectra obtained from three shots on 10 nm Au targets of [energy on target
(J), pulse duration (ps)] of [171.54, 5.2] shown in black, [150.93, 2.3] shown in red and
[147.36, 1.0] shown in blue.
with laser pulses with intensities of 2.2x1019, 4.3x1019 and 9.7x1019 Wcm−2 and pulse
durations of 5.2, 2.3 and 1.0 picoseconds respectively.
Here narrow band features which could be attributed to RPA can be clearly seen in the
proton (Z/A = 1), carbon (Z/A = 0.5) and gold (Z/A = 0.228) spectra, with the spectral peaks
being well separated from the lower energy component. The protons and carbon ions which
have been accelerated have originated from the hydrocarbon contaminants present on the
surface of the gold target. The peaks in the ion spectra appear to be ordered with the proton
peak at a slightly higher energy than the carbon peak, ∼ 3 - 4 MeV/nucleon.
The highest energy peak for protons was calculated to be 20.7 ± 7.2 MeV/nucleon, for
C6+ it was 12.5 ± 5.3 MeV/nucleon, and for Au45+ it was 7.6 ± 2.2 MeV/nucleon. These
energies were all obtained in the same shot which is shown in blue in Figures 3.16, 3.17 and
3.18.
In order to assess the possible influence of radiation pressure effects on the spectral
profiles obtained, a previously developed simple theoretical model was used, which takes
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Fig. 3.17 C6+ spectra obtained from three shots on 10 nm Au targets of [energy on target
(J), pulse duration (ps)] of [171.54, 5.2] shown in black, [150.93, 2.3] shown in red and
[147.36, 1.0] shown in blue.
Fig. 3.18 Au45+ spectra obtained from three shots on 10 nm Au targets of [energy on target
(J), pulse duration (ps)] of [171.54, 5.2] shown in black, [150.93, 2.3] shown in red and
[147.36, 1.0] sown in blue.
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into account the hole-boring and light-sail regimes of the RPA mechanism [46]. For thin
targets (sub-micron) and high intensities, the time required for hole-boring to saturate is
much less than the laser pulse duration, which is approximately equal to the time scale
required for light-sail, thus light-sail will dominate over hole-boring and will have higher
efficiency. In such a limit it can be estimated that the peak energy of the ion will scale as
εα , with α = 2 for ε ≪ 1 and α = 1 for ε ≫ 1 in the ultra-relativistic case, where ε is the
dimensionless fluence parameter and is approximately equal to a20τp/χ [46].




τp = ctp/λ (3.24)
χ = ρ ′l/λ (3.25)
ρ ′ = ρ/mpnc (3.26)
where I0 is the peak laser intensity (in Wcm−2), λ is the laser wavelength (1.054 µm), tp is
the laser pulse duration (in ps), c is the speed of light (300 µm ps−1), l is the target thickness
(0.01 µm in this case), ρ is the target density (19.32 gcm−3 for Au), mp is the mass of a
proton (1.27x10−24 g) and nc is the critical electron density (1x1021 cm−3).
By assuming the switch-on time for the light-sail phase is the time at which the com-
pressed ion front reaches the target rear surface as a result of the hole-boring phase, we have
a simple rigid model where the degree of ionisation of the target ions and the number of
different ion species present in the compressed layer are irrelevant. Hence the contaminant
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Fig. 3.19 Peak ion energies plotted against pulse duration for the three shots summarised in
Table 3.1 for TP-3/TP0 in (a) and TP3 in (b).
layer on the target, which is typically a few nm thick and has a significantly lower density
than the target material, can be ignored without any loss of generality.
Shot tp (ps) Energy (J) Intensity (Wcm−2) Fluence (Jcm−1) a20τp/χ
1 5.2 171.54 2.1748x1019 1.26x109 235.38
2 2.3 150.93 4.3261x1019 1.11x109 207.1
3 1.0 147.36 9.7147x1019 1.08x109 202.2
Table 3.1 Summary of shot details.
The three shots which have been considered all have the same target thickness and ma-
terial (10nm Au), roughly the same energy delivered to the target, but different pulse dura-
tions. The details of these three shots are summarised in Table 3.1 above. The laser focal
spot size remained constant for all three of these shots at 1.36x10−7 cm2, and the fluence is
defined as the pulse energy per unit surface [49].
Figure 3.19 shows a plot of the peak ion energies against pulse duration, and as the ion
energies remain almost constant for the 1.0 and 5.2 ps pulses, this could be an indication of
the favourable dependence on fluence rather than intensity as described earlier. However, as
the 2.0 ps pulse does not produce a similar energy, this is not conclusive and all shots may
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have been subject to fluctuations.
For the non-relativistic case, the energy scaled as (a20τp/χ)
2 as expected, and the hole-
boring phase terminated well before the peak of the laser pulse with the non-linear reflec-
tivity remaining at unity for the duration of the laser pulse. Therefore the results of this
experiment suggested that the ion energy could be enhanced by increasing the fluence of the
laser and/or reducing the target areal density.
Chapter 4
Radiation Therapy
The clinical concept of radiation therapy is to deliver a high dose of radiation to tumours
to kill all cancerous cells, whilst minimising the dose to normal tissue to avoid acute and
late side effects. Radiation therapy is received by approximately 60% of cancer patients
in the USA, either alone or in combination with other therapies, and is usually delivered
to the tumour by electron linear accelerators [132]. The radiation reacts with the water
inside the cells to generate reactive oxygen species (ROS) which cause damage to the DNA.
Apoptosis, or cell death, will be induced in the cells that contain large amounts of damaged
DNA. The supply of oxygen affects the potency of ionising radiation, with more double
strand breaks occurring in cells irradiated in the presence of oxygen [132]. In the presence
of oxygen, the induced damage is also more likely to be permanent.
The advantages of radiation therapy over other treatments such as chemotherapy or
surgery include better cosmesis, the loco-regional treatment of cancer without direct re-
moval of organs or tissues, thus organs may be preserved, and the treatment prescribed is
less restricted by pre-existing medical conditions. However, it is almost impossible to avoid
some damage to normal tissues, though repair and recovery of said tissue is possible, multi-
ple daily treatments over several weeks may be required, especially for curative treatments
and there is also the psychological drawback of not actually "removing" the cancer.
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The dose of radiation that can be used on a patient is limited by the damage induced in
normal tissues. The adverse effects on normal tissues can be minimised by focusing mul-
tiple radiation beams from different angles onto the cancer and by the use of fractionation.
Typically the daily dose given to a patient is 2 Gy, which in total is appreciably greater than
those that have been shown to cause cancer, hence the overall DNA damage will be suffi-
cient to kill the cancer cells rather than just generate changes that can be repaired within the
tumour [133].
4.1 Interaction of Radiation with Matter
An understanding of the interactions of ionizing radiation with matter is essential when dis-
cussing radiation therapy. Ever since Wilhelm Conrad Röntgen discovered X-rays in 1895,
it has been known that radiation interacts in many different ways with matter. Radiation
therapy depends upon the absorption of radiation by biological tissues, and the biological
effects following the interaction represent the effort of the biological tissue to deal with
this absorbed energy. Five important generalisations which should be remembered when
discussing these effects are as follows [134]:
1. the interaction of radiation with cells is a matter of chance, it may or may not happen,
and damage may or may not be produced,
2. the initial deposition of energy is very rapid – approximately 10−17 s,
3. the energy is deposited randomly within the cell,
4. the damage produced in the cells by ionizing radiation is non-unique and cannot be
distinguished from damage produced by other traumas suffered by the cell,
5. the changes which occur biologically only occur after a period of time, the length of
which depends on the initial dose of radiation received.
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Fig. 4.1 A simplified model of the interaction of radiation with matter. Interaction A causes
excitation, B causes ionisation, and C causes multiple ionisations. Each ioisation frees an
electron from the atom to which it was bound. Reproduced from [134].
A simplified model of radiation-matter interactions is to consider the radiation as a
stream of fast moving particles, whether that be protons, photons or other charged or un-
charged particles, and the matter as an array of atomic nuclei each with their own electron
shell system. As the fast moving particles try to penetrate the array of atoms, they will in-
variably collide with the atoms, sometimes transferring the energy of excitation during the
collision, which is quickly dissipated as heat [135]. These types of collision are discussed
in more detail in Section 4.1.1. Occasionally ionisation of the atoms occurs, where the in-
teraction is so violent that one of the bound electrons in the outermost shell is knocked out
and becomes free. This electron may itself have enough energy to cause further ionisations,
and a cluster of ions may be formed in the medium. The amount of energy required for ion-
isation to occur is 34 eV (average energy required to produce an ion pair in tissue [136]), an
amount invariably possessed by both a quantum of X-ray photons and all charged particles
of interest to radiobiology.
With regard to the attenuation and range of the different particles in the target medium,
the mass and charge of the particle are important factors. As the bombarding particle will be
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moving through a highly charged region, an interaction is much more likely to to take place
if the particle itself is charged and will therefore come under the influence of the strong
electric fields associated with the nucleus and electrons of the target material. Since X-ray
photons have no charge and have zero rest mass, they are very difficult to attenuate, unlike
protons which have a larger mass and are charged, therefore are more easily attenuated.
Charged particles, such as protons, eventually become trapped in the high electric field
around the nucleus and have a finite range. X-ray photons on the other hand are stopped by
random processes and are attenuated exponentially, thus do not have a finite range [135].
4.1.1 Photon Radiation
The absorption of photon radiation is a statistical process that can be described by an expo-
nential function:
I = I0e−µρd (4.1)
where I0 is the initial intensity, I is the remaining intensity after penetration through a
layer of thickness d and density ρ , and µ is the mass absorption coefficient in cm2g−1. The
photons interact with the atoms of the penetrated material via four distinct effects:
1. elastic scattering
2. the photoelectric effect
3. the Compton effect
4. pair production
The photon interacts with the electron shell system of the atom in elastic scattering, the
photoelectric and Compton effects, and with the atomic nucleus in the pair production effect
[137].
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Elastic Scattering
When photons pass very close to atoms in the target material, they may cause the electrons in
the target atom to take up vibrational energy. The electron will vibrate at a specific frequency
which corresponds to the incoming photon as this is a resonant process. The electron quickly
re-radiates this energy, as the this is an unstable state, with the radiation being emitted in
all directions with the same frequency as the incoming photon. This process scatters and
attenuates the photon energy, but does not absorb it.
This interaction is dominant when the majority of the electrons behave as bound elec-
trons, which occurs when the binding energy of the electrons is high, i.e. when the scattering
material has a high atomic number, and when the bombarding photons have have relatively
low quantum energy [135].
The probability of elastic scattering is expressed through identifying the mass attenua-
tion coefficient particular to this process, ε/ρ , as is numerically expressed as a cross section
area. The process is more likely to occur if the cross section area is high, and increases with
increasing atomic number of the scattering material,
ε/ρ ∝ Z2 (4.2)






The photoelectric effect normally occurs when the photon reacts with the innermost elec-
trons of the atom and is thus totally absorbed. The liberated electrons are ejected from the
atomic system of the atom, creating vacancies in the shell system, followed by the emission
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of photons of lower energy. If the binding energy of the electron is Ex and the photon energy
is Eγ , the kinetic energy of the ejected atom is Eγ−Ex, therefore Eγ must be greater than Ex
for this interaction to take place. This criteria gives rise to absorption edges in the spectra.
Although the energy is most often released in the form of an emitted photon, it can
also be transferred to another electron, which is in turn ejected from the atom. This second
ejected electron is called an Auger electron. The kinetic energy of this electron corresponds
to the energy difference between the initial electronic transition into the vacancy and the
ionisation for the electron shell from which the Auger electron was ejected. The energy
of the Auger electrons range from a few to several hundred eV, so their range in tissue is
short, thus their energy is deposited in the immediate vicinity of the decay site, and the
photoelectric effect results in the total absorption of the initial photon. The resultant high
local energy density can equal or even exceed that along the track of an α-particle with
corresponding radiobiological damage [135].
The photoelectric effect is dominant for photons below 100 keV. In heavier atoms there
is a larger number of electrons with which the photon can interact, thus the cross section is







where α = e2/(4πε0h¯c) is the fine structure constant, ε0 is the dielectric function, e the
elementary charge, c the velocity of light and h¯ is Planck’s constant. Eγ is in units of MeV.
The electrons which have been liberated by the interaction move through the solid material,
losing energy by colliding with other atoms, raising the temperature of the material until
they are captured in the outer state of another atom.
The strong Z dependence of photoelectric absorption is the basis of diagnostic radiology
[138], where the degree of absorption at any point in the body is determined by the atomic
number and the density of the material at that point. The continuous X-ray spectra which
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Fig. 4.2 Schematic representation of the photoelectric effect, reproduced from [135].
are favoured for diagnostic imaging, contain wide ranges of photon energies, and the strong
energy dependence of photoelectric absorption ensures the absorption cross-section also
extends over a wide range, allowing detail in lightly and strongly absorbing anatomical
features to be imaged effectively.
The Compton Effect
Discovered by Arthur Holly Compton in 1927, this is a scattering effect of photons on
loosely bound electrons, where the incoming photon changes its original direction of mo-
tion, transferring some of its energy to the electron in the process. The energy of the loosely
bound electron is much smaller than that of the incoming photon, and can be considered
as quasi-free during this process. The interaction of the electron and the incoming photon
complies with the laws of conservation of momentum and energy.












Fig. 4.3 Illustration of the Compton effect, reproduced from [138].
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The photon is therefore scattered with a change of energy, which is a function of the
scattering angle. Equation 4.15 can be written in terms of wavelength as E = hc/λ .
λ ′−λ = h
mec
(1− cosθ) (4.16)
Here h/m0c is known as the Compton wavelength, and is equal to 2.426 x 10−12 m. Pho-
tons with wavelength much greater than the Compton wavelength (corresponding to Eγ ≪
511 keV) suffer a relatively small fractional change in photon energy, while photons with
a wavelength much shorter (corresponding to an energy Eγ ≫ 511 keV) have an increment
added which causes the scattered radiation to approach a constant wavelength, irrespective
of the primary wavelength [138].
Compton scattering is an incoherent process in which all the electrons act independently.
The cross section is given per electron, thus the cross section per atom is proportional to the
atomic number Z over a wide range of photon energies:
σC = ZσC (e) (4.17)
The wide range of energies produces a continuous photon spectrum which starts with a
sharp energy, called the Compton edge, and continues to lower energies [137].
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Fig. 4.4 Relative importance of photoelectric absorption, Compton scattering and pair
production reproduced from [138].
Pair Production
The Photoelectric effect and Compton scattering both depend upon the quantum behaviour
of the photon. The third process of pair production occurs when photon energy exceeds
2mec2 (1.022 MeV). When the photon is in close proximity to atomic nucleus, the electro-
magnetic field of the photon interacts with the Coulomb field of the nucleus, causing the
creation of an electron-positron pair. It is necessary for two particles to be emitted in order
to conserve charge, thus no process of this nature can occur below the threshold energy.
Using equation 4.7 and conservation of momentum, the total momentum, pT of the two





































This is the value of the total momentum in the limiting case, in which both particles are
propagated in the same direction from the point of production. From inspection we can see
that this combined maximum momentum is always less than the momentum of the initial




In order for the momentum to be conserved there must be an additional body present,
which can be supplied by a nucleus, and thus the interaction takes place via its Coulomb
field [138].
The remaining electrons in the partially ionised atom screen the nuclear charge, thus the
cross section is dependent on the state of ionisation of the atom. The general form of the
cross section is given by:
σPa ∝ 4αr2eZ
2 (4.22)




is the classical electron
radius. This process becomes more probable as the energy of the photon increases as the
difference between pγ and pT becomes progressively less. The momentum can be divided
between the electron and positron in any proportion, but in the most probable events the
momentum is divided equally, maximising pT and thus minimising pγ . Pair production is
important at high photon energies and becomes even more important at high atomic num-
bers.
The relative importance of the three processes discussed in illustrated in Figure 4.4.
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4.1.2 Swift Charged Particles
In general the charged particles interact with the atoms of the matter which they penetrate.
The interactions take place simultaneously between the charged particle and the electron
shell system and atomic nucleus of the target atom. Interactions involving the electron shell
system are termed energy loss, and interactions with the nucleus are termed nuclear energy
loss.
Heavy Charged Particles
The swift particle carries a transient field which is felt by both the target nuclei and the elec-
trons of the target atom [137]. As the ion passes the target atom, momentum is transferred
which gives more energy to the electrons, because of their much smaller mass, rather than
the heavier nucleus. In general, electronic energy loss is the main process by which energy
is lost.
The stopping power of the medium is the rate at which energy is lost per unit path length.
This process of energy loss is statistical as the amount of energy transferred in each collision
varies. A classical and quantum mechanical calculation of the stopping power in the energy














where z is the actual charge state of the ion, Z, A, and ρ are the atomic mass number, the
atomic number and the density of the stopping material, NA is Avogadro’s number, v = βc





ionisation energy for the material.
The energy dependence can be written as a function of the ion energy using an exponent








if all the constants are combined.
The dominant term in equation 4.23 is proportional to 1/v2, with a smaller contribution
coming from the logarithmic term. Equation 4.24 is an empirical approach which is reliable
if k ≈ 0.8 for practical calculations.








From equation 4.23 it can be seen that the stopping power will rise as the energy of the
particle decreases, thus the number of ions produced per unit path length (the ionisation
density) increases until the end of the particle range is reached.
The dependence of the stopping power on the ion velocity, 4.23 can be rewritten as:
dE
dx
∝ z2 f (v) (4.26)
which shows the dependence of the actual charge of the particle z, allowing the range
of the particle to be expressed as a function of the ion velocity f (v), which is useful for










Equation 4.23 also contains the dependence on the density of the stopping medium,
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as the averaged ionisation energy. These are all statistical processes for
which the average values are known [137].
Electrons and Positrons
When passing through matter, light particles such as electrons and positrons suffer colli-
sional energy loss −dE/dx|coll . However, they suffer an additional loss of energy owing
to their small mass. This energy is lost through the emission of electromagnetic radiation,
termed −dE/dx|rad . This effect arises from a charge, such as the electron charge, being
scattered in the electric field of another charge, mainly that of the atomic nucleus [137].
Energy lost in this way is known as bremsstrahlung radiation. In the case of the electron,
it is radiation arising from the acceleration of the electron as it’s path deviates from the
straight-line path by electrical attraction in the nucleus’s field. In the case of the positron, it
is the radiation produced form the deceleration of the positron through electrical repulsion.
Below 10 MeV, the contribution of the radiative energy loss is relatively small compared
to the other processes. Even at energies of 50 keV, these very light particles travel at ve-
locities approaching the velocity of light, therefore equation 4.23 must be modified, and the
energy loss and range of the particles have to be calculated on the basis of special relativity.
Collisional interactions, such as the Coulomb interaction, are only efficient for a very
short time when the particles are travelling at high velocities. Even though the quantity
−dE/dx|coll is much smaller, the particles can undergo many collisions, thus the range is
much larger than that calculated by simply integrating dE/dx. However, electrons collid-
ing with other electrons lose a much higher proportion of their energy, thus the range of
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electrons is much less well defined than for heavier particles. Furthermore, if the incoming
electron transfers almost all its energy to another electron, the penetrating electron may not
be the same as the original electron. The movement of these electrons causes the tempera-
ture of the material to increase.
As long as the positrons are moving quickly, they behave much as the electrons do.
However, at the end of their range they normally form a hydrogen like atom called positron-
ium (electron-positron bound state), which finally annihilates into γ-quanta [137]. The sum
of the energies corresponds to twice the mass of the electron, 2mec2 = 1.022 MeV.
4.2 Radiation Effects on Human Tissue
4.2.1 Radiation Damage
DNA (deoxyribonucleic acid) is the main target for the biological effects of radiation. Con-
sequently, it is damage to DNA that leads to all observed macroscopic biological effects.
The DNA molecule is the most important molecule with respect to the function and repro-
duction of a cell. DNA is a coiled double-helical polymer comprised of deoxyribose-sugar
molecules linked to one of the four phosphate base groups; adenine, guanine, cytosine and
thymine [137]. Two of the bases, thymine and cytosine, are single-ring groups called pyrim-
idines, the other two, adenine and guanine, are double ring groups called purines [139]. In
this double helix, the two bases meet and associate in the middle of the double helix to sta-
bilise the molecule. Only certain pairs of bases can associate in this fashion: adenine must
pair with thymine, and guanine must pair with cytosine. This means that by describing one
strand of the DNA molecule you have also defined the other strand, and the sequence of the
bases specifies the genetic code. The human body uses one strand of DNA to make a new
copy by matching a complementary set of new bases with the existing strand as the template
[140].
94 Radiation Therapy
Fig. 4.5 The different types of DNA damage [141] and the direct and indirect effects
caused by ionising radiation [142].
Ionising radiation is radiation which carries enough energy to force electrons out of
atoms. When ionising radiation enters the body, there is a probability that it may be trans-
mitted without transferring any of its energy, however, those particles that do interact can
cause the ionisation of atoms along the path. Some ionised atoms harmlessly recombine
with their electrons, but the ionisation also has the potential to break a chemical bond. The
freed electron can go on to ionise further atoms, potentially causing further chemical dam-
age. Those ionisations that do result in immediate chemical harm are referred to as the
direct effect. Ionising radiation primarily affects water, as water makes up a large fraction
of the cells volume. When water is ionised, it can form many reactive chemical species
[132], called free radicals, which last only for a short time (10−9 - 10−6 seconds). How-
ever, during this short time they are able to break chemical bonds in other nearby molecules.
This secondary ionisation of other molecules by reactive water is called the indirect effect,
and is hypothesised to be the dominant mechanism by which ionising radiation harms cells
[140] (see Figure 4.5). Directly ionising radiation accounts for 30-40% of DNA damage
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and indirectly ionising radiation accounts for 60-70% of damage [143].
Ionising radiation contains energies much greater than those in chemical bonds, thus the
latter can be broken by the radiation. Ionising radiation can cause roughly four basic injuries
to DNA; damage to the bases without breakage of the backbone, cross-links formed between
the DNA and itself or another molecule and single (SSB) and double (DSB) strand breaks
in DNA resulting in chromosome damage involving mainly deletions and rearrangements
[140]. The first two defects can be healed by DNA repair enzymes, so it is not clear if these
cause lasting genetic damage.
Base Damage - The sequence of bases within DNA is what stores and transmits the
genetic information, thus any alteration in the DNA base sequence through loss or damage
of the bases can be of major consequence to the cell. Any damage or loss of bases is
considered a mutation, irregardless of the severity of any consequences [134].
Crosslinking - Radiation can produce covalent crosslinks between two regions of the
same DNA strand, termed intrastrand crosslinks, or between two complementary DNA
strands or completely different DNA strands, termed interstrand crosslinks. The DNA
molecules can also be linked to a protein molecule with a DNA-protein crosslink. The
significance of these types of DNA lesions in cell killing is unclear, but they may be of
importance if they are not properly repaired by the cell [134].
Single-Strand Breaks - A SSB involves the cleavage of a bond along the backbone
of one strand of the double helix. Since the other strand is left intact, it is possible to
reconstruct the original sequence perfectly, using repair enzymes that match the unharmed
strand base-for-base. The repair time proceeds rapidly, with a half-life of several minutes,
so SSBs are relatively innocuous with little or no long-term consequences to the cell. If two
SSBs occur on opposite sides of the DNA strand, they are still treated as individual damages
and repaired separately as long as they are far enough apart (more than a few base pairs).
Double-Strand Breaks - DSBs occur when chemical bonds are cleaved along both
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backbones, so that the entire DNA molecule has been split in two [140]. This destroys the
pairing needed to complete the sequence of bases, and the broken DNA ends are vulnerable
to further physical and chemical assault resulting in the loss or damage of bases and the
formation of abnormal DNA structures [144]. All these events can result in the loss of
genetic information. Even if repair enzymes heal the break, the strands may be improperly
joined, or the joined ends may suffer lasting damage. Should this occur, additional layers
of the body’s DNA surveillance system exist to find such errors and either prevents the cell
from dividing or triggers cell death. Thus, this is the most detrimental form of DNA damage
caused by ionising radiation. The yield of DSBs is approximately 0.04 times that of SSBs,
as two breaks in the backbone on either side of the DNA molecule must occur within one
or two helical turns, and they are induced linearly with dose, indicating they are formed by
single tracks of ionising radiation [139].
The energy from ionising radiation is not deposited uniformly in the medium through
which it is traversing, but is located along the tracks of the charged particles set in motion.
There are three arbitrary groups into which these events can be divided depending on the
event size: spurs, blobs and short tracks. A spur contains up to 100 eV of energy and
involves on average three ion pairs [139]. 95% of the energy deposition events involving X-
and γ-rays are spurs, which have a diameter of approximately 4 nm, twice that of the DNA
double helix. Blobs contain about 12 ion pairs with an energy range of 100-500 eV, and have
a diameter of approximately 7nm. These are much less frequent for X- and γ-rays. Since
blobs and spurs have similar dimensions to the DNA double helix, multiple radical attacks
occur if they overlap the DNA helix, producing a wide variety of lesions including base
damage and DSBs. This phenomenon is called a locally multiply damaged site, coined by
John Ward [139]. This multiple damage could extend out to 20 base pairs from the damage
site because of the diffusion of the free radical species produced. In the case of densely
ionising radiation, a greater proportion of blobs is produced, therefore the damage produced
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is qualitatively different from that of sparsely ionising radiation and is much more difficult
for the cell to repair [139].
4.2.2 Reactive Oxygen Species
The free radicals derived from oxygen, known as reactive oxygen species (ROS), represent
the most important radical species generated in biological systems [145–147]. A free rad-
ical is defined as a molecule or molecular fragment which contains one or more unpaired
electron in its atomic or molecular orbit, rendering it chemically unstable [145]. The chem-
ical stability of an atom or molecule is owed to it having an even number of paired electrons
that are paired in spin. Free radicals have an uneven number of electrons that are not paired
in spin, a state which confers a high level of reactivity [134]. Under normal circumstances
ROS are produced specifically by the cell to serve essential biological functions or as a by-
product of metabolic processes such as mitochondrial electron transport [133]. As discussed
in Section 4.2.1, ionising radiation can damage the DNA directly by causing ioisation of the
atoms comprising the DNA, or indirectly by interaction with water molecules, generating
dangerous ROS as intermediaries. These reactive oxygen species may go on to react with
other critical sites such as the DNA or other biomolecules, causing damage to the cell. Since
approximately 80% of the cell is made up of water [134, 148], the probability of radiation
damage occurring through the indirect effect following the ionisation of water molecules is
much higher than for damage occurring through direct ionisations of the important biologi-
cal targets [134].
The generation of ROS through the interaction of ionising radition with water molecules,
is known as radiolysis. In the first "physical" stage, the radiation striking the water molecule
causes the molecule to lose an electron and become extremely reactive [147–149]. This
begins the second and third "physiochemical" and "non-homgeneous chemistry" stages in
which a three step chain reaction converts the water to oxygen. The products of these
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chain reactions are distributed in a highly non-homogeneous track structure, with the vari-
ous chemically reactive species diffusing and reacting with each other and the surrounding
environment until all intra-track reactions are complete [148]. Finally there is a "biological"
stage in which the cells respond to the damage resulting from the products formed in the
preceding stages.
The radiation will only interact with a single water molecule at a time, thus it cannot split
directly into the diatomic gasses H2 and O2, but instead radiolysis results in the sequential
generation of three dangerous reactive oxygen species, with an electron being lost at each
step [149]. In sequence these ROS are the hydroxyl radical (−OH), hydrogen peroxide
(H2O2), and the superoxide radical (O−2 ). This process is very fast, happening in ∼ 10−8 s,
with the products, apart from hydrogen peroxide which is relatively stable, disappearing in














The hydroxyl radical is an extremely reactive molecule which immediately strips elec-
trons from any molecules in its path, propagating a chain reaction by turning that molecule
into a free radical itself. However, it is also very short-lived and can only diffuse approxi-
mately 4nm before reacting [150]. Neither the hydrogen peroxide nor the superoxide radi-
cals are as reactive as the hydroxyl radical, but hydrogen peroxide is more dangerous to the
DNA as its slower reactivity allows the molecule time to travel into the nucleus of the cell
where it can react with the DNA molecule [149]. Oxidation by the removal of electrons by
free radicals can produce several types of DNA damage including oxidised bases and is one
of the main causes of mutation in cells. The presence of iron during the radiolysis process
can exacerbate the consequences of hydrogen peroxide production, as hydrogen peroxide
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can be reconverted back into the hydroxyl radical by receiving an electron from the iron
molecule in the Fenton reaction [145, 146, 148], (equation 4.30).
H2O2+Fe2+ −→ OH−+•OH+Fe3+ (4.30)
This hydroxyl radical could then go on to attack the DNA again. The superoxide radical also
acts as a catalyst for the generation of hydrogen peroxide and the hydroxyl radical in the
presence of iron as it helps regenerate the iron in the form required for the afore mentioned
Fenton reaction, (equation 4.31).
O−2 •+Fe3+ −→ O2+Fe2+ (4.31)
In biological systems, organic radicals are also formed by hydrogen abstraction initiated
by •OH radicals. These radicals then react rapidly with O2 to give peroxyl radicals (RO2•),
which are even stronger oxidising agents. These peroxyl radicals can abstract H• from other
molecules to form hydroperoxides (ROOH) [148].
ROS produced through water radiolysis are not the only source of ROS induced by ion-
ising radiation. It has been shown that ionising radiation can also increase the intracellular
level of ROS several hours after exposure, suggesting that the radiation stimulates ROS
production from biological sources [147]. The early biochemical modifications induced
by ionising radiation were thought to be responsible for the majority of the effects of ion-
ising radiation in mammalian cells, however oxidative changes my continue to arise for
days or months after the initial exposure, presumably because of the continuous generation
of ROS. These effects can manifest themselves in the cells and their progeny, and oxida-
tive stress may spread to non-targeted bystander cells through intercellular communication
mechanisms [148]. It is clear that secondarily generated ROS have a variety of roles within
the cell, including apoptotic signalling, genomic instability and bystander effects, which
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ultimately effect the cellular integrity and survival [147].
4.2.3 The Cell Cycle
Cell proliferation is a cyclic process involving the reproduction of one parent cell to form
two daughter cells, with each daughter cell going on to reproduce two granddaughter cells.
All the DNA contained within the parent cell must be replicated and distributed equally to
the daughter cells. Between these process of DNA synthesis and mitosis are gaps during
which RNA (ribonucleic acid) and protein is made and the cell reorganises itself for the
next round of division [133]. There are four phases through which the cell cycles between
each division, thus it is known as the cell cycle (shown in Figure 4.6). There is a fifth
phase outside the cell cycle where the cells are inactive, but the cells can be induced to
re-enter the cell cycle from this phase [149]. The cycle is controlled by proteins known as
cyclin-dependent kinases (CDKs).
The cell cycle is a complex series of events in which the cells amplify their synthetic
machinary in preparation for DNA synthesis and then reorganise their interphase cromatin
into chromosomes prior to mitosis; a process which needs careful regulation [133]. For
accurate cell reproduction, three main checkpoints must be traversed in the G1, G2 and M
phases. For the cell to transition from the G1 to the S phase, a critical level of regulatory
macromolecules must be achieved. At the G1 checkpoint, growth stimuli such as hormones,
growth factors and cell contacts act to increase the probability of the cell passing this barrier.
This check-point ensures two functions: i) there is adequate machinery for future events; and
ii) the accurate transmission of genetic information [133]. The G2 checkpoint ensures the
elimination of damaged cells which may have escaped the G1 checkpoint or which have
not accurately replicated their DNA. The spindle assembly M checkpoint monitors accurate
chromosome alignment and retraction into the two daughter cells [133].
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Fig. 4.6 The cell cycle and the cell cycle checkpoints. The average length of the cell cycle
is 16 hours: 15 hours in the interphase and 1 hour in the mitosis phase.
Phases of the Cell Cycle
G0: resting phase - In this phase the cells are quiescent and inactive. Cells spend much of
their lives in this phase not dividing or preparing to divide, but carrying out their day-to-day
functions [151]. This phase can last from a few hours to several years depending on the cell
type, and this is where most cells in an adult reside. Mitogens or growth factors can induce
the cells in the G0 phase to re-enter the cell cycle and pass a control point called the G1
restriction point [149] which occurs just before the G1 checkpoint.
G1: the first gap phase - In this phase the RNA and proteins are made for dividing. This
is the most variable phase in the cell cycle, with the length of this phase being the major
determinant in the length of the full cycle. It is this phase in which the future commitment
of the cell to divide, differentiate or die is made and is the focal point for many important
regulatory signals. The cell cycle will be affected if these signals are altered. The cell
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receives information that determines if and when it will go into the next phase, then starts
making more proteins in preparation for division. The RNA required to copy DNA is also
produced in this phase.
Three protein families are involved in the regulation of the G1 checkpoint, namely cy-
clins, cyclin-dependent serine/threonine protein kinases (CDKs) and ccylin-dependent ki-
nase inhibitors (CDIs) [133]. The kinases alter the biological functions of regulatory pro-
teins. The second element of G1 regulation involves DNA repair. Damaged DNA is detected
by mechanisms involving the repressor protein p53, which blocks cycle progression until the
DNA damage is repaired.
S: the DNA synthesis phase - In this phase the chromosomes containing the DNA are
copied so that both daughter cells will contain the same DNA. Synthesis of the DNA is
largely controlled by the build-up of enzymes, regulatory proteins and nucleotide triphos-
phates at the G1/S boundary. During synthesis, the DNA strands are separated and the bases
are exposed, thus they are sensitive to external agents. Once started, synthesis should be
completed as quickly as possible to avoid damage to the exposed bases. Given the impor-
tance of DNA replication, any defects in synthesis would be lethal to the cell. DNA repair
also occurs in the S phase.
G2: the second gap phase - More information about if and when to proceed with cell
division is gathered during this phase. Several synthetic and reorganisational events occur
in this phase. The double compliment of chromatin proteins and DNA formed in the pre-
ceding S phase condense and are packaged into sister chromatids. Additional processes to
rectify defects such as intertwining chromosomes, damaged DNA that escaped repair and
unreplicated DNA are completed in this phase, otherwise these defects may block mitosis in
the next phase. These processes are monitored at the G2 checkpoint, probably by different
means to the G1 checkpoint but still requiring the cyclin/CDK/CDI system.
M: mitosis phase - In this phase the cell divides into two identical daughter cells. Sister
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chromatids must be aligned correctly to the opposite poles of the divding cell, with this pro-
cess being monitored through the spindle assembly M checkpoint. Once again CDKs are
required for these events. There are four stages of mitosis: prophase, metaphase, anaphase
and telophase. In the prophase, chromosomes appear as a result of condensation, the nu-
clear membrane breaks down, duplicated centrosomes separate, and the mitotic checkpoint
proteins are assembled at the centromeres. In the metaphase, the chromosomes are aligned
on the metaphase plate and microtubules assemble to form the mitotic spindle. The mi-
crotubule captures both centromere regions of the chromatid pair resulting in the silencing
of the checkpoint. The metaphase is completed when the last pair is attached to the spin-
dle. The anaphase is characterised by the spindle pulling apart and separating chromatid
pairs. The telophase includes the accumulation of chromosomes at their respective poles,
re-forming of the nuclear membrane, chromosome decondensation and cytokinesis which is
the separation into separate cells [149].
The Cyclin-Dependent Kinase System
Activity changes of protein kinases work to regulate the cell cycle. These kinases are acti-
vated by cyclins, so are thus termed cyclin-dependent kinases. Another group of regulatory
proteins have the opposite effect on the kinases, so are called cyclin-dependent kinase in-
hibitors. Cyclins were so named because of the cyclical cahnges in their concentrations
that occur over a series of cell divisions [149]. The cell cycle checkpoints are regulated
by the inteatcions of the cyclins, cyclin-dependent kinases and the cyclin-dependent kinase
inhibitors [133].
These three components represent different famiies of molecules which are activated at
different phases of the cell cycle. Cyclin D is the first cyclin to be synthesised and remains
at a constant level throughout the cell cycle after rising early in G1. This cyclin, together
with CDK 4/6, drives progression through the G1 phase, and also plays a role in the G1 to S
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transition. The cyclins E, A and B are highest in late G1, G2 and M respectively, with their
prescence contributing to the checkpoint regulation in each of those phases [133]. Cyclin
A-CDK2 is important for S phase progression, with cyclins A, B-CDK1 directing G2 and
the G2 to M phase transition. Each of these cyclins preferentially binds to a particular CDK,
with the presence or absence of specific cyclins and CDKs at different periods determining
which kinase is active during each period [133]. Inhibitory signals involve the CKI family
of proteins, with different signals using different methods to increase CKI activity.
The regulation of CDK activity is crucial for precise cell reproduction. There are four
mechanisms by which this CDKs are regulated: their association with cyclins, their associ-
ation with CKIs, addition of phosphate groups that activate CDK activity, and the addition
of phosphate groups which inhibit CDK activity [149].
Cell Cycle Checkpoints
These checkpoints are a series of biochemical signalling pathways that sense and induce a
cellular response to DNA damage [149]. They are important for maintaining the inegrity
of the genome as disruption of checkpoint function leads to genomic and chromosomal in-
stability which causes mutations in the cell. The G1 checkpoint ensures that DNA damage
is not replicated in the S phase, as it arrests the cell cycle as a response to DNA damage.
The G2 checkpoint also arrests the cell cycle in response to damaged or unreplicated DNA
to ensure that the S phase is properly completed. The M checkpoint, or spindle assem-
bly checkpoint, responds to misalignment on the mitotic spindle by arresting chromosomal
segregation [149].
Retinoblastoma protein (RB) is a key substrate of the cyclin D-CDK 4/6 complex, men-
tioned earlier, which serves as a molecular link for the G1 checkpoint allowing the cell to
transition to the S phase. The activity of the E2F transcription factor family is regulated
by RB, and the transcription factor is essential for the expression of genes needed for the S
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phase of the cycle. RB does this by physically interfering with the transactivation domain
of the E2Fs. The activity of the RB itself is regulated by sequential phosphorylation events
by cyclin-CDKs [149].
The G2 checkpoint is there to prevent any cells which have incurred DNA damage in
previous phases or not correctly completed the S phase from entering the M phase. DNA
damage activates either of two kinases, ATM or ATR [149], which then phosphorylate and
activate the checkpoint kinases Chk1 and Chk2, which in turn target the Cdc25 tyrosine
phosphatases that regulate CDK activity by removing inhibitory phosphates. The B and C
type Cdc25s are important in the G2-M phase transition. The activation of the G2 checkpoint
results in the inhibition of Cdc25s by Chk1/2 [149].
The mitotic checkpoint, or spindle assembly checkpoint, is a signalling cascade that
ensures correct chromosomal segregation during mitosis and the production of two genet-
ically identical nuclei [149]. This checkpoint plays an important role in preventing the
mis-segregation of single chromosomes.
The Cell Cycle and Radiation
As early as the late 1960s, the effect of the cell’s age and phase in the cell cycle on radia-
tion response were being examined [152, 153]. Cells exhibit a different response depending
on the phase of the cell cycle they were in at the time of irradiation [152]. Cells are most
sensitive to ionising radiation during the G2 and M phases of the cell cycle, less sensitive
during the G1 period, and radioresistence rises to a peak during the latter part of DNA syn-
thesis. Conversely, early S phase is the sensitive period for chemical agents and UV light
[133]. The idea of synchronising tumor cells in a phase of the cell cycle more sensitive to
radiation is recognised as a potential way of enhancing the clinical efficacy of radiother-
apy [154–156], however the application is extremely limited. The complete synchronicity
of cell populations is difficult to achieve and maintain, and would be cumbersome duing
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fractionated therapies [157].
It has been shown that ionising radiation can have the effect of slowing down the pro-
gression of the cell through the cell cycle, by inducing delays in the G1, S and G2 phases.
Initial studies carried out on HeLa cells (human cervical adenocarcinoma) indicated a tran-
sient division delay accompanied by an accumulation of cells in the S phase, with lower
doses of radiation producing no S phase delay but a dose dependent lengthening of the G2
phase [158]. Results also indicated that the phase in which the cells were irradaited influ-
enced the extent of the delay produced with cells in G1 being least affected , and cells in S
or G2 showing progressively greater delays [153]. Arresting in G1 as a response to irradia-
tion is thought to be the result of signals transmitted by the p53 tumour suppressor protein
in response to cellular damage. The level of p53 protein rises 1-2 hours post irradiation
and remains at this elevated level for the next 72 hours. The p53 acts as a transcriptional
activator causing increased synthesis of regulatory proteins implicated in cell cycle arrest
[158]. A delay in the progression through the S phase of the cell cycle is caused by the
slowing of the DNA synthesis rate. The response to dose of this effect is biphasic, indi-
cating the radiosensitive (low dose) and radioresistent (high dose) components of the delay
[158]. The radioresistent response is caused by the reduction in the rate of DNA chain elon-
gation [159], while the radiosensitive response is due to a decrease in replication initiation
[160]. The arrest in the G2 phase is affected by differences in cell cycle progression between
radioresistent and radiosensitive cell lines. Results show mammalian cells deficient in G2
arrest are highly sensitive to ionising radiation and do not undergo a G2 delay after exposure
to radiation [158]. Studies using caffeine have shown that this drug reduces or abolishes the
radiation induced G2 delay and renders cells more sensitive to radiation [161].
The phosphatidyl-inositol kinase-related protein ATM (ataxia telangiectasia mutated) is
the most proximal signal transducer initiating cell cycle changes after DNA damage induced
by ionizing radiation [157, 162]. Cells with defective ATM and/or lacking in ATM are
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extremely sensitive to ionising radiation, highlighting the essential role of ATM in DNA
damage and repair [163–165]. Patients with a mutated ATM gene show extreme sensitivity
to radiation, and exhibit defective G1, S and G2 arrest after ionising radiation [157].
Division delay, which is a dose-dependent cellular response, is directly related to the
position in the cell cycle of the cell [158]. Low doses of radiation affect cells in the most
radiosensitive phases of the cell cycle delaying their progression through mitosis for a given
period of time. High doses of radition affect all cells and produces a longer mitotic delay
[134].
The main response of cells to DNA damaging agents is the activation of the cell cycle
checkpoints, which provide a controlled temporary arrest at a specific stage of the cell cycle
to correct possible defects [166, 167]. Ionising radiation, as discussed earlier, induces arrests
in the G1, S and G2 phases of the cell cycle. The G1 checkpoint prevents the replication
of damaged DNA before transition into the S phase, and the G2 checkpoint prevents the
segregation of aberrant chromosomes during the M phase [157]. There are two distinct
G2/M checkpoints, the first being dose independent, ATM dependent, transient and occuring
early after exposure to ionising radiation [168]. This early G2/M block represents the failure
of the cell to progress to mitosis, and may be the mechanism by which low-dose hyper-
radiosensitivity is converetd to resistence [157]. In contrast the late accumulation in G2/M
only becomes measurable after several hours, is dose dependent, ATM independent, and
represents the cells that were in an earlier phase of the cell cycle at the time of the radiation
exposure [168]. G2/M accumulation after exposure to ionising radiation is enhanced in
cells lacking the radiation induced S phase checkpoint and is not affected by the early G2/M
checkpoint [157, 168].
Because the cell cycle is strongly affected by radiation, and radiosensitivity depends




The various different types of damage suffered by the cell were discussed in Section 5.2.1.
The cell has developed several different specialised pathways which sense, respond to and
repair these different types of damage. Different mechanisms are used to repair base damage
than those used to repair strand breaks, and different methods are used depending on the
stage in the cell cycle.
Base Excision Repair
Base excision repair (BER) is, as the name suggests, the pathway through which damaged
bases are repaired. This is a generalised repair mechanism which repairs many ionising
radiation induced alterations to the bases. The damaged base results in a minor disruption
of the DNA structure, with the damaged base and its associated sugar being removed by a
two step process. In the first step the base alteration is recognised by a class of enzymes
known as the DNA glycosylases, which release the damaged base leaving an abasic site
[169]. Secondly, an incision is made at the abasic site by an AP-endonuclease and the
remaining sugar is released by a deoxyribo phosphodiesterase. The one base gap that is a
result of this process is filled by a DNA polymerase, using the undamaged complementary
strand to ensure that the gap is filled with the correct base. The polymerase leaves a nick
in the DNA backbone which is sealed by a DNA ligase, thus completing the repair with no
loss of genetic information [169]. If more than one nucleotide has to be replaced, a complex
polymerase performs the repair synthesis [139]. This form of repair is also used to repair
abasic sites. BER is very efficient, although defects in the process may lead to increased
mutation rates but not usually increases in cellular radiosensitivity [139].
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Nucleotide Excision Repair
Nucleotide excision repair (NER) removes bulky adducts in the DNA such as pyrimidine
dimers [139]. This type of damage interfers with transcription and replication. There are
five essential steps in this pathway; 1) the damage has to be recognised, 2) incisions in the
DNA that bracket the lesion, approximately 24 to 32 nucleotides in length, 3) the region con-
taining the adduct is removed, 4) repair synthesis to fill the gap, and 5) DNA ligation [139].
There are two subpathways in NER: global genome NER which surveys the helix distortion
and transcription-coupled repair identifies damage that interfers with transcription [149].
Sensitivity to ionising radiation is not a result of mutations in nucleotide excision repair
genes, however an increased sensitivity to ultraviolet induced DNA damage and ultraviolet
light is a consequence. This is a relatively complex and time consuming process, therefore
cell proliferation is stopped by a p53 mediated process to allow time for repair. Another
protein, TFII, is utilised in this process, which is more usually associated with the synthesis
of mRNA, thus the damaged cell can divert other functions to achieve repair [133].
Single-Strand Break Repair
Single strand breaks are repaired in a manner similar to BER. An exonuclease removes any
sugar remnants, along with the phospahte group on the 5’ of the sugar [169]. The gap which
results is filled by a DNA polymerase using the complimentary strand as a template, and a
DNA ligase closes the remaining single-strand nick. As a complimentary strand of DNA is
used for this type of repair, this lesion and its repair pose little or no permanent genetic risk.
Double-Strand Break Repair
The repair of DSBs is difficult or impossible and there is a direct link between unrepaired
DSBs and cell death. There are two main repair pathways for DSBs; homologous recombi-
nation (HR) and non-homologous end-joining (NHEJ), with single-strand annealing (SSA)
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and variable diversity joining recombination (V(D)J) emerging as possible alternative repair
pathways for DNA DSBs.
Homologous Recombination (HR) - comprises a series of related sub-pathways that
use DNA strand invasion and template directed DNA repair synthesis, culminating in error
free, but slow, repair [170]. An undamaged strand of DNA is required as a participant in the
repair as a template. This type of repair plays a role in the S and G2 phases of the cell cy-
cle, when an undamaged sister chromatid is available to act as the template. The increased
activity of this pathway during late S/G2 suggest its primary function is to repair and re-
store the functionality of replication forks within DNA DSBs [139]. In HR, the unprotected
ends of the DNA strand exposed by a DSB provide sites for strand specific exonucleolytic
degradation and the generation of protruding single strand ends [169]. The second strand
of complimentary DNA is invaded by a protruding end resulting in base pairing between
the two strands. This invading strand acts as a primer for DNA synthesis along the com-
plementary strand of the intact molecule. A section of the intact molecule is displaced,
called the D-loop, which provides a single-strand region that can pair with the remaining
end of the damaged molecule [169]. Synthesis proceeds along the D-loop, where missing
information is restored, leaving two single-strand nicks. Holliday junctions [139, 144, 169]
form when these nicks are sealed by a polynucleotide ligase. These cross-strand structures
can be resolved to form non-crossover and crossover products [169, 170], depending on
which sections of each molecule are retained, but all genetic information remains intact as
the missing DNA sequences have been replaced. This type of repair accounts for 30-50%
of endonuclease induced DSB repair events in dividing mammalian cells [171].
Non-homologous End-Joining (NHEJ) - this, the most common DSB repair pathway,
involves modifying the two broken ends of the double helix to make them compatible, fol-
lowed by re-joining without reference to an intact partner. NHEJ can be divided into four
steps: 1) end recognition, 2) end processing, 3) fill-in synthesis or end bridging, and 4)
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ligation [139]. A few of the phosphate base groups are lost at each end of the DNA break
when NHEJ is used, so this is an imperfect non-conservative process from the standpoint
of preserving genetic information; it is fast but error prone [144, 171, 172]. Furthermore,
without the use of a template it cannot be guaranteed that the two ends being joined were
from the same initial break [169]. This is the main pathway for the repair of DSBs when the
cell is in the G0, G1 and early S phases of the cell cycle, and continues to repair a minority of
breaks in the late S and G2 phases [172]. Hence, when ionising radiation is used for cancer
treatment, many DSBs are formed, thus the faster repair method of NHEJ is used, resulting
in more errors and cell death.
Single Strand Annealing (SSA) - Single-strand annealing is a transitional process be-
tween HR and NHEJ, which uses direct repeat sequences for its repair process [173]. As
half the human genome consists of repetitive DNA sequences, it is a potentially competitive
repair pathway for DNA DSBs [174]. The DNA DSB ends are digested by an exonuclease,
until homologous regions are exposed on both ends of the break [139]. The two tails, which
are nonhomologous, are removed so that the two exposed ends can be ligated. SSA and HR
share parts of the same pathway, but SSA results in the loss of some genetic information
because of the degradation of the DNA ends by the exonuclease [139, 171] thus it is know
as a nonconservative repair pathway [173, 175].
Variable Diversity Joining Recombination (V(D)J) - V(D)J is the process which me-
diates the development of antibodies as part of the normal immune response. It has been
linked to DNA DSB repair, and may provide an intriguing possible link between ionising
radiation induced DNA damage, p53 stabilisation and cell cycle control [169]. Three dif-
ferent genetic elements are used to assemble an antibody "gene"; the variable (V), diversity
(D) and joining (J) regions [144]. The V, D and J sequences have to be selected form those
available and joined to form the final antibody gene [169]. The V(D)J recombination system
does this by inducing it’s own DSBs and providing for their repair.
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Failure to repair even a single DSB can have dire genetic consequences for the cell. Cell
division becomes challenging as mitosis relies on the segregation of intact chromosomes,
which are not present owing to the physical discontinuity of DSBs. A chromosome deletion
can occur if two or more DSBs occur within the same chromosome. If this deleted section
is not associated with a centromere, the section will be lost during mitosis, thus depriving
the cell of a fraction of its genetic heritage [169]. Inaccurrate repair may result in loss of
genetic information or mutations and inappropriate repair may result in harmful genomic
rearrangements [144]. As DSBs are signals for cell cycle checkpoints, if even one is unre-
paired prior to cell division this may lead to prolonged cell cycle arrest, failure to undergo
cell division and cell death [144].
Cross-Link Repair
The mechanisms used to repair DNA-DNA or DNA-protein cross links are still under in-
vestigation. Currently it is thought to be a combination of NER and recombinational repair
pathways that are needed to repair cross-links. Chromatins that contain actively transcribed
genes are more susceptible to DNA-protein cross-links, and the cross-linked proteins are
usually nuclear matrix proteins [139].
Mismatch Repair
This pathway repairs small insertions, deletions and base-base mismatches that occurred
during replication and escaped editing by polymerases. Base-base mismatches which oc-
curred as intermediaries of homologous recombination are also removed [139]. Incorrectly
matched base pairs are removed by specific exonucleases called exinucleases that digest the
DNA in both directions from the incorrect bases. The gap is then correctly filled by DNA
polymerase and ligated by DNA ligase [133]. These main molecular events can be desricbed
in the following five steps: 1) the mismatch is recognised by hMSH2/6 and hMSH2/3 pro-
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teins, 2) hMLH1/hPMS2 and hMHL1/hPMS1 are recruited, 3) the newly synthesied strand
is identified (flagged by the replication machinary), 4) endonucleases and exonuclease re-
move the nucleotides around and including the mismatch, 5) DNA polymerases resynthesise
a newly replicated strand [149]. Any mutations in the mismatch MSH, MLH or PSM fam-
ilies of repair genes lead to microsatellite instability, which are small base insertions or
deletions, and cancer [139].
4.2.5 LET, RBE and OER
Linear Energy Transfer
As different forms of radiation release their energy at different rates, the concept of linear
energy transfer (LET) is used to define the energy released per unit path length. It is a
measure of the rate at which energy is transferred to the medium and hence the density of
the ionisation [135]. The process of energy loss is dominated by electronic collisions and











+ relativistic terms (4.32)
where dE/dx is the energy loss per unit length, Z is the atomic number of the target, N is
the electron density of the target, me and e are the mass and charge of an electron, v is the
velocity of the ion and Ze f f is the effective charge of the ion. Ze f f can be approximated by
the Barkas formula [177];








The dominant parts of the Bethe-Bloch formula are the dependence on 1/v2 and Ze f f , as
these determine the amount of energy being deposited along the beam profile. As 1/v2 ≈
1/E, a decrease in particle energy will yield an increase in the energy lost.
A given amount of energy released in a short distance does more damage than the same
amount released over a longer distance. It is usual to refer to low and high LET radiation,
with the latter being more effective at causing DNA damage. It follows that radiation that
is easily stopped has high LET, and radiation which is more penetrating has low LET.
High LET radiation, such as that produced by α-particles and neutrons, generates so much
DNA damage that the cell will die, whereas low LET radiation, such as X-rays, is much
less cytotoxic. To help explain why high LET radiation is more damaging than low LET
radiation let us consider the DNA DSB. DSBs are less likely than SSBs, since two separate
chemical events are needed to cause them, but high LET radiation, such as protons, causes
a series of closely clustered ionisations that result in a trail of damage. If these ionisations
occur approximately 2 nm apart, they coincide roughly with the diameter of the DNA double
helix, thus the passage of a single particle has the potential to cause a double strand break.
X-rays on the other hand have a much lower LET and the probability of a single track
causing a double strand break is very low and in general more than one track is required.
Radiobiological Effectiveness
The LET is one of several factors influencing the relatie biological effectiveness, RBE, of
a particle, with other factors being dose, fractionation, tissue type and biological endpoint
[179]. In practice, two different types of radiation, one high LET and the other low LET,
can produce the same biological effects if the dose of the high LET radiation is reduced in
accordance with the RBE of the particle. The RBE, or relative biological effectiveness, is
the ratio of the dose of 250 keV X-rays compared to the dose of the test radiation required
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Fig. 4.7 The relationship between LET, RBE and DSBs [139, 178].
Fig. 4.8 Comparison of the effects of low- and high-LET radiation on a population of cells
[134].
to produce the same biological effect;
RBE =
dose of 250 keV X-rays
dose of test radiation
(4.34)
RBE values are higher for tissues that accumulate and repair large amounts of sub-lethal
damage (SSBs for example) and low for those that do not repair sub-lethal damage. The
RBE can vary with the dose rate because the slope of the dose response curve for sparsely
ionising radiation, such as X- or γ- rays, varies critically with a changing dose rate. In
contrast, the biological response to densely ionising radiation depends little on the rate at
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which the radiation is delivered. In the case of sparsely ionising X-rays the probability of
a single track causing a DSB is low, thus X-rays have a low RBE. At the other extreme,
densely ionising radiation readily produces DSBs, but the energy is wasted, thus the RBE
is lower than optimal LET radiation. This effect is known as overkill where the density of
energy deposited in the DNA molecule is higher than what is need for its breakage.
Fig. 4.9 The relationship between LET and the cell survival curve. The width of the
shoulder represents the part of the dose which is wasted, thus the higher LET radiation has
a greater RBE compared to the lower LET radiation as less of the dose is wasted.
Oxygen Enhancement Ratio
Oxygen is a sensitising agent which renders cells more susceptible to radiation damage.
When irradiating cells with photons or low-LET ions, they demonstrate different survival
behaviour depending on the presence or absence of oxygen [180].
Oxygen is a truly universal radiosensitiser as it it enhances the radiation response of all
organisms from bacteria to mammalian cells to entire organisms. The oxygen enhancement
ratio (OER) is the ratio of radiation dose required for the same biological effect, such as
cell survival or the number of DNA DSBs, in the absence (annoxic) versus the presence of






The OER describes the degree to which the cellular sensitivity to radiation increases or
decreases depending on the oxygen concentration of the cellular environment [182]. For
mamalian cells the OER is generally given as ∼ 2.5-3.5 after high single doses. The effect
is most pronounced for low LET radiations and is not as effective for high LET radiations,
as the amount of damage induced by high LET radiations is large and unrepairable and the
presence of oxygen would not enhance the radiation response to the same extent as low LET
radiation. The OER for high LET radiation varies between 1.7 and 1.2 [134].
The OER can also be defined as the ratio between the dose to hypoxic cells (reduced
oxygen levels) and aerobic cells (usually in air), with the OER decreasing with increasing
oxygen partial pressure in the cell environment. This is usually termed the hypoxia reduction
factor (HRF) rather than the OER [183].
The oxygen effect can vary depending upon when the oxygen is delivered to the sample
being irradiated. The oxygen effect is most pronounced when the oxygen is administered
simultaneously with the radiation, the response is less dramatic when the oxygen is delivered
pre- or post-irradiation. This has been attributed to the fact that the oxygen effect involves
the reaction of the radiation at a chemical level. The exact mechanism of the reaction is still
not fully understood, but the two leading hypotheses are as follows [134]:
1. The oxygen may enhance the formation of free radicals or draw the existing free
radicals formed by the radiation interacting with the water content of the cells, into
chain reactions producing new highly damaging radical species.
2. The oxygen may block restoration of chemical changes which have occurred as a
result of the irradiation thus increasing damage in the cell. These changes would
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normally be reversible in the absence of oxygen.
In the oxygen fixation hypothesis the absorption of radiation leads to the production of
fast charged particles which produce a number of ion pairs as they pass through the sample.
These ion pairs have extremely short life spans of 10−10 seconds and produce free radicals
which have an appreciably longer life span of 10−5 seconds. These free radicals break
chemical bonds, producing chemical changes which initiate a chain of events resulting in
the final expression of the biological damage, which depends on the presence or absence of
oxygen. If oxygen is present, the radicals (R.) will interact with the DNA. The so produced
DNA radical can be reduced by reacting with an SH group, however if RO2 is formed, the
chemical change is permanent. This cannot take place in the absence of oxygen, since then
many of the ionised target molecules are able to repair themselves and recover the ability to
function normally. The oxygen is then said to make permanent or ‘fix ’the radiation lesion
[139].
Because the oxygen increases the amount of damage to the organism by increased for-
mation of free radicals or fixing the damage, more targets will be lethally affected per given
dose of radiation.
The OER is significantly affected by the position of the cells in the cell cycle, when
measured for fast-growing proliferating cells in vitro. The OER was measured at∼ 2.35 for
G2 phase cells, compared to ∼ 2.85 for S phase, with an intermediate value for G1 phase
cells [139].
4.2.6 The Role of Hypoxia
Hypoxia is a pathophysiological property that is defined as a stae of depressed oxygen ten-
sion [184]. Hypoxia can be present in both tumours and normal tissue, causing the impair-
ment of cellular or organ function once critical levels of oxygen depletion are breached.
The increased resistance of hypoxic cells to ionizing radiation is usually believed to be the
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primary reason for treatment failure in tumors with oxygen-deficient areas [185]. Under
hypoxia, the proliferation rate of tumour cells outstrips the vasculature formation rate lead-
ing to the development of oxygen deficient zones within the tumour [186]. Such hypoxic
zones have a reduced response to radiotherapy [187, 188] owing to a decrease in ROS that
are required to produce enough DNA damage to cause cell death [189, 190]. Radiation in-
duced ROS generation is well reported as one of the main determining factors in cellular
damage through the induction of a spectrum of lesions including DNA base damage, SSBs
and DSBs [191]. The radicals produced enter into a competition for either oxidation, which
makes the damage permanent, or reduction which can restore the DNA to its original form
[192].
Fig. 4.10 Radicals are either oxidated, fixing the damage, or reduced, restoring the DNA to
its original form.
Intra-tumoral hypoxia induction is non-uniform, where a temporary occlusion of a blood
vessel produces a region of acute hypoxia which varies within a short time frame. Acute
hypoxia is perfusion limited and is defined as a short-term exposure to a reduction in oxygen
resulting in oxygen concentrations of less than 3%. Chronic hypoxia is diffusion limited,
and is defined as a long-term exposure to a reduction in oxygen resulting in concentrations
of less than 0.1%, induced by a consistently depleted oxygen supply as the distance between
the cells in the growing tumour and the blood suply increases, slowing reoxygenation [184,
193]. Areas of complete anoxia (0% O2) are present in regions of the tumour more than
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150 µm from the vasculature as this is the diffusion limit of oxygen within tissues [189].
Recurring tumours often have a larger hypoxic area than primary tumours, but a tumour’s
hypoxic status cannot be determined easily as the presence of hypoxia is independent of size,
stage, grade or histology [184]. Intratumoral oxygenation often disperses heterogeneously,
therefore the hypoxic content can only be measured accurately through a composite set of
complementary measurements.
It has been demonstrated that the sensitising effect of the oxygen concentration can only
be observed when oxygen is present during irradiation. When the oxygen concentration is
> 3% the full sensitising effect is observed, while at lower concentrations, especially from
1% - 0.1%, a steep decrease in radiosensitivity is measured [194]. However, there is some
discrepancy as some researchers report that chronic and acute hypoxia similarly modulate
radiosensitivity [195].
Because of the radio-protective effect of hypoxia in tumours, new strategies are required
to individualise the treatment and improve the outcome for patients with hypoxic tumours.
As the OER decreases with increasing LET, high LET radiation therapy is envisaged as a
possible solution, particularly employing carbon ions. This treatment modality combines
high RBE with a reduced OER, with a favourable dose depth profile which theoretically can
be targeted at the hypoxic tumour [183, 196].
Defining Tumour Hypoxia
Normoxia is almost universally used to describe the normal oxygen levels in tissue culture
flasks, which is approximately 20-21% O2. This is far from accurate for peripheral tissues
where the oxygen levels can range from 3.4 to 6.8%. Even lung alveoli have a reduced
oxygen level of 14.5% owing to the presence of water vapour and CO2. Measurements
of the oxygen levels in normal tissues do show distinct normal ranges, dependent on the
tissue type, but normoxia is not the relevant oxygenation range. A more accurate level
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of oxygenation to which experimental conditions can be compared is 5% O2 which has
recently been termed physoxia. The lower limit of physoxia is approximately 3% O2, with
cells of different origins having different oxygen sensitivities. Brain tissue for example
is very sensitive to oxygen depletion and can only survive for approximately 3 minutes
without adequate oxygenation, whereas vascular smooth muscle can survive for up to 72
hours [197].
% Oxygen Hypoxia Definition
5.0 Physoxia: physiological oxygen level in peripheral tissues with an average
of approximately 6% (7.5-4 % depending on the tissue). For experimental
studies, 5% is the proposed compromise since this is often used.
2.0 Physiological hypoxia: the lower level at which normal hypoxic responses
are elicited (lower limit ∼ 1%, upper limit ≤ 5%)
1.0 Pathological hypoxia: shows persistence of poor oxygenation suggesting
disruption to normal homoeostasis. Below this level pathological hypoxia
applies.
0.4 Radiobiological hypoxia: the oxygen level at which the cytotoxic effect
of radiation is half maximal.
Table 4.1 Approximate levels of oxygen corresponding to the different levels of hypoxia
[184].
The oxygen level at which tissues respond to maintain their preferred oxygen level
is termed physiological hypoxia. These responses are usually physiological such as up-
regulation of hypoxia response genes or increasing blood flow. The physiological hypoxia
range is generally 2-6% O2 as different tissue types have different hypoxic trigger points,
and the response is presumed to be transitory but sufficient to return the tissue to its preferred
level of oxygen.
Pathological hypoxia is the point at which homoeostatic mechanism no longer responds
effectively to reverse falling oxygen levels. This is usually well below 1.3% O2. In tumours
the homoeostatic processes are disrupted for two main reasons:
1. The vasculature is of very poor quality and cannot adequately and reliably provide
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oxygen leading to,
2. A sizeable proportion of tumour cells are significantly hypoxia tolerant as they do not
die in this environment
The second reason may be attributed in part to the switch to glycolysis for the supply
of energy. In addition, exposure to prolonged pathological hypoxia will naturally select
hypoxia-tolerant tumour cells that are stress resistant and more malignant [184]. This occurs
at approximately 1% O2.
Hypoxia Inducible Factor
Hypoxia Inducible Factor 1 (HIF-1) is a basic-loop-helix-loop motif heterodimeric tran-
scription factor, comprised of an oxygen regulated α subunit and a constitutively expressed
β subunit (also called aryl hydrocarbon receptor nuclear translocator, or ANRT) [198–200],
that is activated in mammalian cells under hypoxic conditions. The α subunit (HIF-1α ,
-2α or -3α) is sensitive to oxygen tension and dominates the transcriptional activity. Under
hypoxic conditions the rate of HIF-1α turnover is inhibited, resulting in an increased rate
of the protein accumulation [201]. It potentiates a variety of biochemical processes that
are aimed at alleviating the effects of hypoxia, and is constantly expressed and degraded by
oxidation dependent oxidation, therefore its degradation is slowed at low oxygen pressure
with elevated protein levels found in many hypoxic tumours [184].
The HIF pathway is a major mediator of the biological effects in tissue after exposure
to hypoxia. Under normal oxygen conditions, the α subunits rapidly degraded by hydroxy-
lation by Fe2+ dependent prolyl hydroxylases (PHD) in the oxygen dependent degradation
domain at proline residues 402 and 564 in human HIF-1α [200, 202, 203], interaction with
the von Hippel-Lindau protein (pVHL) E3 ubiquitin ligase complex and proteasomal degra-
dation [184, 204]. The PHDs require molecular oxygen; under hypoxia they lose activity
and no longer degrade HIF-1α [205]. This confers a sensitivity to hypoxia, under which
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the HIF-1α is stabilised and initiates a multistep pathway of activation that includes rapid
accumulation of HIF-1α and its translocation inside the nucleus [206]. Inside the nucleus
the HIF-1α heterodimerizes with HIF-1β (ANRT), recruits transcriptional coactivators and
binds to hypoxia response elements (HREs) in the regulatory regions of many target genes
[207]. Under normal oxygen conditions, HIF-1α is usually unsatble and virtually unde-
tectable [202].
Fig. 4.11 The spatial relationship between a blood vessel and a solid tumour in the context
of HIF-1 and O2 concentrations. In normoxic conditions of 5%, within 70 µm of the blood
vessel, the HIF-1 is rapidly degraded or has a very low level of expression. Hypoxic
regions exist at distances greater than 100 µm from the blood vessel, where the HIF-1
expression is increased and O2 concentration is decreased [208].
Hypoxia can be physically induced in samples by exposing them to a hypoxic gas mix-
ture (95% N2, 5% CO2) in hypoxic incubators, workstations or chambers. The activity of
PHDs and the subsequent stabilisation of HIF-1α can be affected by chemical agents such
as desferrioxamine and flavonoids [202]. A number of transition metals have also been
identified as hypoxia mimetic agents including desferrioxamine, nickel chloride and cobalt
chloride. It has been reported that specific prolyl hydroxylases have an iron binding centre
critical for enzymatic activities. Iron chelators can remove this iron from the enzyme, re-
placing it with cobalt, inactivating the hydroxylation activity in the process. Cobalt chloride
can also induce HIF-1α expression by binding to the PAS domain resulting in the blockage
of HIF-1α pVHL binding and therby HIF-1α stability [204, 209]. Cobalt chloride (CoCl2)
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has been used by many investigators as a hypoxia mimetic agent in cell culture [209–211],
however this compound may possess some unknown effects in addition to the induction
of Hypoxia-Inducible Factor 1 (HIF-1). The question of whether the effects produced by
chemical hypoxia mimetics regarding cell survival and proliferation are identical to those
when there is reduced oxygen is of considerable biological relevance, given the diverse ac-
tions that many of these chemical agents can exert on biological samples [211]. The actions
of cobalt chloride may be mediated by signalling pathways not necessarily shared by a ‘true’
hypoxic response and may cause oxygen independent biological effects [206].
4.3 Hadron-Therapy
Hadron-therapy is the radiation therapy technique which employs protons, neutrons or car-
bon ions to irradiate cancer tumours. Owing to the advantageous energy deposition prop-
erties of ions compared with the more commonly used X-rays, at least 1% and possibly as
many as 12% of patients currently treated with X-rays would be better treated with protons
[5]. The range of a proton or ion is fixed by its energy, which avoids irradiation of healthy
tissues at the rear-side of the tumour, while the well localised maximum of the energy loss,
known as the Bragg peak (shown in Figure 4.12), in the matter leads to the substantial in-
crease in the irradiation dose in the vicinity of the stopping point [52]. There is also a
reduction in the irradiation of healthy tissue in close proximity to the tumour, as the proton
or ion scattering on the atomic electrons is weak. The radiation induced cancer risk for chil-
dren in particular is reduced, as much less energy is deposited in the body by ion therapy
when compared with conventional X-ray based therapy [5]. The proton energy window of
therapeutic interest ranges between 60 and 250 MeV [8], depending on the location of the
tumour. The required energy for carbon ions extends beyond 350 MeV/nucleon [52, 212].
Ion beam therapy has been used at numerous clinical facilities and has proven to be
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Fig. 4.12 Advantageous energy deposition of ions and protons compared with X-ray
photons [213].
both effective and advantageous in a number of tumours. An example study was carried
out by Yock et al. [214], where they compared traditional photon therapy with proton ra-
diotherapy to assess late complications, acute side effects and survival rates in paediatric
medullablastoma, the most common malignant brain tumour in children. This was a non-
randomised, open label (each participant knew how they were being treated), single centre,
phase 2 (investigating the safety and ethics of the treatment) trial of fifty-nine 3 - 21 year
olds, who had all received surgery prior to the proton therapy being administered within 35
days post surgery to the head and spine [214]. All patients received chemotherapy as part
of their treatment as well. Complications which can arise from treating medullablastoma
with photon or proton therapy, include cognitive impairment and hearing loss. In this study
16% of the children had serious hearing loss five years after proton beam therapy, which
compares favourably with standard radiotherapy, where about 25% have serious hearing
loss five years after treatment [215]. Cognitive impairment was also slightly less, with 1.5
intelligence points (IQ) lost per year compared to 1.9 in studies of standard radiotherapy.
The overall survival was 83% at 5 years, which was reported to be similar to standard radio-
therapy [215]. The main limitation of this study was that it was not a randomised controlled
trial directly comparing the two forms of radiotherapy, but this would have been unethi-
cal. Grutters et al. [216] provide a comparison between radiotherapy with photons, protons
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and carbon ions in the treatment of non-small-cell lung cancer (NSCLC) after performing
a meta-analysis of observational studies. They carried out a systematic review to find eli-
gible studies on conventional radiotherapy, proton therapy, carbon ion therapy, stereotactic
radiotherapy and concurrent chemo-radiation. They obtained pooled estimates of 2 and 5
year disease specific and overall survival, and the occurrence of severe adverse events for
each treatment modality, through a random effects meta-analysis, with the pooled estimates
corrected for effect modifiers [216]. Meta-analysis is used to synthesise quantitative infor-
mation from related studies to produce results which summarise a whole body of research
[217]. The meta-analysis can either be fixed or random effect. Fixed effect assumes all stud-
ies are estimating the same treatment effect, whereas random effects allow for differences
in the treatment effect from study to study [217]. Their results showed that corrected pooled
estimates for 2 year overall survival in stage I inoperable NSCLC ranged from 53% for
conventional radiotherapy to 74% for carbon ion therapy [216]. The 5 year overall survival
for conventional radiotherapy was 20%, statistically significantly lower than for stereotactic
radiotherapy (42%), proton therapy (40%) and carbon ion therapy (42%) [216]. The authors
warrant caution owing to the limited number of patients and limited length of follow up of
the particle studies. The overall findings of this analysis was that the survival rates for parti-
cle therapy were higher than those for conventional radiotherapy, but similar to stereotactic
radiotherapy in stage I inoperable NSCLC. Particle therapy may be more beneficial in stage
III NSCLC especially in reducing adverse events [216].
Ion beam facilities mainly employ protons from synchrotron, cyclotron or linear accel-
erators. Cyclotrons provide higher dose rates than synchrotrons owing to their fast cycling
and larger beam current characteristics, but more advanced accelerator designs such as the
non-scaling fixed-field alternating gradient (NS-FFAG) [218] and dielectric wall accelera-
tors could provide even higher dose rates. Protons are currently the most widespread form
of ion therapy, however, there has been a move towards carbon ions in recent years, as they
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have a higher radiobiological effectiveness (explained in Section 4.4.2) making them an ef-
fective treatment for radioresistant and hypoxic tumours [219]. Normally, in the absence of
oxygen (hypoxia) there is approximately three times less damage formed.
Conventionally, large magnetic steering systems called Gantries have to be employed to
enable multi-directional irradiation of a lying patient. These Gantries weigh up to 100 tons
for proton systems and 500 tons for carbon ion systems [220], making them very costly to
build, and not many hospitals can accommodate the large accelerators required. A potential
solution is to use laser-driven accelerators for cancer therapy [6, 221], as they could con-
siderably reduce the size and cost of accelerators for medical applications. The creation of
specialised, relatively small medical laser proton accelerators would reduce the size of the
accelerator gantry set-up to approximately 2 - 3 m and a few tons, compared to conventional
systems which are approximately 6-8 m in diameter, 10-12 m in length and weigh 100 tons
or more [6].
4.4 Laser-Driven Ion Sources for Hadron-Therapy
There is a wide range of ways in which high quality laser-produced proton beams could be
used for medical accelerators. Bulanov [6] suggested an all optical system in which the ion
beam was accelerated in the treatment room itself, and thus the issues of beam transport and
delivery were minimised. A laser would irradiate the target at the entrance to the treatment
room, which would require the conventional Gantry system to be redesigned, as there would
be no need for the beam transportation channels, central accelerator or the larger part of the
Gantry magnetic system, thus substantially reducing the cost. Antici [222] suggests that
laser-produced beams could be used as high quality injectors in a standard radio-frequency
based particle accelerator, as this hybrid proton accelerator would benefit from both the
excellent properties of the laser based source and the flexibility, reliability and know-how
of beam handling as provided by the RF based accelerator structures.
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There are significant obstacles which have to be overcome before laser-driven ion beams
meet therapeutic specifications, in terms of maximum energy, energy spectrum, repetition
rate and general reliability to the levels required by medical standards. A raw beam is
an extremely dangerous tool which must be shaped and controlled before it can be used
for radiation therapy. The most basic of all requirements is the range of the beam, which
should be 25 to 30 cm in tissue, equating to energies of 200-225 MeV for protons and 400-
430 MeV/amu for carbon ions [212]. This energy has to be available at the entry point
of the patient; therefore higher energies will be required from the accelerator if the beam
has to pass through materials for spreading or shaping. Treatment times must be kept to a
maximum of a few minutes, owing to immobilisation issues and patient comfort, but also
because current RF technologies deliver their dose in this timescale, and a treatment that
would take longer than the current modality is unattractive and uncompetitive. The vast
majority of patients who receive radiation therapy will be treated in the supine position, as
this is both comfortable, improving immobilisation, and coincides with the position in which
the diagnostic scans are taken. Accurate treatment plans can only be developed if there is a
precise knowledge of the target, organs and other body structures, and it is imperative that
the patient is treated in the same position in which the diagnostic scans were taken. For the
greatest flexibility, optimum beam delivery is attained when the therapy beam can be aimed
at the supine patient from any angle in the vertical plane, whilst retaining the freedom to
rotate the patient about the vertical axis. This will allow full access to all the normal entry
angles, but also all the oblique ports, often invoked to avoid critical structures [212]. This is
a major attraction of laser-driven ion sources, as there is the possibility of bringing the laser
into the treatment room and redirecting it with mirrors.
At present the parameters of ion beams achievable are still far from what is required,
and extensive and long-term research is needed to ascertain if and how these laser-driven
ion beams will become a competitive option [52]. Currently there are several major projects
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Fig. 4.13 A conventional cyclotron based system [223] on the left compared to a
conceptual laser accelerated proton therapy instrument [224] on the right.
worldwide which are exploring the potential of laser-driven ion sources for biomedical ap-
plications such as those of Auer [225], Bin [17], Borghesi [226], Doria [227], Hanton [10],
Fourkal [228] and Zeil [229]. Others have started to design the possible delivery systems
for this treatment, including target chambers and shielding [230], particle energy selection
and beam collimation systems [18, 231].
Conventional Accelerator Laser-Driven Accelerator
Size large small
Cost expensive relatively inexpensive
Energy up to 250 MeV several tens of MeV (at present)
Gantry large (100-500 tons) small (1-10 tons)
Dose deposition time 100 ms ns-ps range
Dose rate ∼ 30 Gys−1 > 109 Gys−1
Mode continuous pulsed
Particles produced singly bunched
Table 4.2 Comparison between a conventional particle accelerator and a laser-driven
accelerator [224].
The most important thing to keep in mind is that laser-driven ion beam therapy will not
become successful just with the arrival of a 200-250 MeV proton source, the hardware and
software needed to effectively convert the raw accelerator beam into a suitable therapeutic
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radiation beam is also a major factor. The beam delivery systems available at present require
well defined energy, very narrow energy spread and tightly focused ion beams, which are
currently not producible by laser-driven systems, although Zeil et al. [229] appear to have
made some progress with table-top systems. Other problems include verifying scaling laws
for proton energy with laser power, improving shot to shot reproducibility, developing tech-
niques for accurate dose control and cut-off and addressing the aspects of quality assurance
and patient safety [212]. These are not insurmountable problems, but it will take time before
laser-driven sources replace conventional accelerator sources for ion beam therapy.
The goals of current research are to:
• Increase the beam energy
• Increase the efficiency of the laser energy conversion into ions
• Improve and control the spectra to achieve mono-energetic ions
• Improve beam quality, repetition rate, collimation and purity
• Optimise acceleration with table-top lasers with shorter pulse durations
The routes to achieving these goals lie in optimising the TNSA mechanism of accelera-
tion (see Section 2.4.1) and exploring innovative mechanisms such as the RPA mechanism
(see Section 2.4.2).
4.4.1 Ultra-High Dose Rates
Before the clinical application of laser-driven ions, cell irradiation experiments with laser-
driven beams constitute an important preliminary step in demonstrating the maturity of this
emerging technology. In addition, the biological effectiveness of ultra-short pulsed beams
with nanosecond ion bunches of high charge, compared to quasi-continuous beams from
conventional accelerators, can be assessed [17]. The unique characteristics of laser-driven
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ion beams as compared with its RF counterpart has meant the development of innovative
dosimetric approaches, where a dose of 1-10 Gy is delivered to the cells in short bursts of
approximately nanosecond duration. More generally, time-resolved radiobiological stud-
ies with sub-nanosecond particle bunches might help to elucidate the ultra-fast processes
underlying the biological response of cells to ion irradiation [232].
The first demonstration of the feasibility of cell irradiation using laser-driven protons
was carried out by Yogo et al. [233]. They showed that there was a distinct formation of
γ-H2AX foci, which are an indicator of DNA DSBs, when in vitro human cancer cells were
irradiated with a proton dose of 20 Gy [233]. Kraft et al. [234] also carried out in vitro
proton irradiations of cells using laser-accelerated pulses and showed that there was dose
dependent biological damage. A correlation between increasing the dose from 1.5 to 2.7 to
4.1 Gy and an increase in the number of DNA DSBs was observed, and thus the dose effect
of the biological damage to the tumour. The dose was fractionated and the average dose rate
was comparable to those used in irradiations with conventional accelerator sources (∼ 0.1
Gys−1) [52].
Bin et al. [17] showed that by combining advanced acceleration using nanometre thin
targets and beam transport, truly nanosecond quasi-monoenergetic proton bunches could be
generated with a table-top laser system, delivering single shot doses to living cells of up to
7 Gy. The biological response of the cells, in terms of initial damage to the DNA was quan-
tified using the γ-H2AX assay [235] and the preliminary relative biological effectiveness
obtained was the same as for conventionally produced proton beams at comparable energies
[236].
However, in Wilson et al.’s [237] recent review in the British Journal of Radiology, we
are reminded that ultra-high dose rates may not necessarily be advantageous owing to ad-
verse consequences arising from local oxygen depletion. Both the yield and variety of free
radicals formed when ionising radiation interacts with biological systems are enhanced by
132 Radiation Therapy
the presence of oxygen, as is the fixation of this damage. Within the Bragg peak of an ion
species, there are particle mass and particle charge dependent increases in the local inten-
sity of ionisation on a macroscopic scale (the LET), which in turn results in a higher RBE
[237]. Both LET and RBE are reduced by spreading out many Bragg peaks to cover a tu-
mour target, which then includes more low LET parts away from the peak itself. The local
clustering of high LET biological damage differs from the biological damage produced by
X-rays and electrons, and accounts for the increased RBE as clustered damage is more diffi-
cult to repair by cellular enzymatic processes. A further advantage of using charged particles
is that the extent of oxygen sensitisation on cellular radiosensitivity is reduced for particles
with atomic numbers greater than two, however, this effect is reduced by spreading out the
Bragg peak, although even a mild reduction in the oxygen dependency could be advanta-
geous in the case of carbon ions [237]. The design of future laser-based systems should take
into account the radiobiological concerns associated with the potential oxygen depletion in
hypoxic tumours and should aim to minimise any potential disadvantages associated with
ultra-high dose rate effects.
The main difference between conventionally produced particle beams and laser pro-
duced particle beams, and the potential differences in their radiobiological effects, arise
from the fact that the laser produced beams will be pulsed. While the laser pulses required
for the acceleration of high energy particles are in the range of femtoseconds, the particle
pulses created will be spread in time during the beam transport and the expected duration of
the pulse at the target will be approximately 1 ns. Since the repetition rates of laser acceler-
ators are expected to be rather moderate (tens of Hz in-line with currently available clinical
accelerators [238]), one can envisage that during one session each voxel of the planning
treatment volume can be targeted at most a few times, if the treatment time is to be kept
reasonably short [225]. Thus with one pulse a considerable fraction of the required dose at
a target voxel has to be given. Assuming a deposition of >1 Gy in 1 ns, this translates to an
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ultra-high dose rate of >109 Gys−1.
In a recent publication Fourkal et al. [228] discusses the LET of proton clusters. He
states that in conventional particle accelerators, the particles are produced in long pulses,
with average inter-proton distances larger than those in a laser-plasma interaction scheme[228].
Therefore the radiobiology of such protons will be governed by the interaction of a single
proton with the cell. In the laser-plasma interaction scheme, the protons will be emitted
as a single bunch of particles, less than 1 ps in duration, with inter-proton distances many
orders of magnitude shorter. They will therefore not only interact with the medium they
are traversing, but also each other [228], which under certain conditions may lead to an
interference effect manifested by the increased energy deposition per unit length.
Fourkal’s linear response theory predicts that when the distance between protons in the
cluster becomes less than its velocity divided by the characteristic frequency of the collective
excitations supported by the medium it is traversing, the cluster’s LET starts increasing so
that the stopping power of the individual proton in the cluster increases compared to that of
a single moving particle. The cluster’s LET increase is a consequence of the interaction with
the outer-shell electrons of the medium, where each passing projectile of the cluster excites
the collective oscillations supported by the medium. If the distance between the projectiles
is small enough, the field wakes interfere coherently leading to increased energy loss by the
whole cluster.
If all the protons in a cluster are at the same spatial location, i.e. the inter-particle
distance is zero, the effective charge of the cluster would be Ne, where N is the number of
protons in the cluster and e is the elementary charge, thus the stopping power would scale as
S∼ (Ne)2. If the protons are separated by a great distance, the stopping power of the cluster
will scale as S ∼ Ne2. As the ratio between the two stopping powers is N, the individual
stopping power of a single proton in the cluster will scale from 1 to N depending on how
close the particles are to each other. This increase in stopping power is physically explained
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by considering the hard and soft inelastic collisions between the proton and the inner- and
outer-shell electrons in the medium. In the collisions involving the inner-shell electrons,
the individual electron behaviour dominates and the characteristic response frequency of the
electrons is much larger than the characteristic frequency of the external field created by two
charges (a simplistic view of a cluster). Under this condition, the two external charges are
seen as two separate entities and the stopping power of the cluster owing to the interaction
with the inner-shell electrons is equal to the sum of the individual stopping powers of the
particles. However, the characteristic response frequency of the outer-shell electrons may,
under certain resonance conditions, be comparable to the characteristic frequency of the
external electric field and the collective aspect of the interaction has to be invoked. In
these conditions, the passing projectile will excite a wake of collective electron density
fluctuations behind it [228]. The interference between the two wakes will determine the
effective stopping power of the cluster. If the two projectiles are in the same spatial location,
the two wakes are in the same phase and interfere coherently so that the stopping power of
a cluster scales as a square of the number of particles in the cluster. When the particles are
far apart, the excited wakes will have random phases and will not interfere with each other,
thus the stopping power of the cluster will just be the sum of the stopping powers of the
individual particles in it.
An interesting point which Fourkal further discusses is the effect which the increased
LET of the proton cluster may have on the RBE. He provides two possible scenarios: the
increased LET of the cluster is translated into the increased LET of the individual protons in
it and the data for the single proton RBE can be used to determine the biological effective-
ness of the cluster; the RBE also depends on the charge of the particles, where the higher
the charge the higher the RBE and the cluster could be viewed as a quasi-particle with the
effective charge greater than 1 and a RBE value closer to that for heavier ions. Both of
these scenarios result in an increase in the RBE of the cluster and the RBE of a spread-out
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Bragg peak built out of different energy proton clusters should also be elevated [228], both
conclusions that support the use of laser-driven ions for hadron-therapy.
When a laser interacts with a thin foil target, electrons are expelled from the target by
the action of the laser’s ponderomotive force and the remaining charged substrate expands
owing to the Coulomb explosion effect [228]. Assuming 10% of the electrons completely
escape the target, which was of initial size 10 µm, the proton cloud concentration at 1 m
away would be approximately 2 x 108 cm−3 for protons with a velocity of c/2 [228]. This is
much lower than the threshold value of∼ 1011 cm−3 for the collective effects to be observed.
However, at a distance of 10 cm from the target, the proton concentration is 2 x 1011 cm−3,
which is above the threshold for collective effects to be observed [228]. This suggests that
the point of observation where these collective effects may be detected has to be located no
more than 10 cm from the target. This condition means that these collective effects will not
be observed during the cellular irradiations employing laser driven ions described in Chapter
6 as the cell plane will be more than 10 cm from the target. To place a sample this close
to the target, the sample will have to be placed inside the vacuum, which is not feasible for
cell samples as they will not survive. These investigations could be carried out with plasmid
DNA which is more resilient.
Chapter 5
Biological Tools and Techniques
This chapter describes the biological techniques and equipment employed during the radio-
biological experiments performed as part of this thesis, including the design and validation
of a portable, compact, beam-line hypoxia chamber compatible with both X-ray irradiations
and low energy laser accelerated proton irradiations.
5.1 Cell Culture
Tissue culture was first developed in the early 1900s (a frog embryo nerve fibre was out-
grown by Harrison in 1907 [239]) as a means of studying the behaviour of cells in response
to normal and experimental stress, free of the variations that might arise in the whole organ-
ism. Initial methods used fragments of tissues, but as the techniques employed were refined
and developed, it became possible to study the behaviour of single cells, thus the name
was changed to cell culture [240]. Cell culture refers to the removal of the cells from a
host organism and their subsequent growth in a favourable artificial environment composed
of nutrient solutions, a suitable substrate to support the growth of the cells, and carefully
controlled conditions of temperature, humidity and gaseous atmosphere. The cells may be
directly removed from the tissue of the organism and disaggregated by mechanical or enzy-
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matic means before they are cultivated, or they can be derived from a cell line or cell strain
that is already established [240, 241].
Primary cell culture refers to the stage of the culture process after which the cells have
been isolated from the host tissue and proliferated under the appropriate controlled condi-
tions until they have reached confluence, where they occupy all the available space on the
substrate. After this point the cells must be sub-cultured or passaged. The passage number
of the cells is the number of sub-cultures the cells have undergone. This number should
not be allowed to get too high, otherwise the cells will start to undergo genetic drift and
other variations. The split ratio used when sub-culturing is dependent on when the cells are
required for experiments; for example a 1:2 split should be 70-80% confluent and ready for
use within 1 to 2 days, a 1:5 split will be ready in 2 to 4 days and a 1:10 split will be ready in
approximately 4 to 6 days. Cells should be sub-cultured when they are approximately 80%
confluent (80% of the substrate is covered with cells) and in the log phase of growth. When
the cells are fully confluent they stop growing, and it takes them longer to recover when
they are reseeded. Cells can be sub-cultured if they are less than 80% confluent, but a lower
split ratio should be used to ensure the cell density is high enough for the cells to survive,
however if the cells are over confluent they will start to die off and may not be recoverable
[241, 242].
A cell line is what a primary culture becomes after the first sub-culture. Cell lines which
have been derived from primary cultures are most commonly finite cell lines which have
a limited life span, as normal cells can only divide a limited number of times before they
lose their ability to proliferate through a genetically determined event known as senescence.
Continuous cell lines are formed when finite cell lines become immortal through a process
known as transformation, where the finite cell acquires the ability to divide indefinitely
[241].
The exact conditions of cell culture vary widely and are dependent on what cell type is
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being used and what biological processes are being investigated, although all cell culture
must be carried out in aseptic conditions under a laminar flow hood to prevent the con-
tamination of the cell line. Most cells are anchorage dependent and must be cultured on
appropriate solid or semi-solid substrates to produce monolayer adherent cultures. Other
cells can be grown floating in the culture medium in suspended culture. Most cells are
stored in a cell culture incubator at 37◦C with a 5% CO2 atmosphere and 95% humidity.
5.1.1 AG01522 Cell Line
The cell line used for all the radiobiology experiments carried out for this thesis was the
human fibroblast cell line AG01522. This is a male apparently healthy non-fetal tissue
skin cell line that is untransformed and exhibits fibroblast-like morphology. The cells were
obtained from the Coriell Institute for Medical Research (Camden, New Jersey, USA) from
the original culture initiated on the 21st of January 1976 from explants of minced foreskin
removed ante-mortem one day prior to culturing [243].
These are normal non-cancerous adherent cells, which means they must be attached
to a substrate such as a culture flask in order to proliferate, and they grow in a single layer
called a cell monolayer as a result of contact inhibition. These properties differ from cancer-
ous cells which display a degree of anchorage independence, meaning they can proliferate
in suspended culture, and fail to exhibit any contact inhibition thus overgrow their neigh-
bouring cells and form piles of cells or "foci" on the cell monolayer [133, 149]. Contact
inhibition is the stopping of the continued locomotion of the cell in the direction which has
brought it into contact with an adjacent cell, such that one cell does not use another as a
substratum [244]. This type of anti-social behaviour between the cells is a reflection of the
altered interactions between the cell membranes in contact with each other and the substrate
on which they are growing [133].
AG01522 cells exhibit fibroblast morphology where the cells are bipolar or multipo-
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Fig. 5.1 AG01522 human fibroblast cells at 10 x magnification. Image taken a few hours
after seeding as the cells are starting to attach and spread out.
lar and grow in a flat extended manner and not the round morphology (lymphoblast-like)
adopted by cancerous cells [149, 241]. At confluence AG01522 cells have a cellular cross
sectional area estimated between 800 µm2 [245] and 1370 ± 50 µm2 [246], with a nuclear
area of 144 µm2 and nuclear thickness of 1.2 µm [247].
5.1.2 Sub-culture Technique
The AG01522 were cultured in filtered minimum essential medium eagle with alpha modi-
fications (alpha-MEM, Sigma Aldrich) supplemented with 20% FBS (foetal bovine serum)
and 5% Pen-Strep (penicillin streptomycin antibiotics). This equates to ∼ 100 ml of FBS
and 5 ml of 1 x Pen-Strep being added to a standard 500 ml bottle of alpha-MEM. Only
one or two bottles of media were prepared at a time to keep the media fresh and the cultures
contamination and crystal free. If the media showed signs of crystallisation or contamina-
tion, it was discarded and fresh media prepared. The prepared and unprepared media were
stored in the fridge or cold room at 5◦ and warmed to 37◦ in a water bath before use with
the cells.
The cells used were from a stock of cryo preserved passage 9 cells kept in the CCRCB
-80◦ freezer, originally from the Coriell Institute. The cells were thawed by holding the 2 ml
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vial in the water bath for approximately 3 minutes to thaw the cell suspension, then adding
the suspension drop wise using a Gilson pipette to a 50 ml centrifuge tube containing 10 ml
of fresh cell medium. The combined suspension is gently mixed and pipetted to disperse
the cells evenly in a single cell suspension, then added to a T25 tissue culture flask (a plastic
flask with a cell growth area of 25 cm2 and a vented filter cap). The flask is stored in a
standard cell culture incubator with a 95% air, 5% CO2 atmosphere, 95% humidity and a
temperature of 37◦. After 24 hours, the cell media is removed and replaced with 15 ml of
fresh media. The cells are left to grow until they reach 80% confluence, with the media
being changed every two days. When the cells reach confluency, the media inside the flask
changes colour, and appears turbid when the media becomes infected with bacteria when
the culture flask is swirled. If the cells are over confluent it can be difficult to reseed the
cells in a uniform density as the cell pellet tends to clump, giving uneven growth in the new
culture flask. The cells should either be transferred from the T25 flask into a single T75
flask (a flask with a growth area of 75 cm2), or split into two or three T25 flasks, to allow
the cells more space to proliferate. These cells are now in passage 10. The cells should be
allowed to multiply and grow in number until you have enough for your experiment, usually
around passage 12, and experiments should be carried out with cells of roughly the same
passage number (12-14 in the experiments discussed) for the reasons described in Section
5.1 above.
The methods used for seeding the cells on the cell dishes ready for the experiments
and reseeding the cells in culture flasks after splitting are predominantly the same, with
slight variations in the final steps. The cells are first removed from the incubator and the
old media is discarded. The cells are then washed with 10 ml of sterile PBS (Phosphate
Buffered Saline) three times to remove any remaining media. This washing step removes
any traces of serum, calcium and magnesium that would inhibit the action of the dissociation
agent [241]. The PBS is discarded and 10 ml of 0.05% Trypsin EDTA (diluted in PBS) is
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added to trypsinise the cells in the T175 culture flask. The flask is placed in the incubator
for approximately 3 to 5 minutes for the trypsin to work. The cell flask is gently tapped
to help the cells dislodge from the surface. The trypsin in the flask becomes cloudy when
the cells have detached, and the flask is checked under the microscope to make sure all
the cells are now in suspension. The suspension is neutralised with 10 ml of fresh culture
medium, and is gently pipetted against the side of the flask to break up any clumps of cells
and to ensure all the cells have been detached into the suspension. The amounts of 0.05%
Trypsin EDTA and cell culture medium can be adjusted depending on the size of flask the
cells are in; 5 ml and 5 ml should be used for a T75 flask for example, 3 ml and 3 ml
for a T25 flask. The suspension is then transferred to a 50 ml centrifuge tube and spun at
1200 rpm for 6 minutes to produce a cell pellet. The supernatant containing the trypsin
and media is gently poured off and the cell pellet is re-suspended in 5 ml of fresh media.
The media is gently pipetted several times to dislodge the pellet and form a single-cell
suspension. This is where the methods start to diverge. At this point the cell suspension
can be directly transferred to two or more fresh flasks of the same size, or one larger flask
depending on the volume of cells required and the passage number, with 25 ml of fresh
media added to the flask (T175, less for smaller flasks). When specific volumes of cells
are required for experiments, the cell suspension must be counted to obtain the number of
cells per ml. This was done by several different methods: a Z2 Coulter Counter particle and
size analyser (Beckman Coulter, High Wycombe, UK); a portable Scepter 2.0 Cell Counter
(Merck Millipore, Darmstadt, Germany); and a Hemocytometer. The Coulter Counter and
Scepter were used for X-ray experiments carried out in the CCRCB and laser-driven ion
experiments carried out in TARANIS, the Scepter was used for experiments carried out at
Vulcan, and the Hemocytometer was used for experiments at LULI and the previous work
carried out at Gemini.
When using the Coulter Counter, 0.1 ml of the cell suspension is added to a Coulter
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counting cup containing 9.9 ml of Isoton solution (Beckman Coulter) to produce a 1:100
solution. A background reading is established using a cup containing 10 ml of Isoton, which
must be below 50 before the cell suspension is analysed. The Coulter Counter works by
using electrical sensing technology often referred to as the Coulter Principle. This principle
is based on measurable changes in the electric resistance produced by the cells suspended in
the Isoton solution (which acts as an electrolyte). There is an aperture in the Coulter probe,
between two electrodes, which is the sensing zone through which the cells pass. Each cell in
the sample will displace its own volume in the electrolyte, with this displaced volume being
measured as a voltage pulse, and the pulse height being proportional to the cell volume
[248]. The volume of solution drawn through the probe is 0.5 ml and is precisely controlled
by a mercury free metering system, allowing both accuracy and speed. Thresholds can be
set such that only particles between 5 and 21 µm are counted. The cup containing the cell
sample is then loaded into the Coulter counter, and the number of particles is measured
three times. An average number of particles is calculated and this number is multiplied by
the dilution factor to determine the number of cells per ml in the original cell suspension.
For example if the average count was 1006 in 0.5 ml of the 1:100 solution, the cell number
per ml would be calculated as follows:
1006×2×100 = 201200 cells ml−1 (5.1)
When using the Scepter, 0.5 to 1 ml of the cell suspension is required for the counting
sample, therefore the cell pellet should be re-suspended in 10 ml of media rather than 5 ml
so as not to waste a large proportion of the sample. The 0.5 ml sample of the suspension
should be added to a 1.5 ml micro-centrifuge tube, which should be gently agitated to keep
the suspension single cell before counting. The Scepter is turned on and a sensor tip is
attached when prompted, with the electrode sensing panel facing forwards. The plunger
on the Scpeter is depressed and the sensor tip submerged in the sample, then the plunger
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Fig. 5.2 (a) Schematic of a Hemocytometer [251]. (b) The appearance of the counting grid
visualised under the microscope [10]. (c) Counting system to ensure accuracy and
consistency; cells within the large square and those crossing the edge on two out of the
four sides are counted [252].
is released to draw 50 µl of the suspension into the channel embedded in the sensor. The
Sceptor detects each cell passing through the sensor’s aperture, calculates the concentration
and displays a histogram as a function of cell diameter or volume on its screen [249]. The
Scepter also employs the Coulter Principle, where the cells flow into the sensor, increasing
the resistance and thus the voltage by Ohm’s law (V = IR). Voltage spikes of the same size
are bucketed into a histogram, giving you quantitative data on the cell morphology which
can be used to evaluate the health of your cells [250]. The concentration displayed on the
Scepter is the number of cells per ml of the solution.
When using the Hemocytometer, it is first cleaned with ethanol and the coverslip affixed.
10 µl of the cell suspension is gently pipetted at the edge of the coverslip and allowed to
run under the coverslip by capillary action. The coverslip has a series of lines etched on
it producing a 3 by 3 grid of 1 mm2 squares. Each of the corner squares is divided into
16 squares of area 0.0625 mm2, and the centre square is divided into 25 0.04 mm2 squares
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which are subdivided into 16 squares themselves [253]. The corner squares should be used
for counting the AG01522 cells. The Hemocytometer is visualised under a microscope and
the four 1 mm2 corner squares are counted as shown in Figure 5.2. This produces 4 counts
which should be averaged, with the cell concentration per ml calculated as follows:
avaerage number of cells in a 1 mm2 square × dilution factor ×104 (5.2)
The cell counts obtained with the Coulter Counter and the Scepter are both very accurate
and are in good agreement with each other for concentrations up to 5 x 105 cells per ml when
theoretical and measured cell concentrations are compared. The Hemocytometer is in good
agreement up to concentrations of 2.5 x 105 cells per ml. The Coulter counter and the
Scepter both use the Coulter method to calculate the number of cells, hence why they are in
good agreement, but as the Hemocytometer is a manual method, human error creeps in at
higher concentrations, with the concentration usually being over estimated [254].
The original cell suspension can then be diluted accordingly for plating specific cell
quantities, or the total number of cells can be obtained to determine the split ratio for re-
seeding. The cell suspension is diluted to the desired concentration with fresh cell culture
media and transferred to fresh culture flasks for re-seeding or sterile cell dishes for experi-
ments.
5.1.3 Mycoplasma Testing
Mycoplasma contamination is one of the most prevalent and serious sources of cell line
contamination. Mycoplasma represent a large group of micro-organisms called Mollicutes,
characterised by a lack of a rigid cell wall and plasma-like form. They have extremely
basic genomes, forcing them to function as parasites in order to meet their energy demands,
thus they adhere to other cells and exploit their host cells to survive. These characteristics,
coupled with their small size (0.3 - 0.8 µm), make them invisible to the naked eye and
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Type Incidence
primary cell cultures 1 %
early passage cell cultures 5 %
continuous human or animal cell lines 15 - 35 %
Table 5.1 Incidence of Mycoplasma contamination in cell culture [255]
very hard to detect by optical microscopy even at high concentrations (> 107 cfu/ml, colony
forming units per ml) [255–257]. Bacterial and Fungal infections are also important in
cell culture, but they are not so serious as they are usually obvious and easily detected.
Mycoplasma contamination does not cause any visible changes to the growth media such
as turbidity or a change in pH, which are commonly associated with bacterial or fungal
infections, thus infections can remain undiscovered for several months.
The use of contaminated cells endangers almost all aspects of cell physiology, often
leading to the loss of unique cell lines and erroneous results. One of the first signs of
an infection is a slowdown in cell profliferation as the cells and Mycoplasma compete for
nutrients. Other signs include cell aggregation and poor transfection efficienices. The My-
coplasma grow very slowly, and do not kill the host cell outright but affect variuos cellular
parameters. As they cause so many changes, the infected cell line can nearly be considered
as a different cell line [258]. This is a real problem as it seriously impacts the reliabil-
ity, reproducibility and consistency of experimental results, thus Mycoplasma testing is an
important quality control measure.
The primary sources of mycoplasma contamination are cross contamination from untested
infected cells, contaminated cell culture medium reagents such as serum and trypsin, or di-
rect infection from the researcher [256, 257]. Personnel are the main source of M. orale,
M. fermentans, and M. hominis, which account for more than half of all Mycoplasma in-
fections, M. arginni and M. laidlawii originate in FBS, and trypsin is a main source of M.
hyorhinis [259]. To effectively prevent Mycoplasma contamination, good aseptic technique
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Species Frequency Natural Host
M. orale 20 - 40 % Human
M. hyorhinis 10 - 40 % Swine
M. arginini 20 - 30 % Bovine
M. fermentans 10 - 20 % Human
M. hominis 10 - 20 % Human
M. laidlawii 5 - 20 % Bovine
Table 5.2 Most common species of mycoplasma that cause cotamination [255]
must be used, laboratory accidents should be reduced, the laboratory should be kept clean,
and a strict policy of quarantining all incoming cell lines until testing has confirmed they
are Mycoplasma free [258]. Once Mycoplasma have been detected, the contaminated cell
line should ideally be discarded as the contamination can spread rapidly to other cultures
through the dispersion of aerosol droplets. However, if this is not a feasible option, they can
be treated with Mycoplasma-eradication products, including Mycoplasma selective antibi-
otics (the lack of cell wall means Mycoplasma are unaffected by many common antibiotics
such as Penicillin and other beta-lactam antibiotics that target the cell wall [260]), which can
eliminate the Mycoplasma and restore the cell behaviour within a few days/weeks [256].
There are several different methods of Mycoplasma testing including histological stain-
ing, electron microscopy (TEM and SEM), biochemical methods (e.g. enzyme assays
and protein analysis), immunological procedures (such as fluorescence staining), DNA flu-
orochrome staining, microbial culture, RNA hybridization (filter/liquid) and polymerase
chain reaction (specific and universal PCR primers) [255]. All cell samples used for the
experiments in this thesis were tested for Mycoplasma by the laboratory technician in the
CCRCB at regular intervals and found to be Mycoplasma free.
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5.1.4 Cell Doubling
An experiment was preformed using AG01522 human fibroblast cells to determine the dif-
ference in doubling time of cells plated on the Mylar used for all our radiation exposure
experiments and normal cell culture slide flasks.
Approximately 100,000 cells were seeded onto 6 cell dishes, each with a 3 µm My-
lar substrate stretched between a stainless steel ring and plate, sealed with an O-ring, and
100,000 cells were also seeded in 6 cell culture slide flasks. These cells were cultured in the
same growth medium with the same supplements, and stored on the same shelf of the cell
culture incubator at 37◦C, 5% CO2 and 95% humidity. Two samples each of those plated
on Mylar and slide flasks were left in the incubator for 72 hours, another two for 48 hours
and the final two for 24 hours.
After 24 hours, the first two samples of each type were removed from the incubator and
trypsinised with 1 ml of 0.01% Trypsin EDTA. The Trypsin was continually pipetted over
the cell sample and the dish or flask gently agitated to remove all the cells, checking under
the microscope to ensure all cells had detached. The solution was then neutralised with
1 ml of fresh culture media, and the suspension was still continuously agitated to ensure
a single cell suspension. A 10 µl sample of this suspension was then added to a Coulter
cup containing 9.9 ml of Isoton solution, and counted twice with the Coulter Cell Counter.
The cell concentration per ml, and thus the total number of cells in the 2 ml sample were
calculated. This process was repeated with the four 48 hour samples and the four 72 hour
samples at the appropriate times. The results are presented in Table 5.3.
The cell doubling time was calculated for the cells grown on Mylar and the cells grown
on the slide flasks using the following formula:
Doubling time =
Duration× log(2)
log(Final Concentration)− log(Initial Concentration) (5.3)
Using this equation, the doubling time for cells grown on Mylar was found to be 13.73
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24 Mylar 24 Slide Flask
hours Sample 1 Sample 2 hours Sample 1 Sample 2
Count 1 59200 55200 Count 1 98800 118000
Count 2 51200 54000 Count 2 109200 98800
Average 54900 Average 106200
St. Dev. 3321 St. Dev. 9269
St. Err. 1660 St. Err. 4635
48 Mylar 48 Slide Flask
hours Sample 3 Sample 4 hours Sample 3 Sample 4
Count 1 165200 199200 Count 1 235600 279600
Count 2 172000 201200 Count 2 219200 276400
Average 184400 Average 252700
St. Dev. 18472 St. Dev. 30000
St. Err. 9236 St. Err. 15000
72 Mylar 72 Slide Flask
hours Sample 5 Sample 6 hours Sample 5 Sample 6
Count 1 134800 210000 Count 1 207600 255200
Count 2 152800 202800 Count 2 210400 258800
Average 175100 Average 233000
St. Dev. 36999 St. Dev. 27775
St. Err. 18499 St. Err. 13888
Table 5.3 Summary of the number of cells in each 2 ml sample from each of the two counts,
average number of cell from the counts, the standard deviation and the standard error of the
AG01522 cells grown on 3 µm Mylar (surface area of 16.63 ± 0.73 cm2) and cell culture
slide flasks (surface area of 9.2 ± 0.2 cm2), measured 24, 48 and 72 hours after seeding.
± 0.66 hours, and the doubling time for cells grown on the slide flasks was 19.19 ± 1.63
hours. The cell counts at the different data collection times are shown in Figure 5.3.
Unfortunately, the counts obtained show that almost 50% of the original seeded cells
were not present on the Mylar 24 hours after seeding. This could be due to errors in the
original calculations when plating the cells, however this is unlikely as the same solution
was used to plate all the samples and more than 100,000 cells were present in the slide
flasks. The cell solution may not have been a single cells suspension, thus more cells were
plated on the slide flasks than the Mylar, or more cell clumps were deposited on the Mylar
affecting the ability of the cells to attach and proliferate, or there is something present on
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Fig. 5.3 Graph showing the total number of cells in the 2 ml samples 24, 48 and 72 hours
after seeding. The samples were counted using a Coulter Counter, with the total cell
number calculated using the method described in Section 5.1.2.
the surface of the Mylar which the cells do not like. However, once the cells do attach, they
appear to proliferate faster on the Mylar than on the slide flasks.
There could also be problems with using the Coulter Counter to obtain the counts, as the
Coulter Counter is most accurate with raw cell counts of between 500 and 5000. The raw
cell counts obtained before plating the original samples and after harvesting the samples at
the different time points were between 125 and 700, thus some of the counts fall outside this
range and may not have been properly detected by the Coulter Counter as the concentration
was too low.
All the experiments presented in Chapter 6 were carried out on Mylar, so whatever effect
occurred was present for all experiments. Being aware of this issue allowed us to adjust the
numbers of cells plated to ensure the values we required would be present on the Mylar. For
example we would normally plate 300,000 cells, but we increased this to 400,000 cells to
account for some lost cells.
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5.2 Detection of DNA Damage
A DNA DSB is the only form of critical DNA damage, as it is believed that a single un-
repaired DSB is sufficient for the induction of the cell death process [261, 262]. A DSB is a
type of DNA damage in which two complementary strands of the double helix are damaged
simultaneously in locations close to each other, as described in Section 5.2.1. The factors
leading to the formation of DSBs include exogenous factors such as ionising radiation and
endogenous factors, which are associated with physiological processes occurring in the cell
[263], such as a constant process of oxidative damage by ROS that are produced inside the
cell as a result of metabolic processes. It is estimated that in a single cell cycle at least 5000
single stranded DNA breaks can occur as a result of ROS production[261]. Approximately
1% of these DNA breaks are converted into double strand breaks, mainly during DNA repli-
cation, while the remaining 99% is repaired. Thus, during the cell cycle in a single nucleus,
about 50 so called “endogenous” double strand breaks are formed. Accumulation of unre-
paired DNA damage induced by ROS leads to cell ageing and may be responsible for the
induction of neoplastic transformation.
In humans, the efficient repair of DNA DSBs is essential for cell survival. Two major
pathways have evolved to deal with these lesions, HR and NHEJ as described previously
(Section 5.2.4). The mechanism of HR is based on using the genetic information from
a corresponding undamaged region present on the second DNA molecule or homologous
chromosomes and therefore is active mainly during the S and G2 phases of the cell cycle,
while NHEJ is based on a direct ligation of the two ends of damaged DNA molecules and
repairs double strand breaks mainly in the G1 phase.
5.2.1 γ−H2AX
It was reported several years ago that in mammalian cells the phosphorylation of the subtype
of histone H2A, called H2AX, in the position Ser139 occurs in response to double strand
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Fig. 5.4 (a) Schematic of a chromatin containing histones [266]. (b) γ-H2AX foci [10].
break formation [235, 263] (hundreds to thousands of H2AX are phosphorylated per double
strand break [264]). γ-H2AX induction is one of the earliest events detected in cells follow-
ing exposure to DNA damaging agents; it appears within minutes and reaches maximum
levels after 30 minutes [235]. H2AX represent 2-10% of the H2A subfamily of histone
proteins in chromatin and has not been found to be concentrated at a specific region of the
DNA, but instead is randomly incorporated into histones throughout the DNA. The phospho-
rylated form of H2AX is called γ-H2AX, as it was first observed in cells exposed to γ-rays
[262]. Since then, many researchers have focused on the explanation of the mechanisms
which induce phosphorylation of H2AX and its role in DNA damage signaling and repair.
H2AX proteins within a few mega-bases of the damage site are involved, but it is unclear
how this phosphorylation propagates form the damage site. After DNA repair, γ-H2AX is
dephosphorylated [263], which is useful for the assessment of DNA repair [265].
Histone H2AX is a substrate of several phosphoinositide 3-kinase-related protein ki-
nases (PIKKs), such as ATM, ATR (ATM and Rad3-related), or DNA-dependent protein
kinase (DNA-PK) [261, 264]. ATM kinase is considered as a major physiological mediator
of H2AX phosphorylation in response to double strand break formation. ATM is activated
by its autophosphorylation at Ser1981 position, which leads to dissociation of the inactive
ATM dimers into single protein molecules with increased kinase activity. A tri-protein com-
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plex called MRN complex recognises DNA damage, recruits ATM to the site of damage and
also functions in targeting ATM to initiate phosphorylation of the respective substrates. It
is also reported that ATM activation requires prior ATM acetylation, mediated by Tip60
histone acetyltransferase. H2AX can also be phosphorylated by ATR and DNA-dependent
protein kinases. ATR phosphorylates H2AX in response to single strand DNA breaks and
during replication stress, such as replication fork arrest. DNA-PK mediates phosphoryla-
tion of H2AX in cells under hypertonic conditions and during apoptotic DNA fragmentation.
However, DNA damage caused by ionising radiation leads to phosphorylation of H2AX that
is mediated by all PIKK kinases, ATM, ATR and DNA-PK [261].
Measuring DNA damage has been of interest in the research community because of its
predictable nature. Development of an antibody specific to γ-H2AX made it possible to
detect H2AX phosphorylation and thus detection of DNA damage in individual cells. The
presence of γ-H2AX in chromatin can be detected shortly after induction of double strand
breaks in the form of discrete nuclear foci produced by large numbers of γ-H2AX molecules
[262]. Since each focus represents a double strand break in a 1:1 manner [264], their fre-
quency reports the incidence of double strand breaks [263]. Compared with alternative
methods of DNA damage assessment, the immunocytochemical approach is less cumber-
some, more precise, requires only a small sample size and offers much greater sensitivity
[235, 261, 262, 264]. The presence of γ-H2AX containing nuclear foci can be measured
by microscopy, flow cytometry and possibly Western blotting of cell/tissue lysates, with
normalisation for the total H2AX levels.
γ-H2AX foci are most commonly detected and quantified by fluorescence, which in-
volves the primary γ-H2AX antibody described above and fluorescent secondary antibodies.
Immunofluorescence requires the use of epifluorescent microscopes, which allow the naked
eye to count cells with DNA damage. γ-H2AX foci are manually counted by eye through the
microscope or in images previously captured, it is laborious, time consuming and subject to
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human error. It is therefore clear that there is an incentive to develop high throughput foci
counting systems for research and routine clinical assay. However, validation of these auto-
mated systems unavoidably relies on comparisons with manual counting, but once achieved,
enables the extension to the analysis of foci size and intensity [262]. To assess the γ-H2AX
foci, the results of immunofluorescence have been tested against the comet assay. This as-
say has been deemed quick, simple and reliable, but recently it has been established that
the γ-H2AX assay is 100 times more sensitive to detecting damage levels than the comet
assay [264]. Microscopy reveals valuable information inaccessible by other methods, such
as differential response in tumour tissues (homogeneous vs. non-homogeneous DNA dam-
age induction) and the extent of DNA damage (separate foci in weakly damaged cells vs.
pan-staining in suspected apoptotic cells) [262]. The γ-H2AX assay can also be exploited
to study distinct cell cycle phases and individual cells [265].
The most important clinical application of γ-H2AX measurements is to follow double
strand break levels induced by radio- and chemotherapy as a marker of treatment efficiency
and in dose/scheduling estimation, as well as to determine the efficiency of DNA repair to
predict possible tumour sensitivity of resistance to DNA damaging anticancer agents.
5.2.2 53BP1
Owing to the action of the DNA damage checkpoints, cells generally do not enter the S
or M phase before DNA lesions are properly repaired. Cancer cells have often lost some
aspects of checkpoint function, therefore they have a greater sensitivity to DNA damaging
agents, which in turn provides them with a higher rate of genomic evolution to acquire a
growth advantage. The DNA damage checkpoint is a signal transduction cascade that relays
information from DNA lesions to components of the cell cycle [267]. In response to DNA
damage, the downstream effector checkpoint kinases Chk1 and Chk2 are activated by the
ATM-related protein kinases [268], then Chk2 phosphorylates p53, arresting the cell cycle
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at the G1/S or G2/M boundary respectively [269]. Yeast genetics have identified the genes
that appear to be involved in the early stages of sensing and processing DNA damage and
have been classified into three different groups; yeast homologues of ATM-related kinases
that are structurally similar to phosphatidylinositol 3 kinase, putative sliding clamp and
clamp loader complexes structurally related to PCNA and RFC, and proteins with BRCT
domains [267]. The sliding clamp and its loader are required for the phosphorylation of
BRCT proteins, and BRCT proteins are required for the phosphorylation and activation of
the checkpoint kinases. The carboxyl termini of the BRCT proteins contain a tandem repeat
of BRCT domains, each consisting of ∼ 95 amino acid residues that were first identified in
BRCA1. In humans, BRCA1 is thought to function as a counterpart of the BRCT proteins
in yeast. Some proteins involved in checkpoint control or repair are relocalised to nuclear
foci after DNA damage, including BRCA1 [267].
ATM-dependent phosphorylation of the p53 tumour suppressor is known to mediate cell
cycle arrest in response to DNA damage [268]. The gene which encodes p53 is the most
frequently mutated gene in all cases of human cancer, with the levels of the p53 protein being
activated and stabilised in cells exposed to ionising radiation. One protein which interacts
with p53 is 53BP1 [268, 270]. 53BP1 is relocalised to a number of nuclear foci after DNA
damage by ionising radiation [269], with DSBs being most effective in inducing this focal
phenotype. The focal redistribution of 53BP1 is related to the extent of its phosphorylation
[271], which is also induced by DNA damage [268].
The 53BP1 foci colocalise with other damage induced foci such as γ-H2AX foci to
DSB sites [269–271], with their peak number approximately equal to the number of DSBs
induced by ionising radiation and their dephosphorylation over time with kinetics that paral-
lel the rate of DNA repair [272]. 53BP1 foci are quantified in an analogous way to γ-H2AX
foci using antibodies specific to 53BP1, a detailed description of which is given in Section
5.3.
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Fig. 5.5 (a) Schematic of BRCA1 protein [273], (b) 53BP1 foci.
53BP1 concentrates at discrete nuclear foci within 5-15 minutes [272] and the assembly
of the foci is not cell cycle stage dependent, in contrast to BRCA1 which shows a focal
distribution in the S phase. Ionising radiation induces BRCA1 focal assembly in cells pre-
sumed to be in either the G1 or G2 phases of the cell cycle, whereas irradiation induced
53BP1 foci occur in almost all cells except those in mitosis [267].
In a comprehensive study by Paull et al. [274], it was shown that the different types of
damage-induced foci, including BRCA1, all originate from γ-H2AX foci at certain stages of
the post-irradiation period, with the associations appearing in a sequential order. Kinetically
the appearance of 53BP1 foci and 53BP1’s hyper-phosphorylation occur slightly later than
the appearance of γ-H2AX foci and H2AX’s hyper-phosphorylation, but earlier than other
types of damage-induced nuclear foci [267, 272, 274]. This is explained by the fact that
53PB1 needs to be recruited to the foci after DNA damage in contrast to H2AX which is
already present at DSBs. More than half of the radiation induced DSBs are rejoined in the
order of minutes, with the rest persisting for several hours; 53BP1 may be implicated in the
repair and/or checkpoint control associated with the latter [267].
5.3 Immunofluorescence
Immunofluorescence is the labelling of antibodies or antigens with fluorescent dyes, a tech-
nique often used to visualise the sub-cellular distribution of biomolecules of interest. Tissue
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sections or cultures are studied using a fluorescent microscope or confocal microscopy.
The γ-H2AX and 53BP1 immunofluorescence assays are techniques that use fluores-
cently labelled antibodies to locate and quantitatively study DNA DSBs in biological sam-
ples. The 53BP1 assay was used on the main laser-driven ion radiobiology experiments
presented in this thesis, as well as the previous work presented in Section 7.1.1 which was
the first time that this particular assay was chosen instead of the γ-H2AX assay normally
used for this type of radiobiology experiment. The majority of the experiments involving
X-rays also employed the 53BP1 assay, with the remainder employing the γ-H2AX assay.
This 53BP1 assay was chosen as in testing it had provided better results in terms of clearly
discernible foci, and when combined staining of HIF-1α was required the HIF-1α antibod-
ies compatible with 53BP1 staining produced much better staining of the HIF-1α than those
compatible with the γ-H2AX antibodies (antibody compatibility is discussed below).
The immunofluorescence technique is an established and sensitive approach which al-
lows the direct imaging of the location of the double strand breaks [267, 272]. This assay
has been optimised for a variety of radiation types in order to monitor qualitative and quan-
titative changes [11, 272].
Immunofluorescence can also be used to visualise the induction of hypoxia, by similarly
labelling HIF-1α . This produces more of a pan staining of the cell nucleus rather than
discrete foci as seen in DNA DSB staining.
Several different markers can be studied at the same time using the immunofluorescence
technique, as long as the primary antibody and the corresponding fluorescent secondary
antibody for each marker are raised in different animals. For example, samples which were
exposed to a hypoxic gas mixture prior to irradiation we stained for both 53BP1, raised
in rabbit, to study DNA DSB damage, and HIF-1α , raised in mouse, to study hypoxia
induction. These antibodies are also available raised in other animals to allow for different
combinations of markers to be studied. For example, the antibodies used for the γ-H2AX
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were raised in mouse and were used in combination with HIF-1α antibodies raised in rabbit.
The secondary antibodies used were all raised in goat, with anti binding properties of the
species the primary was raised in. For example GAR488, is anti rabbit and is used in
conjunction with 53BP1 raised in rabbit.
5.3.1 Immunofluorescence Protocol
The main steps of the immunofluorescence protocol are the same for the 53BP1, γ-H2AX
and HIF-1α assays. These steps are fixation, permealisation, blocking, primary and sec-
ondary antibody addition, and slide mounting.
Fixation
Fixation refers to the killing of the cells whilst maintaining the environment at the point
of kill. During this step it is important that the cellular structure remains in its native con-
formation as far as possible, with the ideal fixation conserving the cellular and sub-cellular
architecture whilst providing unblocked antigens for good antibody binding [275]. Once
the sample is fixed the rest of the protocol can be carried out without losing the biomarker
of interest [276]. There are several different fixatives that can be used, but these can be
roughly divided into two groups: organic solvents and chemical crosslinkers. Organic sol-
vents fix the cells through denaturation by removing and replacing the free water in the cells
and tissues causing a change in the tertiary structure of the proteins by destabilising the
hydrophobic bonding [277]. They also create large holes in the cellular membrane by dis-
solving lipids [278]. Crosslinkers chemically react with the proteins and other cell and tissue
components, becoming bound to them by addition and forming inter- and intra-molecular
crosslinks [277]. They create bonds chiefly between lysine residues, keeping the structure
of most proteins intact [278]. Both types of fixatives were used throughout the biological
investigations presented.
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Fixation using an organic solvent (a 1:1 solution of methanol:acetone) was employed
on the previous work discussed in this thesis (Section 6.1.1), the radiobiology experiments
carried out at LULI (described in Section 6.3) and the experiments carried out at TARANIS
(described in Section 6.2).
Fixation with Methanol:Acetone
• All the media is removed from the cell samples.
• Each sample is washed twice with 5 ml of PBS.
• All the remaining PBS is removed.
• 5 ml of chilled 1:1 methanol acetone solution is added to each sample, which is stored
in the fridge for 10 minutes
• The fixing solution is removed from the samples, which are then washed thrice with
5 ml of PBS.
Fixation using a crosslinker (4% PFA - paraformaldehyde solution1obtained from dilut-
ing a stock 8% PFA solution in PBS) was employed on the TAP radiobiology experiment
(described in Section 6.4) and the comparative X-ray experiments carried out in the CCRCB
(Section 6.5).
Fixation with PFA
• All the media is removed from the cell samples.
• Each sample is washed twice with 5 ml of chilled PBS.
• All the remaining PBS is removed.
• 2 ml of 4% PFA is added to each sample for 10 to 12 minutes at room temperature.
1Paraformaldehye is technically not the correct term to use when referring to this fixative, as paraformalde-
hyde is a polymerised formaldehyde which cannot be used as a fixative. It is instead a methanol free formalde-
hyde solution obtained by boiling paraformaldehyde [279], hence why the name paraformaldehyde has stuck.
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• The PFA is removed from the samples, which are then washed thrice with 5 ml of
PBS.
PFA becomes less effective as a fixative the older it is, so large quantities should not be
made. It also has to be carefully disposed by diluting to even lower concentrations in sealed
containers, then left for several days before being flushed away.
The first step of washing the cells must be carried out very quickly when dealing with hy-
poxic samples, as as soon as they are removed from the hypoxia chambers they immediately
start to reoxygenate. If too much time is taken to complete this step a true representation
of the interaction conditions will not be preserved in the sample. This step was carried out
in approximately 30 seconds, thus a small amount of re-oxygenation does occur, but not
enough to influence the results.
Fixation is carried out at the specific time points post irradiation which are relevant to
the biological marker being studied. Samples which have been fixed are stored in the fridge
covered in at least 3 to 5 ml of PBS, until all samples are fixed and ready for the next stage
of the process.
Permeabilisation
Through permeabilisation the cellular structures are made accessible to the antibodies which
would otherwise be unable to pass through the lipid membranes of the cell [275]. Fixation
with organic solvents can permeabilise the cells to some degree and this step can be skipped,
however, fixation with chemical crosslinkers does not and additional treatment with deter-
gents such as Triton X-100 or organic solvents such as methanol is required [276].
Permeabilisation using an organic solvent was employed on the previous work discussed
in this thesis (Section 6.1.1), the radiobiology experiments carried out at LULI (described
in Section 6.3) and the experiments carried out at TARANIS (described in Section 6.2).
Permeabilisation with Methanol
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• Any remaining PBS is removed from the samples.
• 2 ml of chilled methanol is added to each sample, which is incubated on ice for 10
minutes.
• The methanol is removed from the samples, which are then washed thrice for 5 min-
utes with 5 ml of chilled PBS.
Permeabilisation using a detergent solution was employed on the TAP radiobiology ex-
periment (described in Section 6.4) and the comparative X-ray experiments carried out in
the CCRCB (Section 6.5).
Permeabilisation with Triton X-100
• Any remaining PBS is removed from the samples.
• 2 ml of the permeabilisation buffer of 0.5% Triton X-100 in PBS is added to each
sample for 10 minutes at room temperature.
• The buffer is removed from the samples, which are then washed thrice for 5 minutes
with 5 ml of PBS.
Blocking
Before adding any antibodies to the samples, all epitopes on the tissue sample should be
blocked to prevent non-specific binding of the antibodies, which will greatly improve the
staining [276, 280]. Normal serums are common blocking reagents as they carry antibodies
that bind to reactive sites thus preventing non-specific binding of the secondary antibody,
although the serum must be from the same species that the secondary antibody was gener-
ated in as opposed to the primary antibody, otherwise the secondary antibody’s specificity
to the primary antibody will be lost [275, 280].
The samples were blocked with a blocking buffer of 10% Goat Serum, as the secondary
antibodies used were all generated in goat, and 0.1% Triton X-100 in PBS. However, the
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amount of Triton X-100 was increased to 0.25% when there was significant pan staining of
the cell cytoplasm.
• Any remaining PBS is removed from the samples.
• 2 ml of the blocking buffer is added to each sample for 1 to 2 hours , with the samples
being stored inside the incubator at 37◦C for the duration.
• The blocking buffer is removed from the samples, but there is no need to wash the
samples after this step.
Antibody Addition
The antibodies used in this step were specific to 53BP1 or γ-H2AX for DNA DSB detection
and HIF-1α for hypoxia induction verification. The antibodies can be mixed to test for
more than one protein at a time as long as they originate from different species. The perfect
primary antibody will have good affinity and specificity to the protein of interest. The
antibody/antibodies are diluted to the desired concentration in the blocking buffer used in
the previous step. For the DNA damage antibodies, a concentration of 1:1000 was used, and
for HIF-1α 1:500 was used.
Primary Antibody
• Add 1 ml per sample of primary antibody/antibodies in blocking buffer, and leave on
the rocker at room temperature or place in the incubator for 1 to 2 hours
• Wash samples thrice with 3 ml of washing buffer, then once with 5 ml of PBS
The washing buffer was 0.1% Triton X-100 in PBS. The washing steps help to reduce the
background signal produced by unspecific binding of the secondary antibody, by sucking all
the antibody solution out of the specimen, so it is important to allow several minutes for this
step to ensure the efficient diffusion of the washing buffer into the sample.
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The sceondary antibodies fluorescently label the primary antibodies. The secondary
antibody/antibodies are diluted in the same concentrations and blocking buffer as the pri-
mary antibody/antibodies. Ensure the secondary antibody is anti the species the primary
was raised, for example a primary raised in mouse should be used in conjunction with an
anti-mouse secondary. The secondary antibodies used were Alexa Fluor GAR488 (goat anti
rabbit) and GAM594 (goat anti mouse). The Alexa Fluor conjugated antibodies are excel-
lent bright and stable fluorophores which are cross-absorbed for goods species specificity
[276]. It is necessary to carry out all further work in the dark to prevent bleaching of the
samples, as the dyes are light sensitive.
Secondary Antibody
• Add 1 ml per sample of secondary antibody/antibodies in blocking buffer, and leave
on the rocker at room temperature or place in the incubator for 1 hour
• Wash samples twice with 3 ml of washing buffer, then once with 3 ml of PBS
• Remove all remaining solution
Slide Mounting
The cell nuclei are stained to allow better orientation of the cell sample during microscopy,
but also indicates the cellular status of the sample. Gibco Prolong Gold Antifade Mountant
with DAPI (abbreviated to DAPI) was used to stain the cell nuclei and mount the samples on
coverslips. Small 2 ml dropper bottles of pre diluted DAPI were the most convenient way of
adding the DAPI to the samples. The DAPI is able to enter the nucleus and intercalate into
the DNA, even without permeabilisation [275]. The mounting medium helps preserve the
sample and raises the refractive index to give good performance with oil objectives, often
containing scavengers which soak-up free radicals and reduce photo-bleaching [276].
• Ensure the samples are as dry as possible
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• Mark the back of the sample with any relevant information using a permanent marker
to determine where to place the coverslip. Seal the markings with clear nail varnish
• Add 2 drops of DAPI to the cell side of each sample, trying to avoid creating any
bubbles, and attach a coverslip to each sample
• Remove the excess by gently dabbing the sides of the coverslip with a tissue, and
leave to dry for 24 hours in the dark
• Seal the edges of the coverslip with clear nail varnish
• Attach a glass slide to the other side of the sample using a few drops of Superglue,
again trying not to create any bubbles
• Cut the sample from the dish when the Superglue is dry
• Store at 4◦ in the fridge or -20◦ in the freezer until you wish to study the slide under
the microscope
A concise step by step guide for the finalised protocol used in the main laser-irradiation
experiments is provided in Appendix B.
5.4 Fluorescence Microscopy
After the samples were mounted, images of the cells were obtained using the Carl Zeiss Ax-
iovert 200M fluorescence microscope with CCD acquisition capability and Axiovision Rel
4.8 software package, located in the CCRCB. A x63 magnification oil immersion objective
and x40 magnification objective were used to focus the microscope and take several images
of each region of interest on each slide. For each region of interest a sufficient number of
images were taken to allow the counting and recording in a minimum of 100 cells. The foci
were counted using the Cell Counter application in ImageJ (NIH, USA), where the foci are
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Fig. 5.6 Screen-shot of the ImageJ Cell Counter application used to count the DNA DSB
53BP1 or γ-H2AX foci in the experimental data.
still recognised manually by the user, but the program records the number, allowing more
accurate and efficient data acquisition. Overlapping cells, cells with high background and
abnormally sized/shaped cells were ignored; only cells with clearly discernible foci were
counted. Fluorescence microscopy for all experimental data presented in this thesis was
carried out at the CCRCB.
5.5 Hypoxia Chamber
The treatment of hypoxic tumours is challenging even with the most advanced X-ray based
therapies, which often leads to the failure of such treatments. Recently ion beam therapy
using carbon ions and other high LET particles has been shown to be effective in killing
hypoxic tumour cells [13–16]. However, as discussed previously, the very high installation
and operational costs currently make ion beam therapy a very expensive treatment option
[281] in its current form. In recent years there has been a demonstration of the capability of
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high-energy lasers to generate suitable ion beams for cancer therapy [17–19], which could
greatly reduce the cost involved in the construction of future facilities [6]. However, the
radio-biological effects of these ion beams under hypoxic conditions are largely unexplored,
therefore a portable and compact hypoxia chamber was developed. This chamber is suitable
for characterising the biological effects of laser accelerated beams under a range of different
oxygen concentrations.
To fully understand the relationship between laser accelerated ion induced DNA dam-
age and oxygen dependency it is necessary to have a compact and reliable device capable
of maintaining hypoxia for the duration of the radiation exposures and afterwards. Sev-
eral groups have demonstrated their hypoxia inducing devices, including modular incubator
chambers that are filled with low O2 gas (1% O2, 5% CO2, 94% N2) [282], hypoxia cell
culture incubators with external high pressure N2 gas supplies [283], hypoxic work stations
that offer precise control of oxygen concentration [284], and more recently size variable
inflatable hypoxia chambers [54]. All these methods of hypoxia induction work well within
the cell culture laboratory, however they are not necessarily compatible with the irradiation
procedures and set-ups required for laser accelerated ion beams owing to the complex geom-
etry and designs of the interaction chambers. Also, sample reoxygenation problems arise
as soon as cells are removed from the hypoxic environment. The modular and inflatable
chambers may be compatible with X-ray irradiations but not with proton or ion irradiations,
as the material and size of the chamber may not allow the particles to reach the cellular
target within the hypoxia chamber, however, a compact hypoxia chamber compatible with
irradiations employing high-energy ions from conventional accelerators has been developed
[193, 194].
Nevertheless, a commercially available compact hypoxia chamber for use with laser-
driven ion sources is unavailable. Presently the protons and ions produced from the inter-
action between high-power lasers and thin foils reach the energy of 10 - 20 MeV compared
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to 60 MeV produced by conventional accelerators. At 10 - 20 MeV, these ions have a rela-
tively short range and are unable to penetrate existing hypoxia chambers, which led to the
design of the following compact and portable hypoxia chamber for laser ion radiobiology
applications.
Fig. 5.7 (a) The new compact hypoxia chamber. The chamber is small enough that 6 can be
stored in a standard 3 shelf incubator. (b) Continuous measurement of the O2
concentration inside the hypoxia chamber using a Rapidox 1100Z meter. (c) Schematic of
the new hypoxia chamber. The chamber is 12.0 by 9.6 by 3.8 cm in size, with the main
body constructed from PEEK and the windows from Saran. (d) Stainless steel and
aluminium cell dish. (e) View of the cell dish placement inside the new hypoxia chamber.
The cell dish is secured in place by an aluminium bracket.
5.5.1 Design
The main body of the new hypoxia chamber, shown in Figure 5.7 (a) and (c), is a 12.0 cm
by 9.6 cm, 3.8 cm deep box made of polyetheretherkeytone (PEEK), and the front and back
faces of the box have circular apertures 4.7 cm in diameter. The apertures are covered with
12.5 µm Saran (polyvinylidene chloride, PVDC), (Goodfellow Cambridge Ltd, Hunting-
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don, England), attached with 0.4 cm and 0.2 cm thick PEEK rings on the front and back
respectively, creating two transparent windows held in place by six screws in each ring. All
openings are sealed with silicon O-rings.
Two metal gas ports, one inlet and one outlet, are attached to the right side of the box.
These ports are connected to two-way valves by 14 cm lengths of polyurethane tubing.
The inlet port extends inside the chamber to the left hand side of the box to ensure the
best possible gas flow. These valves can be connected to a 95% N2, 5% CO2 gas supply,
(BOC, Linde Group, Munich, Germany) and a Rapidox 1100Z oxygen meter, (Cambridge
Sensotec, St. Ives, Cambridgeshire, England), for real time measurements of the oxygen
concentration within the hypoxia chamber.
Three different tests were carried out to characterise the new hypoxia chamber, two
concerning the physical characterisation and one concerning the biological characterisation.
5.5.2 Physical Characterisation
Primarily, the ability of the hypoxia chamber to maintain a hypoxic environment was tested,
followed by a study of the variation in the radiation dose inside and outside the chamber.
Oxygen Concentration
The empty chambers were connected to a hypoxic gas supply (BOC, 95% N2, 5% CO2)
through the inlet port, and the outlet port was connected to the inlet port of a Rapidox 1100Z
meter using polyurethane tubing. The outlet port of the Rapidox meter was connected to a
small flask of water to check the gas flow rate while filling the chamber. The chambers
were gassed until the low oxygen alarm sounded on the Rapidox meter (approximately 15
minutes), which meant the oxygen concentration inside the chamber was between 0.1% and
0.5%. The gas supply was then disconnected and the Rapidox meter attached to the inlet
port of the chamber as well as the outlet to allow a continuous measurement of the oxygen
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Time O2 Rate of change (%/min) Rate of change (%/min)
(mins) (%) for each time interval from initial value
A B C A B C A B C
1 0.49 0.27 0.02 - - - - - -
5 0.51 0.28 0.03 0.0050 0.0025 0.0025 0.0050 0.0025 0.0025
10 0.52 0.28 0.04 0.0020 0.0000 0.0020 0.0033 0.0011 0.0025
15 0.53 0.29 0.06 0.0020 0.0020 0.0040 0.0029 0.0014 0.0029
20 0.55 0.30 0.07 0.0040 0.0020 0.0020 0.0032 0.0016 0.0026
25 0.56 0.31 0.08 0.0020 0.0020 0.0020 0.0029 0.0017 0.0025
30 0.57 0.32 0.09 0.0020 0.0020 0.0020 0.0028 0.0017 0.0024
60 0.65 0.39 0.16 0.0027 0.0023 0.0023 0.0027 0.0020 0.0024
120 0.85 0.47 0.26 0.0033 0.0013 0.0017 0.0030 0.0017 0.0020
360 1.59 0.85 0.66 0.0031 0.0016 0.0017 0.0031 0.0016 0.0018
1440 4.05 2.37 2.50 0.0023 0.0014 0.0017 0.0025 0.0015 0.0017
Table 5.4 Summary of the oxygen concentration measurements for the 3 chambers. The
Rapidox 1100Z meter and the hypoxic gas supply were connected to each chamber. The
chamber was gassed for approximately 15 minutes, and then the oxygen concentration was
measured continuously for the next 24 hrs. The rate of change for every 4 or 5 min interval
was calculated, as was the rate of change from the starting value of 0.49%, 0.27% and
0.02% for chambers A, B and C respectively.
concentration inside the chamber for the next 24hrs. This was repeated for the 3 chambers,
the results are shown in Figures 5.8 (a) and (b), and summarised in Table 5.4.
As shown in Figure 5.8 (a), each of the 3 hypoxia chambers tested was able to maintain
a physoxic environment (< 5% O2) for the full 24 hr test period. Chamber A maintained
pathological hypoxia (< 1% O2) for 2 hrs, physiological hypoxia (< 2% O2) for 7 hrs and
physoxia for 24 hrs. Chamber B maintained radiobiological hypoxia (< 0.4% O2) for 1 hr,
pathological hypoxia for 7 hrs and acute hypoxia (< 3% O2) for 24 hrs. Finally Chamber
C maintained radiobiological hypoxia for 3 hrs, pathological hypoxia for 8 hrs and acute
hypoxia for 24 hrs. This demonstrates that the chambers are able to maintain a hypoxic
environment for 24 hrs, allowing the study of radiation induced DNA damage and repair
kinetics under fully hypoxic conditions without the need to remove the samples from the
chambers.
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Fig. 5.8 (a) Recorded O2 concentration inside 3 of the hypoxia chambers compared with
the accepted levels of physiological (< 2.0% O2), pathological (< 1.0% O2) and
radiobiological hypoxia (< 0.4% O2) [197]. All 3 chambers maintained a physoxic (< 5%
O2) [197] environment for the full 24 hr test period. (b) Zoomed in view of the first 2 hrs.
Dose
A fully assembled cell dish, complete with a radio chromic film (RCF) mask and normal
EBT-3 film [123, 285], was placed inside the hypoxia chamber. The chamber was then
placed inside the 225 kVp XRAD225 X-ray cabinet (precision X-ray Inc. Newhaven, CT,
USA) located in the Centre for Cancer Research and Cell Biology (CCRCB). The X-ray tube
was fitted with a 2 mm copper filter to cut off the low energy part of the spectrum and was
operated at 13 mA with a dose rate of 0.591 Gy/min. The hypoxia chambers were irradiated
with 0, 0.5, 1, 2, 4 and 8 Gy at a distance of 50 cm from the source. These irradiations were
repeated with just the cell dishes and RCF films. The dose was obtained from a set of films
alone irradiated with the same range of doses. The results of these irradiations are shown in
Figure 5.9.
Dosimetry is one of the most important aspects of radiobiology studies and irradiation
conditions significantly impact the physical dose delivered. How the geometry and material
of the hypoxia chamber could impact the dose was investigated as shown in Figure 5.9
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Fig. 5.9 Graph showing the dose of 225kVp X-rays deposited on the EBT-3 normal film
mounted underneath the cell dish placed inside the hypoxia chamber (red), and the dose
deposited when the dish and film were irradiated outside the hypoxia chamber (blue). The
calibration was calculated from a set of EBT-3 films irradiated in the X-ray cabinet without
being mounted on the dish, or being inside the hypoxia chamber.
where the dose of 255 kVp X-rays deposited on EBT-3 films, irradiated inside and outside
the hypoxia chamber is shown. At low dose values, below 4 Gy, the dose deposited on the
films was comparable inside and outside the chamber, but above 4 Gy slight differences in
the deposited dose were observed, however the dose was still the same within error. At even
higher doses this may not be the case, and the slightly higher dose within the chamber could
be attributed to scattering phenomenon inside the chamber. However, we intend to use the
chamber primarily with low doses (between 0.5 and 2 Gy) where little or no difference in
the dose deposited was observed.
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5.5.3 Biological Characterisation
The final test was to evaluate the expression of the hypoxia biomarker HIF-1α in the cellular
samples placed inside the new hypoxia chambers compatible with X-ray and low energy
laser accelerated proton irradiated set-ups.
HIF-1α
Human skin fibroblast cells (AG01522) were seeded on to 3 µm mylar mounted on cell
dishes (see Figure 5.7 (d)) 24 hrs prior to the irradiations. On the day of the irradiations,
the cell dishes were mounted inside the hypoxia chambers. These chambers were then
connected in series and kept inside a CO2 incubator, and gassed with a hypoxic gas mixture
(BOC, 95% N2, 5% CO2) for the next 4 hrs to ensure that radiobiological hypoxia [197]
levels were attained inside the chamber. Irradiations with X-rays were carried out using
the aforementioned X-ray machine in the CCRCB, and proton irradiations were carried
out employing the petawatt arm of the Vulcan laser facility at the Rutherford Appleton
Laboratory, Oxford, UK. The samples were irradiated with 1 Gy of 225 kVp X-rays or ∼1
Gy of 15 MeV protons, and fixed with 4% paraformaldehyde (PFA) for 10 - 12 minutes
(room temperature) at 0.5 and 24 hrs post-irradiation. Until fixation, the samples were kept
inside the sealed hypoxia chambers, maintained at 37 ◦C in a normal tissue culture incubator.
For staining, the PFA was discarded and the samples were rinsed thrice with PBS (Phos-
phate Buffered Saline) and later permeabilized with 0.5% Triton X-100 (Sigma Aldrich)
in PBS for 10 minutes at room temperature and subsequently blocked in 2 ml of blocking
buffer (10% goat serum and 0.25% Triton X-100 in PBS) at 37◦C for 2 hours. The sam-
ples were then stained for both 53BP1, a biomarker of DNA DSB damage, and HIF-1α
to show the induction of hypoxia. Approximately 1 ml of the primary antibodies, 1:1000
53BP1 (Novus Biologicals, Littleton, CO, USA) and 1:500 HIF-1α (Abcam, Cambridge,
UK) diluted in the blocking medium was added to the dishes and incubated at 37◦C for
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Fig. 5.10 AG01522 human skin fibroblast cells were irradiated with 15 MeV laser
accelerated protons employing the petawatt arm of the Vulcan laser facility at the
Rutherford Appleton Laboratory, Oxford, UK. The samples were kept inside the hypoxia
chambers after the irradiations to maintain the hypoxic environment. The samples were
fixed at 0.5 and 24 hrs post irradiation, then stained for HIF-1α to show the induction of
hypoxia, 53BP1 to highlight DNA DSB damage and DAPI for detecting the cell nuclei.
Images were acquired using the Carl Zeiss Axiovert 200M fluorescence microscope (at 40x
magnification) with a CCD camera and the Axiovision Rel 4.8 software package, located
in the Centre for Cancer Research and Cell Biology, Queen’s University Belfast.
1 hour and later washed three times in PBS containing 0.25% Triton X-100. The cells
were later probed with secondary antibodies, goat anti-rabbit-Alexa Fluor 488 conjugated
and goat anti-mouse-Alexa Fluor 594 conjugated, (Invitrogen, Life Technologies, Carlsbad,
CA, USA) at a dilution of 1:1000 and 1:500 respectively in blocking buffer and incubated
for 1 hour at 37◦C. The samples were then washed and mounted on coverslips using an
ant-fade reagent containing DAPI (Invitrogen, Life Technologies, Carlsbad, CA, USA).
53BP1 foci formation is regarded as one of the hallmarks of DNA DSB damage. We
detected 53BP1 foci formation in AG01522 cells irradiated with 15 MeV protons employ-
ing the petawatt arm of the Vulcan laser facility, with simultaneous staining of HIF-1α ,
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a hypoxia biomarker, through immuno-fluorescent microscopy as shown in Figure 5.10.
Qualitatively, the red channel shows the HIF-1α staining, the green is 53BP1 and the blue
is the DAPI contrast staining of the cell nuclei. The images show the nuclear localisation of
the 53BP1 foci in the hypoxic and oxic samples. More foci are present at 0.5 hr in the oxic
samples compared to the hypoxic, but this is reversed with the 24 hr samples.
Fig. 5.11 53BP1 foci induction and repair in AG01522 human skin fibroblast cells after
exposure to 15 MeV laser accelerated protons and 225 kVp X-rays under oxic and hypoxic
conditions. The initial damage is shown at 0.5 hrs and the residual damage is shown at 24
hrs post irradiation.
Figure 5.11 shows the quantification of the initial (0.5 hrs) and residual (24 hrs) 53BP1
foci in AG01522 cells irradiated with 15 MeV protons and 225 kVp X-rays. The average
number of 53BP1 foci/nucleus/Gy at 0.5 hrs under oxic conditions was comparable for
both protons and X-rays, 24.21 ± 3.38 and 24.87 ± 0.76 respectively. There was a slight
difference in the number of residual foci present, with 1.74 ± 0.21 for X-rays and 1.88 ±
0.60 for protons (control values of 1.81 ± 0.11 and 1.85 ± 0.08 for Protons and X-rays
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respectively). Similarly, under hypoxic conditions the initial foci values were 14.16 ± 2.51
and 9.67 ± 1.19, and the residual values were 3.82 ± 1.26 and 1.07 ± 0.09 at 24 hrs for
protons and X-rays respectively (control values of 1.84 ± 0.12 and 2.16 ± 0.07 for protons
and X-rays respectively). The values for the 15 MeV protons have been averaged over four
shots each for the 0.5 hr oxic and hypoxic samples and the oxic 24 hr samples, with the
hypoxic 24 hr values averaged over three shots. The 0.5 hr oxic and hypoxic and 24 hr oxic
values have been averaged over two samples, but the 24 hr hypoxic value is from a single
sample. All values have the control value subtracted. This shows that the chambers were
compatible with both X-ray and laser-driven ion irradiation conditions.
5.5.4 Conclusions
In conclusion, a new compact portable hypoxia chamber has been designed for use with low
energy laser-driven ion sources. The chamber has proved capable of maintaining a radiobi-
ologically hypoxic (<0.4% O2) environment for up to 3 hrs, an acutely hypoxic (<3% O2)
environment for 24 hrs, and there was no dose enhancement inside the chamber compared to
outside the chamber at the low doses the chamber will be used with. The chamber was used
in conjunction with a 225 kVp X-ray source and 15 MeV laser accelerated protons to induce
DNA damage in AG01522 cell samples under oxic and hypoxic conditions. These samples
were tested for 53BP1 foci as a marker of DNA DSB damage and HIF-1α as a biomarker
of hypoxia induction. Results showed that hypoxia was indeed induced in the cell samples
as well as DNA damage, with more initial damage in the oxic samples and more residual
damage in the hypoxic samples.
These tests show that the new compact portable hypoxia chamber will be a valuable tool
in the study of the biological effects of laser-driven ions under hypoxic conditions.
Chapter 6
Biological Effects of Laser-Driven Ions
As described earlier, the amount and complexity of the DNA damage induced determines
the biological outcome. While a good indicator of the amount of damage induced is the
dose absorbed by the cells, the complexity of the damage is linked to the clustering of DNA
lesions. If the spatial distribution of DNA lesions is a critical parameter for all charged
particle exposures, using pulsed laser-driven ions sources at their temporal limit has yet
to be fully investigated. Several effects related to the ultra-short nature of the deposition
have been suggested. There could be an alteration in the production of free radicals owing
to oxygen depletion effects [237], there could be a spatio-temporal overlap of independent
tracks resulting in collective effects [228] and there could be a lack of interaction between
direct and indirect DNA lesions [286] (see Section 5.4.1). These have all been suggested as
possible effects to alter the biological response to laser-driven beams. Very little is known
about this ultra-fast dose deposition regime and the only way to assess these predications
is via experiment. Previous work has not highlighted any deviation from the known cell
response to the longer ion bursts used in radiotherapy, however, these investigations have
been limited to protons and in most cases to Gy-level doses obtained by accumulating mul-
tiple irradiations with an effective dose rate of Gys−1 as in conventional radiation therapies
[234, 287].
176 Biological Effects of Laser-Driven Ions
The use of proton and carbon ions of different energies is fundamental in studying the
role of ionisation clusters. The LET is a critical parameter in radiobiology which changes
towards the end of the particle path [179] with great concerns for radiation therapy applica-
tions as this coincides with the tumour volume. Moreover, the range of secondary electrons
is proportional to the energy of the main beam with increasing probability of spatio-temporal
overlap of the secondary radiation tracks for high energy beams [11]. This may impact on
the qualitative difference in the DNA damage induced along the beam path, i.e. depth in the
sample or patient.
Rabdiobiological experiments employing laser driven ions have been carried out for
several years and can be grouped into two categories when considering the effects related to
the short pulse nature of the beams. The first category is experiments in which the dose was
delivered in a number of fractionated consecutive pulsed irradiations, however, while these
experiments may be more relevant to modalities of future laser-based treatment, they are less
suited to highlighting the collective effects related to the ultra-short nature of the irradiation,
as fractionated approach reduces the effective dose rate on the cells to the Gys−1 range
normally used in radiotherapy. The second category of experiments employ single shot
irradiations, such as the Gemini experiment described in the next section. These experiments
have been limited to energies of 1 - 5 MeV and on cell pulse durations in the order of ns,
which also poses strong limitations to the possibility of observing collective effects. So far,
no experiment has highlighted any deviations from the results of experiments carried out
with conventional RF beams.
None of the experiments carried out to date have addressed oxygen depletion effects on
the biological response as all samples were irradiated in air, thus were well oxygenated.
The TARANIS experiment described in section 6.2 was the first to use the newly designed
hypoxia chamber described in section 5.5, and the TAP experiment described in section 6.4
was the first investigate the effect of chemically induced hypoxia and a free radical scav-
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enging environment. These experiments are a clear step forward from prior studies, inves-
tigating for the first time conditions where clear differences from conventional radiotherapy
should be observed.
6.1 Previous Work
In two previous experiments carried out by the LIBRA consortium on the Gemini laser
to investigate ion acceleration, a double plasma mirror configuration was employed. This
facilitated the irradiation of ultra-thin low-Z foils with intensities up to 1020 Wcm−2 as the
ASE contrast was reduced to 10−10 below the peak intensity [11]. The very large number
of ions produced per shot when ultra-thin foils of amorphous carbon were irradiated (in the
order of 1012-1013 MeV−1Sr−1 for protons and 1010 MeV−1Sr−1 for carbon ions) offered
a unique platform for cellular irradiation experiments, the first of their kind on the Gemini
laser. In a single laser shot a dose corresponding to more than 1000 high-energy protons per
cell could be delivered and a carefully designed system allowed ultra-high dose rate delivery
at >109 Gys−1, thus opening up the possibility to explore the biological effects of ultra-high
dose rates and ultra-fast dose deposition.
6.1.1 Gemini 2013 - First Carbon Ion Irradiations
The LIBRA consortium pioneered single shot radiobiology utilising laser-driven ions in
effective experiments carried out on the TARANIS [96] laser at Queen’s University Belfast,
where radiosensitive Chinese Hamster fibroblast cells (cell line V79) were irradiated with
proton bursts of nanosecond duration in the 1-5 MeV range [10, 227]. The survival rates
of the cells observed were in line with published results from conventional sources, which
was an encouraging result in view of future therapeutic uses of ultra-short bursts of laser-
driven ions. It was during this experiment that the methodology used in the Gemini 2013
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experiment was developed, though some modifications had to be made to accommodate
the higher energies and different ion species available on Gemini. Although the energies
of TARANIS and Gemini are comparable at approximately 10 J, conversion efficiency is
much higher on Gemini at greater than 10% compared to 1% on TARANIS. The beam is
also much more collimated, 4-5 degrees versus 30-40 degrees at 5 MeV [11] and the proton
fluxes are an order of magnitude higher on Gemini compared to TARANIS. This leads to
dose rates higher by up to two orders of magnitude at comparable dose, or doses >10 Gy.
Of particular interest to the 2013 campaign was the use of carbon ions at high energies and
flux, which are simply not available from standard lower intensity interactions from thicker
target foils.
Fig. 6.1 Experimental configuration used to characterise the beam. For the cellular
irradiations the 0.9 T magnets were removed.
The main aim of the Gemini experiment was to establish a procedure for cell han-
dling and irradiation compatible with the laser-plasma interaction environment, allowing
the investigation of the effects of irradiating AG01522 human fibroblast cells with laser-
accelerated proton and carbon ions at ultra-high dose rates. The set-up used also allowed
same shot comparisons of high and low LET radiation.
Amorphous carbon and aluminium targets were irradiated at laser incidence of 0◦ and
35◦ with linear and circular polarisation. The ion beam was generated by focusing a single
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Gemini beam with an f/2 parabola onto the ultra-thin targets at intensities of∼ 1020 Wcm−2,
employing the double plasma mirror configuration as in previous LIBRA campaigns. A
maximum cut-off energy of 20 MeV/nucleon for protons and carbon ions was achieved
using 25 nm amorphous carbon targets and linear polarisation at 0◦. A crucial element of the
experimental arrangement was the beam delivery system capable of separating the different
charged species whilst maintaining the high flux on the cell plane. This components design
was an evolution of the design used for cell irradiations on TARANIS [227, 288], and was
also based on the experience gained in developing high dispersion ion spectrometers [110].
The beam was characterised prior to the cellular irradiations using a TPS with micro
channel plate detection (0.9 T magnets and a variable magnetic field), high sensitivity RCF
(EBT2) stacks and CR39 placed outside the chamber in the cell sample position. The pro-
ton spectra were found to be exponential in nature, associated with the TNSA acceleration
mechanism, with a proton flux of ∼ 2 x 1010 MeV/nucleon/Sr at 10 MeV, and a maximum
cut-off energy of 23 MeV. The spectra of the C6+ indicated peak-like structures which could
be attributed to the RPA mechanism of acceleration, with a maximum cut-off energy of 13
MeV/nucleon and flux of ∼ 8 x 109 MeV/nucleon/Sr at 7 MeV [38]. For the cellular irradi-
ations a 5.5 µm aluminium filter was placed in front of the cell dish to prevent low energy
carbon ions (≤ 3.7 MeV/nucleon) from reaching the samples, as these energies overlapped
with the high energy protons (approximately 12 MeV protons).
For the cell irradiations, the dispersed beams were transported to the cell dish, placed
outside the experimental chamber, through a Kapton window of 50 µm thickness, with
transverse dimensions of a few centimetres. The cells were placed vertically on a specially
designed dish during the exposure, and were quickly removed for processing as required.
The particular aspects that were investigated in the Gemini 2013 experiment were the
DNA damage and subsequent cellular response of AG01522 cells exposed to laser-driven
proton and carbon ions at ultra-high dose rates, with the one main objective of the charac-
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terisation of DNA DSBs. The 53BP1 immunofluorescence technique (discussed in Section
6.3) was used to monitor the formation of DNA DSBs and their subsequent repair as a func-
tion of dose and time post irradiation. For a given dose the cells were stained and analysed
0.5 hours, 1 hour, 2 hours, 6 hours and 24 hours post irradiation, which allowed the recon-
struction of the dynamics of cell repair after DNA damage. This aspect, as yet unexplored
with laser-driven ions prior to this experiment, could be strongly affected by the temporal
history of the dose deposition.
10 MeV Protons
Time (hrs) Corrected Dose (Gy) Mean Foci/Nucleus
0.5 1.53 ±0.12 45.5 ±1.7
1 1.00 ±0.08 22.1 ±0.8
2 2.07 ±0.05 24.7 ±0.8
6 2.31 ±0.08 20.53 ±0.07
24 1.68 ±0.17 5.1 ±0.3
5 MeV/nucleon Carbon Ions
Time (hrs) Corrected Dose (Gy) Mean Foci/Nucleus
0.5 2.18 ±0.05 29.4 ±1.4
1 2.47 ±0.05 20.2 ±0.8
2 5.7 ±0.9 47.7 ±1.2
6 2.9 ±0.6 22.7 ±1.2
24 1.6 ±0.7 13.2 ±0.8
Table 6.1 Raw experimental data obtained for 10 MeV protons and 5 MeV/nucleon carbon
ions [38].
Images of the cells were obtained using the Carl Zeiss Axio Imager.Z2 fluorescence mi-
croscope with CCD acquisition capability and MetaSystems Isis software package, located
at the Rutherford Appleton Laboratory. A x63 magnification oil immersion objective was
used to focus the microscope and take several images of each region of interest on each
slide. The number of foci/nucleus across the sample were carefully aligned with the corre-
sponding dose profile and a clear trend in the foci between the proton and carbon ion region
was observed in each shot with a dramatic rise in the foci count in the lower energy carbon
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ion region close to the Bragg peak [38]. This corresponded to a high deposited dose in the
EBT2 film used for dosimetry. The regions of interest were identified as the regions irradi-
ated by 10 MeV protons and 5 MeV/nucleon carbon ions, and the dose was calculated from
the corresponding area of the RCF film. The mean number of foci/nucleus was divided by
the respective dose to give the mean foci number/nucleus/Gy.
Fig. 6.2 Temporal kinetics of phosphorylated 53BP1 foci in cells exposed to protons,
carbon ions and X-rays over a 24 hr period [38].
The 53BP1 foci kinetics were measured over a 24 hr period with initial values of 27.8±
2.6 and 11.5± 0.7 foci/nucleus/Gy at 30 mins post irradiation and 0.5± 0.14 and 6.3± 3.8
at 24 hrs post irradiation for 10 MeV protons and 5 MeV/nucleon carbon ions respectively.
The RBE was calculated as 1.6 ± 0.2 and 13 ± 9 for protons and carbon ions respectively.
The value obtained for protons agrees with that reported in literature and did not appear to
show any enhanced biological effectiveness owing to the ultra-high dose rate. Conversely
there seems to be a significant enhancement in the biological effectiveness of carbon ions
(literature values are between 2.1 and 3.3 [289] compared to 13 ± 9), however this was
attributed to an underestimation of the dose by the RCF even though the expected RBE
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value lay within the margin of error.
6.2 TARANIS Experiment
This experiment was the first time the newly designed hypoxia chamber would be tested
with laser accelerated protons. The chamber had already been tested with X-ray irradia-
tions and had been shown capable of maintaining a pathologically hypoxic environment (<
1% O2). This experiment was used as a proof of principle experiment to develop the cell
handling procedure and irradiation methods for use in the TAP experiment described later.
The effect of hypoxia on DNA DSB induction and repair was investigated by irradiating
the AG01522 normal human fibroblast cell samples inside the specially designed hypoxia
chamber and also irradiating oxic samples inside the chamber to create a direct comparison
for foci kinetics. The end point staining was γ-H2AX for DNA DSB induction and HIF-1α
for hypoxia induction.
6.2.1 Experimental Arrangement
The irradiations were carried out employing the TARANIS laser located in the Centre for
Plasma Physics, Queen’s University Belfast. The experimental setup of the interaction
chamber is shown in Figure 6.3, where the parabola, target mount and magnet beam dis-
persion system are clearly visible. A 500 µm slit aperture was placed 55 mm behind the
target with the 1.0 T magnets used for dispersing the proton beam a further 9 mm from
the slit. The end of the magnet was 165 mm from the 50 µm Kapton window which was
attached across a 70 mm aperture in the sealing flange of the interaction chamber. The hy-
poxia chamber was positioned 56 mm from the Kapton window on the air side of the flange,
as shown in Figure 6.5. The mask shown in Figure 6.5 (a) was used to attach the un-coated
EBT-3 film to the back of the hypoxia chamber.
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Fig. 6.3 (a) The experimental setup of the target chamber in TA2 of the TARANIS laser
facility. (b) A close up of the magnet and the target mount inside the chamber.
Aluminium and gold targets were used to characterise the beam and irradiate the cells.
IPs, RCF and CR39 were used to characterise the beam on the cell plane position. The flux
of protons on the cell plane was determined using CR39 and was found to be 2.17 ± 0.10
x 107 protons per cm2. The positions of certain energies on the cell plane were determined
using IPs and aluminium filters of 200 and 325 µm. Figure 6.4 shows the proton spectra
produced by the laser interaction. The sharp cut-off at approximately 24 mm produced
by the aluminium filter shows the position of the 6.85 MeV protons, providing an energy
fiducial to calibrate the spectrum. The laser energy was approximately 10 J at an angle of
incidence of 30 ± 5◦, and the dose rate was approximately 109 Gys−1. For the cellular
irradiations the majority of the targets were 10 - 12.5 µm Au.
The original design of the hypoxia chamber was employed for these irradiations, which
had 4 gas port inlets, as can be seen in Figure 6.5. After this experiment modifications were
made to the design to reduce the size of the chamber as this design would not fit inside the
re-entrant pipe that would be used in the TAP experiment described in section 6.4.
The cell samples were placed inside the chambers for all irradiations, with the RCF
attached to the outside of the chamber as previous irradiations with the RCF attached to the
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Fig. 6.4 An example of the proton spectra of 6.85 MeV protons on the cell plane. The
distance is measured from the straight edge of the reference RCF.
Fig. 6.5 (a) The RCF mask used to attach the un-coated EBT-3 film to the back of the
hypoxia chamber. The position of the hypoxia chamber during the irradiations form (b) the
back and (c) the side.
back of the dish had resulted in damaged RCF as the cell medium had leaked from the dish
destroying the data. The samples were irradiated in a vertical position.
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6.2.2 Irradiation Setup
For the cellular irradiations, the cells were plated on specially designed cell dishes shown
in Figure 6.6 consisting of a stainless steel ring with groves on the front and back surfaces
for silicon O-rings, a 3 µm Mylar surface for plating the cells and two aluminium plates
used for securing the Mylar in place. The dishes were assembled with two full layers of
Mylar on the front and back surfaces, then one side was trimmed to just below the centre
line of the dish. Before plating, the dishes were sterilised for 30 minutes with 225 kVp X-
rays using the X-ray cabinet in the CCRCB. The cells were cultured in minimum essential
medium eagle supplemented with 20% FBS and 100 µgml−1 of penicillin/streptomycin and
seeded at a density of 450,000 cells per dish 24 hours prior to the irradiations. The correct
concentration of the cell suspension was calculated using a Coulter Counter as described in
section 6.1.2. The samples were kept in normal cell culture incubator with a 5% CO2 95%
air atmosphere, 95% humidity and a 37◦C temperature. The cell culture and plating were
carried out in the Prise Lab of the CCRCB, then the samples were transported in sealed
sterile boxes to the smaller bio-lab on the second floor of the CPP where they were kept in
a smaller incubator with the same environment.
Fig. 6.6 (a) Schematic of the stainless steel dish with Mylar attached to the first side with
an aluminium plate and O-ring, (b) an aluminium plate, (c) and how the dish is assembled.
The front layer of Mylar is cut to just below the centre line of the dish after it is assembled.
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Oxic Environment
Just prior to the irradiations the samples were removed from the incubator and the media
covering the cells was removed and replaced with 1 ml of fresh medium. The samples were
secured inside the hypoxia chamber using a plastic bracket, and the lid on the chamber was
gently replaced while the gas ports were open to prevent the Saran window from being un-
necessarily stretched and damaged. The chamber was transported down to the interaction
area in a sterile sealed box, where it was then removed and placed vertically 56 mm from
the Kapton window. The RCF was then attached to the back of the chamber. The half
layer of Mylar on the front side of the dish allowed the samples to be covered with warmed
cell medium for as long as possible before the shot, and they would again be recovered in
media as soon as the chamber was laid horizontally. The depth of the Mylar was such that
the 1 ml of medium would be held in the bottom half of the dish, outside the irradiation
zone thus not attenuating the beam energy. This negated the use of the motorised syringe
used for the Gemini experiments described previously, but which would be employed in the
LULI experiment described in section 6.3. This method of retaining the cell medium was
in preparation for the TAP experiment where the preparation time for each shot would be
much longer and the samples would be in danger of drying out if left uncovered for too long.
Hypoxic Environment
The hypoxic samples were prepared in the same way as the oxic samples, only the cells
were plated at least 28 hours prior to irradiation. At least 4 hours prior to irradiation the
samples were removed from the incubator and the cell medium was removed and replaced
with 1 ml of fresh full serum media. The samples were placed inside the large aluminium
hypoxia chambers belonging to the CCRCB as only one of the new chambers was available
for testing at this time. Each of these chambers could hold up to six samples. The large
hypoxia chamber was tightly sealed with a lid and O-ring while the gas ports were open,
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then a hypoxic gas supply of 95% N2 and 5% CO2 was connected to one of the inlet ports of
the chamber, with a second piece of polyurethane tubing used to connect an outlet port to a
flask of distilled water to monitor the flow rate of the gas. A flow rate of approximately one
bubble per second was used to flush all the oxygen from the chamber. The large chamber
was gassed for a minimum of 4 hours with the hypoxic gas mixture to remove all the oxygen
from the samples and media within the chamber. Just prior to the irradiation the gas was
disconnected form the large chamber and one of the samples was removed. the lid was
quickly replaced on the large chamber, and the removed sample was quickly mounted inside
the new small hypoxia chamber using the plastic bracket (this process was completed in less
than a minute). The lid was then tightly sealed on the small chamber while all the inlet and
outlet ports were open. the hypoxic gas supply was then connected to the small hypoxia
chamber via one of its inlet ports. The other set of inlet and outlet ports were used to
connect the small chamber to a Rapidox 1100Z meter to monitor the oxygen concentration
inside the chamber. The small chamber was gassed for approximately 10 minutes to ensure
there was no oxygen left inside the chamber. After 10 minutes all inlet and outlet ports were
closed at the same time to prevent damage to the Saran windows of the chamber, and the gas
supply and Rapidox meter were disconnected. The chamber was then transported down to
the laser interaction chamber in sterile sealed container and placed vertically as close to the
Kapton window as possible. Once the chamber was in position, the RCF holder was used to
attach the un-coated EBT-3 film to the back window of the chamber.
After the irradiations the un-coated EBT-3 was removed from the back of the chamber
and the chamber was laid horizontally in a sterile sealed box for transportation back to the
bio-lab. Both the oxic and hypoxic samples were removed from the chambers and placed
inside the incubator until they were required for fixing. The samples were fixed in the bio-
lab in CPP, but before starting the staining procedure the samples were transported back to
the Prise lab at the CCRCB.
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Sham irradiations of control samples were carried out for the oxic and hypoxic irradi-
ation conditions, with the samples being prepared, mounted and transported in exactly the
same way as the irradiated samples, the only difference was the samples were not subject to
any irradiation. Control samples were also kept inside the incubator.
6.2.3 Data Analysis and Results
The samples were removed from the incubator, the cell media was removed, the samples
were washed twice with PBS and fixed and five time points of 0.5, 1, 2, 6 and 24 hours
post irradiation with an ice cold 1:1 solution of methanol and acetone. At least one shot
was required per time point, with the aim to complete at least one complete time point
set within the same day to try and limit the differences in the irradiation and incubator
conditions across the set. This fact can be used to identify if outlier values within a group
of samples fixed at the same time point are just rogue values, or if all samples on that day
were affected in the same way. the results presented are averaged over several samples and
several days. The samples were then stored in the fridge for 10 minutes before the fixative
solution was removed and the samples were washed thrice with PBS. The samples were then
kept in the fridge until all the samples were fixed and it was time to commence the staining
process. The samples were permeabilised with chilled methanol and incubated on ice for
10 minutes before being washed thrice with chilled methanol for 5 minutes. The samples
were then blocked with a buffer of 10% goat serum and 0.1% Triton X-100 in PBS, then the
primary antibodies were added at a dilution of 1:1000 for γ-H2AX and 1:500 for HIF-1α
in blocking buffer. γ-H2AX was chosen for staining as this was a well established protocol,
and a new HIF-1α antibody compatible with γ-H2AX was being trialled. All samples were
stained for both bio-markers for comparison of the DNA DSB foci kinetics and hypoxia
induction. After incubation with the primary anti-bodies and washing with a washing buffer
of 0.1% Triton X-100 in PBS and PBS, the secondary antibodies were added at the same
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TARANIS 6.85 MeV Protons
Time Oxic Hypoxic







Table 6.2 Summary of the TARANIS replicates for each time point and irradiation
condition for 6.85 MeV protons. The values represent the number of samples successfully
stained with clearly discernible foci.
concentration as the primary antibodies, GAM594 1:1000 (visualised in the red channel)
and GAR488 1:500 (visualised in the green channel). The cell nuclei were contrast stained
with DAPI during mounting of the samples on glass microscope slides. The back of the
Mylar on which the cell monolayer was situated was marked with a vertical line at one side
and a curved line at the other edge to indicate the high and low energy ends of the proton
spectrum respectively using the mask which attached the RCF to the rear of the hypoxia
chamber. The centre of the irradiation zone was also marked. Table 6.2 summarises the
number of replicates for each irradiation condition and time point. As can be seen, for most
combinations only one sample had clearly discernible foci after the staining process.
Images of the cells were obtained using the Carl Zeiss Axiovert 200M fluorescence
microscope with CCD acquisition capability and Axiovision Rel 4.8 software package, lo-
cated at the Centre for Cancer Research and Cell Biology, QUB. A x 63 magnification oil
immersion objective was used to focus the microscope and take several images of the region
irradiated by the 6.85 MeV protons indicated by the calibration shots. A sufficient number
of images were taken to allow the counting and recording of foci in at least 50-100 cells per
shot. The foci were counted using the Cell Counter application in ImageJ, where the foci are
recognised manually by the user, with the program recording the number, allowing faster
190 Biological Effects of Laser-Driven Ions
and easier data acquisition than manually counting the foci through the microscope eyepiece
itself. Overlapping cells, cells with a high background and abnormally sized/shaped cells
were all ignored; only foci in cells with clearly discernible foci were counted. The images
were obtained by lining up the vertical line marked on the Mylar in the centre of the field
of view then moving 18.2 mm horizontally towards the curved line marked on the other
side of the slide using the motorised stage of the microscope. When the correct position
was reached the stage was moved vertically to ascertain the extent of the radiation zone by
looking at the number of foci induced in the nuclei. Figure 6.7 shows example images of
the oxic and hypoxic samples irradiated with 6.85 MeV protons.
Fig. 6.7 Example foci images obtained for the nuclei irradiated with 6.85 MeV protons.
The γ-H2AX foci have been stained red, the nuclei are contrast stained blue and the
hypoxia induction bio-marker HIF-1α has been stained green.
The average number of foci per nucleus was obtained for each time point and is plotted
in Figure 6.8. As can be seen from Figure 6.8, there is not a significant difference between
the oxic and hypoxic samples, and both data sets have large associated errors related to the
actual counts obtained and the position of the energy line on both the RCF and the sample
slide. The sample may have moved during the mounting process, thus the images and counts
were obtained for a lower energy than that indicated by the mask. The values all originate
from one sample per time point and irradiation condition, apart from the 0.5 hr oxic value
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which is the average of two samples. All time point values have had the relevant control
value of 1.98 ± 0.78 for oxic samples or 1.75 ± 0.76 for hypoxic samples subtracted.
Fig. 6.8 The 53BP1 foci kinetics of laser induced DNA DSBs. The values shown are the
average number of foci per nucleus (with the control value of 1.98 ± 0.78 for oxic and 1.75
± 0.76 for hypoxic samples subtracted) as the dose was unobtainable from the RCF as it
was below 0.1 Gy for the majority of the shots, hence the low values for the average
number of foci per nucleus. These values have the control value subtracted, hence why the
value can become negative (for example the 24 hr time point error bars) if the foci count
falls below the control value.
The 6.85 MeV proton data sets (LET of 6.3 keV/µm) do not show a huge difference
between the hypoxic and oxic samples, but they do show that a higher percentage of the
damage in the hypoxic samples is repaired, and repaired faster, than the damage induced in
the oxic samples. This is owing to the absence of oxygen to create free radical species which
damage the DNA by indirect actions, and also the lack of oxygen to ’fix’ the DNA damage
and make it harder or impossible to repair. However not too much can be read into these
values as they are much lower than expected and the dose has not been taken into account
as will be explained below.
Figure 6.9 shows the percentage of foci remaining at each time point as compared to the
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Fig. 6.9 The percent foci remaining at each time point compared to the number of foci
present 0.5 hrs post irradiation.
number of foci present 0.5 hrs post irradiation. This figure also shows that more DNA DSBs
are repaired and faster for the hypoxic samples, although as before there are large error bars,
so in reality the values are the same within error. The relative foci induction, RFI, for oxic
versus hypoxic conditions for 6.85 MeV proton irradiations was also calculated for each
time point, summarised in Table 6.3, and the average value was found to be 0.77 ± 0.04,
indicating that more foci were produced in oxic than hypoxic conditions (this was the case at
all time points). As can been seen in the table large errors are also involved in these values.
It must be noted that all the samples were removed from the hypoxia chambers directly
after the irradiations, even the hypoxic samples, as only one new chamber was available for
testing. In hindsight this was seen as a mistake as the samples were able to re-oxygenate
as soon as they were removed from the chamber, thus affecting the biological changes that
would occur during the subsequent hours before fixation. However, this will prove valuable
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Time Point (hrs) RFI
0.5 0.89 ± 3.42
1 0.80 ± 2.44
2 0.75 ± 1.83
6 0.74 ± 1.54
24 0.65 ± 0.31
Table 6.3 Summary of the RFI for each time point for oxic versus hypoxic irradiation
conditions for 6.85 MeV protons.
when comparing the results to the outcomes of future experiments, as it will show that any
differences in response arise from the prolonged hypoxic exposure during the repair period
rather than the initial hypoxic condition when the samples were irradiated.
The un-coated EBT-3 films were scanned using an Epson Perfection V75 Pro calibrated
flat-bed transmission scanner with RGB 48 bit settings and 1200 dpi (dots per inch) reso-
lution. The raw images were then taken into the ImageJ Macro and the dose was obtained
from the positions indicated by the calibration shots using aluminium filters. The 6.85 MeV
proton line was located 18.2 mm from the vertical line marked on both the EBT-3 film and
the Mylar of the cell dish using the RCF mask. Unfortunately approximately two thirds
of the shots were irradiated with a dose undetectable by the ImageJ Macro, and the other
third were irradiated with doses on average of less than 0.1 Gy, thus when these values were
used to calculate the average number of foci per nucleus per Gy the values obtained were
vastly over estimated compared to previous results. A contributing factor could have been
the placement of the RCF outside the hypoxia chamber rather than directly behind the Mylar
with the cell monolayer. At the time of this experiment it was thought the un-coated EBT-3
film would be damaged if it was placed inside the hypoxia chamber and kept inside the in-
cubator for extended periods of time, hence why it was kept behind the rear window on the
outside of the hypoxia chamber. In previous cellular irradiations the RCF had been directly
attached to the rear of the cell dish, however media from the cell dish had leaked onto the
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RCF and damaged the surface thus making it impossible to recover the dose information.
To combat this the RCF was wrapped in 0.9 µm Mylar to protect it, something which was
also done in this experiment as a precaution. Later tests proved that the EBT-3 film was
capable of surviving for more than 24 hours in the incubator on the back of the cell dish
inside a gassed and un-gassed hypoxia chamber, thus this method was adopted for future
experiments as it ensured the film was as close as possible to the location of the cell plane
for a more accurate dose measurement. The EBT-3 film was still wrapped in the 0.9 µm
Mylar to protect against leakage of cell media.
Even though the physical results obtained for these cellular irradiations did not provide a
large or good quality data set they were useful for establishing the procedures that would be
used for the TAP experiment. Modifications to the design of the hypoxia chamber could be
made to prepare it for use in the TAP experiment discussed in section 6.4. The positioning
of the RCF could also be adjusted to provide a more accurate recording of the dose received
by the cell plane. Despite the problems, it was established that the new compact hypoxia
chamber was compatible with a laser plasma interaction environment and was able to induce
hypoxia in the samples inside the chamber.
6.3 LULI Experiment
The unique capabilities of the pico2000 laser system in terms of high proton flux and high
energies available have been employed to carry out single shot investigations of the cellular
response to proton irradiation, through ultra- fast proton dose deposition in normal human
cell models. This involved cell preparation and handling on-site at the LULI facility at Laser
Lab Europe, and subsequent analysis of data at Queen’s University Belfast.
The main aim of this experiment was the characterisation of DNA double strand breaks
(DSB) by means of the 53BP1 immunofluorescence assay. The DNA DSB formation and
repair in AG01522 normal human fibroblast cells was monitored as a function of dose and
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time post irradiation. For given time points of 0.5, 1, 2, 6 and 24 hours post irradiation the
samples were fixed, stained and analysed allowing the reconstruction of the dynamics of
cell repair following irradiation by laser-accelerated protons.
6.3.1 Experimental Arrangement
The biological samples were irradiated with a multi-MeV proton beam generated by the
interaction of a high intensity laser pulse with a metal foil. The targets were 5-100 nm gold
foils, as high Z targets produce spatially uniform proton beams, ensuring uniform irradiation
of the sample. In order to expose the samples to protons within a selected narrow energy
range, a beam transport and delivery system was installed inside the interaction chamber,
which was capable of separating protons possessing different energies and also maintained
a high flux on the cell plane. The system consisted of a modular assembly of static magnets,
with a slit entrance aperture, that angularly dispersed the particles according to their energy.
As only protons were desired to irradiate the samples, metal filters of suitable thicknesses
were placed just in front of the sample to suppress the unwanted heavier ions, while the
X-rays were suppressed using suitable lead shielding in the chamber.
Fig. 6.10 (a) Target chamber arrangement, showing the re-entrant tube and magnet
assembly. (b) Aerial and (c) lateral detail of the target arrangement, beam transport
delivery system and the position of the biological sample within the re-entrant tube.
The AG01522 cells were grown on 3µm Mylar in a specifically designed stainless steel
196 Biological Effects of Laser-Driven Ions
and aluminium dish. A uniform layer of approximately 500,000 cells covering the whole
dish allowed single shot exposures of spatially separated cells to several different proton
energies and doses. The dish was placed vertically outside the target chamber behind a 50
µm Kapton window. The use of the Kapton window prevented substantial energy loss in the
ion beam prior to irradiating the cells whilst still maintaining a proper sealing of the vacuum
chamber. The cell dishes were equipped with an automated syringe system to remove and
add the cell media before and after the shot respectively, to preserve the integrity of the cells.
Normal and customised EBT2 radiochromic film was placed directly behind the Mylar on
which the cells were grown, in order to monitor the dose deposited on a shot to shot basis.
This was done by employing a specially designed mask (Figure 6.11) that ensured the film
was placed in the same position for each shot, allowing accurate identification of the particle
energy at given positions which was then correlated with the position of the DNA damage.
Monte Carlo simulations showed that the cells were placed in the tail of the Bragg curve
far from the Bragg peak, ensuring a uniform energy deposition across the cell layer and
permitting a a precise characterisation of the dose delivered to the biological sample based
on the analysis of the dosimetric films.
Fig. 6.11 Mask used to attach the RCF with the positions of the 6 MeV, 10 MeV and 15
MeV protons marked.
The experiment was carried out in target area 1 of the LULI2000 laser facility employ-
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ing the pico2000 beam-line at it’s standard operational parameters of 80 J in 1 ps at 1ω . The
beam was focused on to the foil targets at angle of incidence of approximately 22.5◦ using
the f = 800 mm, f/4 off axis parabola permanently installed inside the Milka target cham-
ber. The experimental setup is shown in Figure 6.10, with the beam transport and delivery
system being shown in more detail in Figure 6.10 (b) and (c). The targets were located at
the normal target chamber centre on the permanent motorised target stage, and the beam
delivery system was installed inside the chamber along the target normal axis with the sys-
tem entrance slit approximately 5 cm from the target. The re-entrant tube was required to
allow the biological sample to be placed as close to the beam delivery system as possible,
reducing the overall distance from the target, thus maximising the irradiation dose on the
cells.
6.3.2 Irradiation Setup
The biological samples were prepared and stored in the Laboratory of Optics and Bio-
sciences, Ecole Polytechnique-INSERM-CNRS (LOB). All the components of the cell sam-
ple dishes were cleaned with water and sterilised under the laminar flow hood using 70%
ethanol and PBS. This was not the preferred method of sterilisation as previous investiga-
tions had been unable to seed and grow cell cultures on the Mylar after preparing the dishes
in this way, however there was no access to an X-ray cabinet at this facility, the preferred
sterilisation method, thus this approach was adopted. The dishes were then assembled by
stretching 3 µm Mylar across a stainless steel ring and sealing with an aluminium plate and
silicon o-ring. The assembled dishes were again washed with 70% ethanol and PBS under
the laminar flow hood. When space permitted the sterile assembled dishes were stored in
the laminar flow cabinet until required, otherwise there were placed in sterile petri dishes,
wrapped in sterilised aluminium foil and placed in a dedicated drawer until required. These
dishes were only unwrapped under the hood and were left under the UV light for at least an
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hour prior to seeding samples.
The cell samples were transported to the LULI facility by commercial air transportation
in two T175 tissue culture flasks completely filled with 800 ml of reduced serum cell culture
medium (10% FBS and 100 µgml−1 penicillin/streptomycin). The flasks were sealed with
parafilm, wrapped in bubble wrap, and sealed inside an insulating polystyrene box. One of
the flasks leaked during transportation, thus it was discarded owing to possible contamina-
tion issues. A replacement flask was sent by air mail. On arrival the low serum media was
immediately discarded, the cells were washed once with sterile PBS and 25 ml of full serum
media (20% FBS instead of 10% FBS) was added to the flask. The cells were left for at least
24 hours before they were split from one T175 into four T75 flasks. Using smaller flasks
allowed the cells to grow faster and some flasks could be kept undisturbed when seeding for
the experiments to ensure an adequate cell stock while waiting for the replacement cells.
The AG01522 cells were cultured in filtered Minimum Essential Medium Eagle with
alpha modification supplemented with 20% FBS (foetal bovine serum) and 100 µgml−1
penicillin/streptomycin and stored in T75 and T175 tissue culture flasks in a tissue culture
incubator with a 5% CO2 and 37◦C atmosphere. The cells were trypsinised with 10 ml of
0.05% Trypsin EDTA which was neutralised with 10 ml of culture medium. Approximately
10 µl of the suspension was pipetted onto a haemocytometer and the cell number calculated.
The cell suspension was diluted accordingly with culture medium in order to seed approxi-
mately 500,000 cells on each sterile cell dish. Seeding was carried out 24-48 hours prior to
irradiation to allow the cells sufficient time to attach to the surface of the Mylar. Any excess
cell suspension was reseeded to keep a stock of cells growing.
Oxic Environment
Immediately before irradiation, the dishes were removed from the incubator and a second
layer of Mylar was stretched over the open side of the stainless steel ring and secured and
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sealed with a second aluminium plate and O-ring. The dish was connected to a syringe
filled with full serum cell culture medium, part of a remotely operated pump system, by
polyurethane tubing and appropriate plastic connectors to allow for a tight seal. The pump
system consisted of the syringe, tubing and connectors which would then be placed in a
specially designed motorised bed which allowed a push/pull mechanism controlled by a
remotely operated motor. The cavity between the two layers of Mylar was slowly filled with
medium, so as not to dislodge the attached cells. The dish was then carefully transported
from the LOB, in a box containing a flask of warm water to maintain the temperature of the
cells at 37◦C, to the target area where the RCF was attached using the mask (Figure 6.11).
The dish was mounted vertically on a sliding rail in the re-entrant tube and the syringe was
placed on a motorised bed. The whole assembly was pushed inside the re-entrant tube along
the rail. The syringe remotely removed the medium from the cells approximately 2 minutes
prior to the laser shot at a flow rate of 0.22 mls−1, where the cells were irradiated with
protons produced from the interaction of the laser with the target. Removing the medium
reduced the loss of energy owing to transmission through the liquid, whilst the flow rate
was chosen to maintain the integrity of the cell dish. The syringe was then used to recover
the irradiated cells with medium so they could be transported back to the LOB. The second
layer of Mylar and the excess medium were removed from the cell dishes, and the dishes
were placed back inside their petri dishes in the incubator until they were required to be
fixed.
The irradiations were carried out in an oxic environment where the cells were not treated
with any chemicals or gassed prior to, during or post irradiation. The facilities required for
hypoxia experiments were not available at LULI. Sham irradiations of control samples were
also carried out, with the samples being prepared, mounted and transported in exactly the
same way as the irradiated samples, the only difference was the samples were not subject to
any irradiation. Control samples were also kept inside the incubator.
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The same syringe system employed had already been tested during the 2013 experiment
carried out employing the Gemini laser. This system was required for these irradiations as
the safety checks, preparation including the cell dish positioning and shot time required a
significant amount of time at LULI compared to the time required at TARANIS (up to 10
minutes compared to 2 minutes). If there are any delays in the chain of events leading up to
the shot, the cells would be subject to large amounts of stress as they would start to dry out
and cool down too much. The syringe system allows the cells to be covered in the warmed
cell medium until 30 seconds before the shot, then recovered immediately after the shot,
thus reducing the stress to and maintaining the health of the cells. If the cells become too
stressed, biological changes may be a result of this stress rather than damage inflicted by the
laser accelerated protons.
6.3.3 Data Analysis and Results
The irradiated cell samples were washed twice with PBS before being fixed with an ice cold
1:1 solution of acetone and methanol for 20 minutes, at five specific time points of 0.5, 1,
2, 6 and 24 hours post irradiation. At least one shot was required per time point, with the
aim to complete at least one complete time point set within the same day to try and limit
the differences in the irradiation and incubator conditions across the set. This fact can be
used to identify if outlier values within a group of samples fixed at the same time point are
just rogue values, or if all samples on that day were affected in the same way. The results
presented are averaged over several samples and several days. The cells were permeabilised
with chilled methanol and incubated for 10 minutes on ice, after which the methanol was
poured off and the cells were washed 3 times for 5 minutes with chilled PBS. The PBS was
then discarded and 2 ml of blocking buffer (10% goat serum, 0.1% Triton X-100 in PBS)
was added per dish to block non-specific binding and the dishes were incubated at 37◦C
for 1 hour, after which the dishes were drained. Next approximately 1 ml of the primary
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LULI Oxic, Protons
Time 10 MeV 13 MeV 15 MeV
Point (hrs) Replicates Replicates Replicates
Control 2 2 2
0.5 2 2 2
1 3 2 1
2 3 3 1
6 3 3 2
24 2 2 1
Table 6.4 Summary of the LULI replicates for each time point and proton energy for the
irradiations under oxic conditions. The values represent the number of samples
successfully stained with clearly discernible foci.
antibody, 1:1000 anti 53BP1 in blocking buffer, was added to each dish at room temperature
for 1 hour. 53BP1 was chosen to visualise the DNA DSBs this time as the staining from
the TARANIS experiment using γ-H2AX did not prove satisfactory. The dishes were then
washed thrice with washing buffer (0.1% Triton X-100 in PBS), and once with PBS. The
dishes were drained and approximately 1 ml of the secondary antibody, 1:1000 GAR488 in
blocking buffer, was added to each of the dishes. The secondary antibody was left on the
dishes for 1 hour and from this point the samples had to be kept in the dark, as light would
bleach the data from the cells. The samples were washed twice with washing buffer then
once with PBS, then all the remaining solution was removed.
The samples were mounted on glass slides by depositing two drops of Gibco ProlLong
Gold Antifade Mountant with DAPI (DAPI) onto the cell side of the Mylar and gently
lowering a cover-slip over the irradiated zone indicated by the RCF mask. Excess DAPI
was removed by gently pressing with a tissue and the samples were left to dry for 24 hours
in the dark. A glass slide was attached to the reverse side of the Mylar using super glue, left
to dry, and a scalpel was used to cut around the glass slide to remove the sample from the
dish. The glass slide was marked to show the positions of where 6 MeV, 10 MeV and 15
MeV protons should have irradiated the cells using a template produced from simulations
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and RCF data. Excess Mylar was cut away from around the cover slip and the edges were
sealed with clear nail varnish. The samples were stored at -20◦C while on-site at the LOB
and on their return to Queen’s University Belfast. During transport they were kept as close to
-20◦C as possible by packing the samples in slide boxes inside insulated polystyrene boxes
with ice blocks. Table 6.4 summarises the number of replicates for each proton energy and
time point. As can be seen from the table, for 10 MeV and 13 MeV there are at least two
or three samples for each time point which had clearly discernible foci after the staining
procedure, but for 15 MeV there was only one sample for the 1 hr, 2 hr and 6 hr time points.
After the samples were mounted, images of the cells were obtained using the Carl Zeiss
Axiovert 200M fluorescence microscope with CCD acquisition capability and Axiovision
Rel 4.8 software package, located at the Centre for Cancer Research and Cell Biology, QUB.
A x 63 magnification oil immersion objective and x 40 magnification objective were used
to focus the microscope and take several images of each region of interest on each slide.
For each region of interest a sufficient number of images were taken, to allow the counting
and recording of foci in at least 50-100 cells. The foci were counted using the Cell Counter
application in ImageJ, where the foci are still recognised manually by the user, but the
program records the number, allowing faster and easier data acquisition. Overlapping cells,
cells with a high background and abnormally sized/shaped cells were ignored; only cells
with clearly discernible foci were counted. An even more efficient approach for counting
the foci would be to use an automated cell analysis program, however as the cells are plated
on 3 µm Mylar which is no longer taut when the samples are removed from the dishes,
the cells are no longer resting on a completely flat surface. This causes variation in the
focal length required to visualise the cells on the microscope, including variations within
the same cell where a portion of the nucleus will be in focus and the other portion out of
focus. Manual adjustment of the focus may be more time consuming, but allowed a higher
accuracy in the count in this instance.
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Fig. 6.12 Example images of the 53BP1 foci taken at the positions irradiated by 10 MeV,
13 MeV and 15 MeV protons as indicated by the positions on the RCF mask, at the five
different time points of 0.5, 1, 2, 6 and 24 hrs post irradiation and the control.
Figure 6.12 shows example images of the stained cells taken with the Axiovert 200M
fluorescence microscope. The foci are clearly visible and well defined. The images were
taken along three specific lines, as indicated by the RCF mask, at the positions irradiated
by 10 MeV, 13 MeV and 15 MeV protons. Although the 6 MeV line was indicated on the
mask, the microscope was unable to focus on this line, so an alternative line at 13 MeV was
chosen instead, measured by focusing on the 15 MeV line and moving the microscope stage
2557.5 µm towards the 10 MeV line. A vertical scan along the 10 MeV line was performed
for the first 0.5 hr sample, where an image was taken every 170 µm using the x 63 objective
starting just outside one edge of the radiation zone and finishing just outside the other edge
of the radiation zone. The average number of foci per nucleus for each of these images was
determined and plotted as a function of distance across the sample. The dose for the shot
was obtained from the normal EBT-3 film located behind the cell dish using the ImageJ
Macro discussed in Section 3.3.3, and was also plotted as a function of distance across the
sample. As can be seen in Figure 6.13, this showed that the average number of foci per
nucleus and the dose were relatively uniform across the centre of the radiation zone, but fell
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away towards the edges, thus subsequent images for analysis were taken within a central
region of the slide (approximately 4 mm). The dose from the customised EBT-3 film was
not aligned with the foci number per nucleus as a calibration for this type of film was not
available at the time of analysis. The films were scanned with an Epson Perfection V75 pro
calibrated flat-bed transmission scanner with setting of RGB 48 bit and a resolution of 300
dpi.
Fig. 6.13 Average number of foci per nucleus aligned with the dose across the normal
EBT-3 RCF along the 10 MeV proton line for the first 0.5 hr sample.
Figure 6.13 was used to extract a dose response for the particular shot used to identify
the region for foci counting. A dose response is a simple x-y graph relating the magnitude
of a stressor, in this case the dose of proton irradiation, to the response of the receptor,
in this case the number of DNA DSB foci induced in AG01522 normal human fibroblast
cells. The dose response relationship describes the changing effect on an organism caused
by different doses after a certain exposure time, in this case 0.5 hrs. In the figure the average
number of foci per cell at a certain position on the sample, is plotted against the dose at
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Fig. 6.14 Dose response extracted from Figure 6.13 where the average number of foci per
nuclei has been plotted against the dose at that position.
the corresponding position on the RCF behind the sample. The higher the dose obtained
from the RCF, the greater the average number of foci per nucleus obtained from the stained
sample.
Along each of the specified energy lines, within the central 4 mm zone, an image was
taken every 170 µm using the x 63 objective or 256 µm using the x 40 objective. The
microscope was centred on each of the lines, with the field of view being 226 µm or 344
µm across for the x 63 or x 40 objective respectively. The mean number of foci counted for
a minimum of 50 cells and a maximum of 200 cells per slide was recorded for each energy
line on every slide. The dose for each shot at the position of each energy line was then
obtained from the normal EBT-3, and the average number of foci per nucleus per Gy was
calculated for each time point. Figure 6.15 shows the average number of foci per nucleus
per Gy at each time point for the regions of the sample irradiated with 10 MeV, 13 MeV and
15 MeV protons, and Figure 6.16 shows the percent of foci remaining at each time point
compared to the average number visible 0.5 hrs post irradiation. All values are averaged
over two to three shots for the 10 MeV, 13 MeV and 15 MeV positions apart from the 1 hr,
2 hr and 24 hr time points for the 15 MeV line which are just one sample each. All values
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have the control value of 1.81 ± 0.05 subtracted,
Fig. 6.15 Kinetics of DNA DSB damage and repair visualised through 53BP1
immunostaining and displayed as the average number of foci per nucleus per Gy with
respect to time post irradiation.
Figure 6.15 has some promising features in the form of a peak in the number of DSBs,
followed by a period of recovery. The 53BP1 foci are dephosphorylated over time with
kinetics which parallel the rate of DSB repair. The kinetics, which are measured as a mean
number of foci per nucleus per Gy over time (shown in Figure 6.15 and as a percent of
foci remaining compared to the number of foci visible 0.5 hrs post irradiation shown in
Figure 6.16), represent the fast and slow components of DNA repair. The fast component
is apparent from the measured time points of 0.5 to 2 hrs post irradiation, with the slow
component extending from 2 to 24 hrs post irradiation. The fast component represents the
repair of simple DSBs and the slow component represents the repair of more complex DSBs.
The three different proton energies of 10 MeV, 13 MeV and 15 MeV all have similar LET
values of 4.6 keV/µm, 3.7 keV/µm and 3.3 keV/µm respectively, hence why they show
approximately the same trend and values for the average number of foci per nucleus per
Gy for each time point. The slight discrepancies in the values may be owing to over- or
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under-estimation of the number of foci for these time points, a slight error in the position of
the lines on the glass slides of each sample or an error in the position of where the dose was
obtained from the EBT-3.
Fig. 6.16 Percent foci remaining at the different time points with respect to the average
number of foci 0.5 hrs post irradiation.
Figure 6.16 shows a similar situation with most of the data sets following approximately
the same trend. The 10 MeV and 13 MeV proton data sets are closely matched for the
longer time points of 6 and 24 hrs, whereas the 13 MeV and 15 MeV proton data sets are
more closely matched at the 1 and 2 hr time points (the same can be seen in Figure 6.15).
Figure 6.17 shows the relative foci induction for each of the five time points investigated.
The relative foci induction (RFI) is measured as the ratio of the average number of foci
induced by the proton irradiations (FProtons) of 10 MeV, 13 MeV and 15 MeV compared to





This is an analogous measure to the RBE, which is more commonly used for cell survival
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Fig. 6.17 The relative foci induction measured as the ratio of the average number of foci
per nucleus per Gy induced by the proton irradiations (10 MeV, 13 MeV and 15 MeV)
compared to the average number of foci per nucleus per Gy induced by 225 kVp X-rays for
each time point.
studies such as clonogenic assays. The RFI was calculated individually for each time point
and plotted along with the generally accepted RBE of 1.1 for proton irradiations, as shown
in Figure 6.17. The average RFI for each proton energy was calculated to be 1.20 ± 0.18,
1.32 ± 0.29 and 1.62 ± 0.55 for 10 MeV, 13 MeV and 15 MeV protons respectively, all
of which are higher than the generally accepted value of 1.1, but this value falls within the
margin of error. The RFI appears to be much higher at 24 hrs for all the discussed proton
energies, but especially for 15 MeV protons. The dose calculated from the EBT-3 normal
films at the 15 MeV position was very low, the effect of which is amplified by division when
calculating the average foci per nucleus per Gy and thus the RFI. Figure 6.18 shows the shot
to shot dose variation calculated from the normal EBT-3 films at the three different energy
positions.
The average dose across all shots for the 10 MeV proton line was 1.19± 0.30, for the 13
MeV line it was 0.73 ± 0.24 and for the 15 MeV line it was 0.45 ± 0.22. The experimental
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Fig. 6.18 Shot to shot dose variation for all shots calculated from the positions for each
energy line indicated from the RCF mask.
Proton Energy (MeV) Average Dose (Gy) Max Dose (Gy) Min Dose (Gy)
10 1.19 ±0.30 1.92 ±0.11 0.70 ±0.04
13 0.73 ±0.24 1.25 ±0.07 0.43 ±0.03
15 0.45 ±0.22 0.84 ±0.05 0.17 ±0.01
Table 6.5 The average dose calculated across all shots for each proton energy line, the
maximum dose obtained for each line and the minimum dose obtained for each line.
aim was to obtain dose values around 1 Gy, which was achieved for the 10 MeV and almost
achieved for the 13 MeV, but the dose values for the 15 MeV line were much lower at
approximately half a Gy. This could also be a contributing factor in the large RFI value
obtained at 24 hrs, as an error in a small dose value used for division can dramatically
increase the error in the average number of foci per nucleus per Gy and subsequently the
RFI.
Figure 6.15, Figure 6.16 and Figure 6.17 show data obtained from comparison X-ray
irradiations carried out at the Centre for Cancer Research and Cell Biology at Queen’s Uni-
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versity Belfast (CCRCB). These irradiations will be described in section 6.5.
6.4 TAP 2015 Experiment
Tumour hypoxia represents one of the most important challenges in current radiotherapy.
Hadrontherapy employing protons and high LET charged particles has gained momentum
worldwide as an effective modality for tumour therapy, including success in inducing cell
death in cancer cells under hypoxia as reported by several investigations. Significant ad-
vances in laser technologies have led to the prospect of using laser accelerated ions, emitted
in ultra-short bursts, as a future cost saving alternative to conventional accelerators. For laser
accelerated ions the dose rates which are likely to be achieved may impact on the oxygen
dependency of the radiation response. An understanding and characterisation of the radio-
biological effects at the ultra-high dose rates delivered by these short ion pulses on human
cells under hypoxic conditions is important for the development and further advancement
of this technology towards clinical applications.
Previously we have shown the effectiveness of laser accelerated protons and carbon ions
(as described in the previous work in sections 6.1.1, 6.2 and 6.3) in the induction of DNA
double strand breaks in human cells (AG01522). The Gemini and TARANIS campaigns
highlighted limitations in terms of the dose available in a single shot, and a need to relax
the energy selection and pulse duration, as both both experiments had similar on target laser
energy, which is the main parameter for determining the flux of accelerated protons and
consequently the dose. The Vulcan petawatt laser provides up to 100 times more energy
on target and a commensurately higher number of protons per shot in a spectrum extending
to 40 - 50 MeV, providing ample opportunity to overcome these limitations. Here we aim
to demonstrate for the first time laser accelerated proton induced DSBs in human cells un-
der physically induced hypoxia, chemically induced hypoxia and a free radical scavenging
environment.
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What we want to know is do laser accelerated protons deposited at ultra-high dose rates
produce different biological effects under oxic, physically hypoxic, chemically hypoxic and
free radical scavenged conditions, as compared to X-rays and conventionally accelerated
protons? This was performed using the new compact hypoxia chamber designed specifi-
cally for this experiment and tested previously employing the TARANIS laser at Queen’s
University Belfast. The irradiations were carried out employing the petawatt arm of the
Vulcan Nd:glass laser system at the Rutherford Appleton Laboratory, with the cell culture
being performed on-site in a dedicated bio-lab, and subsequent analysis carried out in the
CCRCB.
6.4.1 Experimental Arrangement
The experimental setup incorporates the key requirement of minimizing the distance be-
tween the cell sample and the laser target, thus keeping the duration of the selected burst
of ions as short as possible. A tilted insertion tube was employed, allowing the cells to be
placed approximately 30 cm from the laser interaction point whilst keeping the cell samples
outside of the vacuum. The proton beam used for irradiations was generated by focusing the
Vulcan beam onto 25 µm aluminium targets, at intensities above 1020 Wcm−2 and native
contrast. The protons will be accelerated by the Target Normal Sheath Accleration (TNSA)
mechanism. A 1.0 T was used in conjunction with a collimator and pinhole to disperse and
spatially select a proton beam in the order of MeV per mm on the cell plane. The pinhole
and collimator were both on axis with the target and the cel sample. The protons will tra-
verse a flange mounted 50 µm Mylar window before reaching the cell plane, as employed
in the Gemini, TARANIS and LULI experiments. A slide rail was mounted inside the inser-
tion tube and an extended handle was used to slide the hypoxia chamber into the tube. The
chamber was attached using a special motorised mount attached to the hypoxia chamber and
bolted to the slide rail. The chamber was positioned inside the tube with sub mm precision.
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In contrast to the previous campaigns employing the Gemini, TARANIS and LULI facili-
ties, the large proton flux available on Vulcan allowed for a much narrower energy selection,
reflected in a shorter pulse of protons reaching the cells. Dose rates of 109 - 1010 Gys−1
were achieved in ion pulses of ∼ 40 ps and a delivered energy of ∼ 600 J [290].
The number of tracks overlapping in space and time is a key parameter for the onset
of collective effects, which can bes estimated from the number of protons falling within
the section of an ionization track in ∼ 1 ps, which is the typical timescale for the comple-
tion of pre-thermal physiochemical and physical process in the track such as the formation
free radicals. Significant spatio-temporal overlap was obtained for proton energies above
15 MeV even for doses of a fraction of less than 1 Gy, arising from the combination of the
short burst duration and the larger sectional area of the ionization tracks obtained for faster
protons, which generates more energetic secondary electrons. These conditions were not
achievable for energies below 10 MeV. Higher doses to the cell plane were achieved by en-
larging the entrance slit to the magnet, which commensurately increases the pulse duration
and ∆E, but leaves the dose rate and the track overlap substantially unchanged as all param-
eters scale linearly. Further control of the dose was achieved by varying the laser intensity
on the target to decrease the dose whilst leaving the pulse duration, E and ∆E unchanged
[290].
The cell samples had to be shielded from other ionising radiations, as shown by the
shielding layout in Figure 6.19. Lead block shielding at the back of the pinhole and around
the 50 µm Mylar window was used to stop the energetic electrons and the bremsstrahlung
they produce. The thin 25 µm Al targets will help reduce the high energy X-rays and
gammas from the interaction region. The electrons that did enter the magnet the slit will be
deflected out to a beam dump through an aperture on the side of the magnet. Monte Carlo
simulations showed that the dose delivered to the cells via protons was at least two orders of
magnitude higher than the dose delivered by other radiation sources [290]. The effect of any
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Fig. 6.19 (a) The experimental arrangement used for the TAP experiment showing the
different elements of the beam delivery system and shielding. (b) A schematic of the
experimental arrangement.
isotropic background radiation on the cells was monitored by observing the dose delivered
to regions of the cell dish not directly exposed to the protons (the regions above and below
the irradiated stripe) and served as a control. For these irradiations the 15 MeV portion of
the proton spectrum was centred on the cell dish.
The setup used allowed controllable dose, energy spread and pulse duration at proton
energies in the range of 5 to 30 MeV. Normal human fibroblast cell line AG01522 was used
to allow direct comparisons with both previous proton and X-ray experiments as well as
existing data from proton beams from conventional accelerators. The 53BP1 and HIF-1α
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Fig. 6.20 The rail used to position the hypoxia chamber inside the insertion pipe, and the
position of the pipe inside the interaction chamber. The front window of the hypoxia
chamber is aligned with the flange mounted Kapton window.
immunofluorescence assays allowed the assessment of any deviations form the expected
cellular response to proton irradiations. In the presence of an energy dispersed proton dose,
this assay allows the collection of information over a range of energies on a single shot
basis, and will allow the reconstruction of the temporal dynamics of cell repair.
6.4.2 Irradiation Setup
The passage 9 AG01522 normal human fibroblast cells were transported to the Rutherford
Appleton Laboratory by commercial air travel in one T75 flask containing 800 ml of reduced
serum media (10% FBS 100 µgml−1 penicillin streptomycin in minimum essential medium
eagle with alpha modifications). On arrival the reduced serum media was discarded and
replaced with full serum media (20% FBS) and after 1 week the T75 was split in a 1:3 ratio
to T175 flasks to increase the cell number. Two vials of passage 12 cells from the previous
Gemini experiment which had been stored in the liquid nitrogen freezer in the Research
Complex at Harwell, were also retrieved, thawed and seeded into 6 T75 flasks as the cell
numbers were not increasing as quickly as expected. The cells were stored in a normal tissue
culture incubator with a 95% air 5% CO2 atmosphere, 95% humidity and a temperature of
37◦C.
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For the irradiations the samples were plated on customised stainless steel dishes, a pic-
ture of which is shown in Figure 6.22 and a schematic representation in Figure 6.6. These
dishes were assembled with a 3 µm Mylar substrate on which to grow the cells, secured by
silicon O-rings and aluminium plates. A second layer of Mylar is added to the front of the
dish which is trimmed to just below the level of the irradiation zone, approximately a third
of the way up the dish. The dishes were placed inside clean petri dishes and transported
to the X-ray machine in the Public Health England building on the Harwell Campus for
sterilisation. Six dishes at a time were sterilised inside the petri dishes with the lids on for
45 mins, with 225 KVp X-rays with the copper filter removed from the cabinet operated at
13.3 mA, receiving a dose of more than 1000 Gy. The dishes were then transported back
to the bio-lab in a sealed box cleaned with 70% ethanol and placed inside the laminar flow
hood until they were required. Every morning the UV light was turned on for approximately
2 hours. The hypoxia chambers were also cleaned inside and out with 70% ethanol before
and after every shot to reduce the possibility of contaminating the samples and the sterile
environment inside the laminar hood.
The irradiations were carried out under four different conditions: oxic, physical hypoxia,
chemical hypoxia and a free radical scavenging environment.
Oxic Environment
The irradiations of the oxic samples were carried out in a 21% O2 environment. The samples
were seeded 24 hours prior to the irradiations on the sterile cell dishes at a density of 450,000
cells per dish. The concentration of the cell suspension was determined using a Sceptre
counter as described in section 6.1.2. Just prior to the irradiations the existing media on the
cell dish was removed and replaced with 1 ml of fresh full serum media. The customised
EBT-3 film was wrapped in 0.9 µm Mylar and attached to the underside of the cell dish
using the mask shown in Figure 6.22. The sample was then secured inside the chamber
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using an aluminium bracket and the lid was sealed while the two gas ports were open inside
the laminar flow hood, preventing damage to the delicate Saran window of the chamber.
The gas ports were then sealed and the chamber was transported to the laser interaction area
for irradiation. The samples were irradiated in a vertical position with the front layer of
Mylar allowing the 1 ml of media to be caught in the bottom third of the dish during the
irradiations. This was below the irradiated portion of the dish. After irradiation the samples
were transported back to the bio-lab where the customised EBT-3 film was removed from
the back of the dish, and the samples were stored in the normal cell culture incubator until
they were required for fixation.
Hypoxic Environment
These irradiations were carried out in a 0 to 0.1 % O2 environment induced by physically
removing the oxygen from the sample through gassing the hypoxia chamber. The compact
hypoxia chamber was specially deigned for laser-driven irradiations. The hypoxic samples
were seeded at least 28 hours prior to the time of the irradiation on the sterile dishes at a
density of 450,000 cells per dish. The concentration of the cell suspension was calculated
using a Sceptre counter. The samples were kept a normal cell culture incubator for 24 hours,
then they were removed and 1 ml of full serum media was added to each dish to replace the
discarded media. The customised 0.9 µm Mylar wrapped EBT-3 film was attached to the
back of the dish using the RCF mask and the dish was secured inside the chamber. The
lid was sealed tightly while the gas ports were open, then the chamber was taken from the
laminar flow hood to the normal incubator which had a gas inlet port at the back. Now all
six hypoxia chambers were connected in series to the hypoxic gas supply of 95% N2 and
5% CO2. The first chamber in the series (the one closest to the gas supply) was used as the
24 hour sample, with the last chamber being used as the 0.5 hour sample. The final chamber
was also connected to a flask of sterile water to monitor the flow rate of the gas supply. A
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flow rate of∼ 2 bubbles per second was used to gas the chambers to ensure the small amount
of media on the cells did not dry out over the 4 hour gassing period. After a minimum of 4
hours gassing, the final chamber in the chain was removed by closing the valves at the same
time to seal the chamber, then restoring the gas flow to the other chambers. The chamber
was transported to the laser interaction area where it was placed on the sliding rail inside
the insertion tube. After irradiation the chamber was taken back to the bio-lab where the
sample was removed from the chamber as quickly as possible and placed inside the hypoxic
incubator which had a 1% O2 environment, 37◦C and 95% humidity. The RCF was removed
from the back of the sample for processing.
Cobalt Chloride Environment
For these irradiations hypoxia was induced chemically by the addition on the hypoxia
mimetic agent CoCl2 prior, during and post irradiation. The cell samples for these irra-
diations were seeded 48 hours prior to the irradiation time with full serum media and kept
in the normal cell culture incubator. A 25 mMol stock CoCl2 solution was prepared by dis-
solving 0.237 g of CoCl2 in 40 ml of pure distilled water then filtered using a sterile syringe
filter. After 24 hours the samples were removed from the incubator and 3 ml of fresh full
serum media was added to each sample along with 18 µl of the stock CoCl2 solution to give
a final concentration of 150 µMol. The samples were returned to the incubator for a further
24 hours to allow the CoCl2 time to remove all the oxygen from the sample. After 24 hours
the samples were removed from the incubator, the customised EBT-3 protected with 0.9 µm
Mylar was attached to the back of the sample with the RCF mask. The dishes were secured
in the hypoxia chamber and the old media was replaced with 1 ml of fresh reduced serum
media and 6 µl of the CoCl2 solution. The lid was secured on the hypoxia chamber while
the gas ports were open to protect the Saran windows, then the valves were closed and the
chamber transported to the interaction area. After the irradiations the chamber was taken
218 Biological Effects of Laser-Driven Ions
back to the bio-lab and the samples were removed from the chamber in the laminar flow
hood, the RCF was removed and fresh full serum media with the correct concentration of
CoCl2 solution was added to the samples. The samples were stored in the normal incubator
until they were required for fixation.
Dimethyl Sulfoxide Environment
For these irradiations dimethyl sulfoxide, or DMSO, was used as a free radical scavenger.
The use of this scavenger pre, during an post irradiation would allow the quantification of
the effects of direct ionisation caused by the ions and secondary electrons relative to the
indirect DNA lesions induced by radical species. These samples were seeded on the sterile
3 µm Mylar at least 28 hours prior to the irradiation time. Several 50 ml tubes of stock 0.5
% DMSO solution were made by adding 250 µl of DMSO to 50 ml of reduced serum cell
media. After 24 hours of incubation in the normal cell culture incubator the samples were
removed and the full cell media on the dishes was removed and replaced with 3 ml of fresh
DMSO supplemented incomplete media. The samples were incubated for a further 2 - 4
hours with these media. Just before the irradiations the customised EBT-3 wrapped in 0.9
µm Mylar was attached to the back of the dish and he excess media was removed to leave
1 ml of supplemented media on the dishes. The samples were then secured in the chamber
using the aluminium bracket, the lid was sealed while the ports were open, then the valves
were closed while transporting the chamber to reduce contamination. After the samples
were irradiated in a vertical position in the laser interaction area, the samples were taken
back to the bio-lab and removed from the chamber under the laminar flow hood. The media
was removed and 3 ml of fresh DMSO supplemented reduced serum media was added to
each sample. They were stored in the normal cell culture incubator until the samples were
required for fixing.
For all irradiation environments the samples were placed inside the hypoxia chamber,
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secured by an aluminium bracket. The hypoxia chamber was placed inside a dedicated
container and transported from the bio-lab to the interaction area where the chamber was
transferred to a portable heat box. The chamber was stored here until it was required for
the irradiations. The heat box was used to maintain the chamber at 37◦C. The chamber was
attached to the sliding rail inside the entrance pipe using a specially designed motorised
mount which was connected to a power supply. The motor action was tested before pushing
the chamber to the end of the rail inside the pipe using an extended arm. The laser area was
searched and sealed before requesting a shot from the laser. The hypoxia chamber was kept
in the horizontal position until the shot had been approved as this process could take several
minutes. Once the shot had been approved the external motor control was use to raise the
chamber into a vertical position as shown in Figure 6.21 (b). As soon as the laser had been
fired the chamber was returned to the horizontal position to allow the media to recover the
cells and prevent any unnecessary stress to the cells or the sample drying out. The chamber
was then transported back to the bio-lab where the oxic, CoCl2 and DMSO samples were
removed from the chamber and placed in the normal incubator, and the hypoxic samples
were either kept inside the hypoxia chamber and re-connected to the gas supply or removed
and placed in the hypoxic incubator with a 1% O2 atmosphere until they were required for
fixing.
The hypoxia chamber was positioned at the entrance of the Bragg peak of the proton
track, which allowed precise dose measurement using customised EBT-3 film attached di-
rectly behind the cell monolayer of all the samples. At the cell plane, the 15 MeV portion
of the proton spectra was centred on the cell dish.
Sham irradiations of control samples were carried out for each of the four irradiation
conditions, with the samples being prepared, mounted and transported in exactly the same
way as the irradiated samples, the only difference was the samples were not subject to any
irradiation. Control samples were also kept inside both incubators.
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Fig. 6.21 (a) The position of the hypoxia chamber before and after the irradiations and (b)
during irradiations.
6.4.3 Data Analysis and Results
The samples were fixed at five specific times post irradiation: 0.5, 1, 2, 6 and 24 hours
post irradiation. The same laser shot cannot be used for multiple time points as once the
sample is fixed, the cells have been killed in situ at that specific time. One shot was required
per time point, with the aim to complete at least one complete set of all six time points
within the same day to try and keep the irradiation and incubator conditions as consistent
as possible across the set. This fact can also be used to identify if outlier values within a
group of samples fixed at the same time point are just rouge values, or if all samples on that
day were affected in the same way. The results presented are averaged over several samples
over several days.
The media was removed from the samples they were washed twice with PBS before
being fixed with 2 ml of 4% PFA for 10 to 12 minutes at room temperature. 4% PFA was
used instead of methanol as this had proved too harsh in testing, affecting the staining of the
bio-markers. When fixing the hypoxic, CoCl2 and DMSO samples, this had to carried out
very quickly to prevent any change in the conditions present in the cell dish as compared to
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the irradiation and incubation conditions. The samples were then washed three times with
PBS and stored in the fridge covered in PBS to prevent them drying out before commencing
the staining procedure. The samples were stained in batches of 12 to 24 samples at a time.
For the immunofluorescence, the cells were stained in their original position; therefore a
uniform cell layer covering the region of interest provided a large set of data on the cell
response to different irradiation conditions and parameters.
The samples were permeabilised with 0.5% Triton X-100 in PBS for 10 minutes at room
temperature, before washing with PBS three times 0.5% Triton X-100 in PBS was used
instead of a 1:1 solution of acetone and methanol as this had proved too harsh in testing,
affecting the quality of the bio-marker staining. After permeabilisation non-specific binding
was blocked with a buffer of 10% goat serum and 0.25% Triton X-100 in PBS for 2 hours at
37◦C. After blocking the primary antibodies were added to the samples. The first complete
set of each irradiation type were stained for DNA damage and hypoxia induction using
53BP1 at 1:1000 and HIF-1 at 1:500 in blocking buffer respectively. 53BP1 was chosen
instead of γ-H2AX, as the corresponding new HIF1-α antibody for 53BP1 produced much
better results in testing for the staining of the hypoxia response. Subsequently only CoCl2
and hypoxic samples were stained with HIF-1α to conserve the antibody. The primary
antibody was left on the samples for 2 hours at 37◦C to enhance the quality of the staining.
From this point the samples were kept in the dark to prevent the data being bleached from
the samples. After 2 hours the primary antibody was removed and the samples were washed
three times with a 0.1% Triton X-100 in PBS washing buffer and once with PBS. The
secondary antibodies of GAR488 (visualised in the green channel of the microscope) at
1:1000 and GAM594 (visualised in the red channel of the microscope) at 1:500 in blocking
buffer were used for 53BP1 and HIF-1α respectively. These antibodies were left on the
dish for 1 hour at 37◦C. The secondary antibodies were then removed and the samples were
washed twice with washing buffer and once with PBS.
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TAP 15 MeV Protons
Time Oxic Hypoxic DMSO CoCl2
Point (hrs) Replicates Replicates Replicates Replicates
Control 3 5 3 3
0.5 4 4 3 3
1 2 3 3 2
2 5 4 1 3
6 3 4 2 3
24 4 3 2 3
Table 6.6 Summary of the TAP replicates for each time point and irradiation environment
for 15 MeV protons. The values represent the number of samples successfully stained with
clearly discernible foci.
At this stage all excess liquid was removed from the dish either by pipette or vigorously
shaking the dish. The sample was then turned over and the RCF mask was used to mark
the position of the 15 MeV proton line on the back of the Mylar. An L and an H were also
marked on the Mylar to indicate the low and high ends of the proton spectra. The mask
was created by making a cut wide enough for a 0.7 mm permanent marker in a 125 µm
Mylar substrate at the position of the 15 MeV proton line as indicated by calibration shots
and simulations. The slit was 11.5 mm from the straight edge of the centre cut out of the
RCF holder and 14 mm from the straight edge of the RCF, which was towards the lower
end of the proton spectrum. The mask is shown in Figure 6.22. The marks on the back of
the Mylar were sealed with clear nail varnish to protect them from the Superglue which was
used to mount the samples on glass slides. Two drops of DAPI were added to the centre
of each dish and the dish was gently agitated to evenly distribute the solution. The mask
was again used to correctly position the cover-slip over the cells, and the samples were left
overnight, or longer if required, to dry. The next day the edges of the cover-slip were sealed
with clear nail varnish. If any additional marks were required on the Mylar, they were added
and sealed with clear nail varnish. A glass slide was then attached to the back of the sample
using a few drops of Superglue, ensuring it was centred on the cover-slip. They were left
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to dry, then all the samples were cut from this dishes, the glass slides marked with the shot
details and they were stored at -20◦ both at RAL and the CCRCB where they were scored.
Table ?? summarises the number of replicates for each irradiation environment and time
point. All time point and environment combinations had two to five replicates with clearly
discernible foci after the staining process, apart from the DMSO 2 hr combination which
only had one replicate.
Fig. 6.22 The average number of foci per nucleus across one cell sample aligned with the
dose from the customised EBT-3. Both measurements are taken from the position of the 15
MeV proton line as indicated by the RCF mask, which is attached to the cell dish as shown.
After the samples were mounted and transported back to the CCRCB, images of the
samples were obtained using the Carl Zeiss Axiovert 200M fluorescence microscope with
CCD acquisition capability and Axiovision Rel 4.8 software package. A x 40 magnification
objective was used to focus the microscope and take an image every 260 µm along the
15 MeV line marked on the slide. This provided a full profile of the cell’s response with
respect to ion energy and dose across the width of the irradiation zone. The foci were
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counted using the Cell Counter application in ImageJ. Only cells with clearly discernible
foci, not overlapped by other cells, were counted towards the foci number. Example images
of the oxic and hypoxic samples are shown in Figure 6.23. The average number of foci
per nucleus was calculated for each image and plotted as a function of distance across the
sample. This was aligned with the dose across the sample as obtained from the EBT-3 film
placed behind the cell monolayer, as shown in Figure 6.22.
Fig. 6.23 AG01522 human skin fibroblast cells were irradiated with 15 MeV laser
accelerated protons employing the petawatt arm of the Vulcan laser facility. The samples
were kept inside the hypoxia chambers after the irradiations to maintain the hypoxic
environment. The samples were fixed at 0.5 and 24 hrs post irradiation, then stained for
HIF-1α to show the induction of hypoxia, 53BP1 to highlight DNA DSB damage and
DAPI for detecting the cell nuclei.
Reference dosimetry was performed at a selected position in the spectrum, using strips
of customised EBT-3 placed horizontally behind the cell dish inside the hypoxia chamber
with no cells present. This absolute reference, together with the transmitted dose and ion
transport simulations allowed the dose deposition in the cell to be reconstructed [288]. The
cells were located in the entrance of the Bragg peak of the proton spectra ion, to allow
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a reasonably accurate measurement of the dose profile from the customised EBT-3 film
placed directly behind the cells. The EBT-3 films were scanned with an Epson Perfection
V75 pro calibrated flat-bed transmission scanner with resolution of 300 dpi and RGB 48
bit. The dose was obtained from the ImageJ Macro discussed in Section 3.3.3 using the red
channel as it is most sensitive at the energies and doses obtained in this experiment. An
example of the dose map produced from this Macro is shown in Figure 6.24.
Fig. 6.24 The raw scanned image of the RCF which is converted to a dose map using an
ImageJ Macro. The position of the 15 MeV proton line and an example image of the foci is
shown.
The average number of foci per nucleus and the dose for each shot were used to cal-
culate the average number of foci per cell per Gy, as shown by the left had plot of Figures
6.25, 6.26, 6.27 and 6.28 for the oxic, physical hypoxia, chemical hypoxia and free radical
scavenging environment respectively. The right had plot of each of these Figures shows
the percent foci remaining at each time point compared to the average number of foci per
nucleus per Gy present at 0.5 hours post irradiation. The values are averaged over several
shots, two to five in all cases apart from the value for the 2 hr DMSO 15 MeV proton and
the hypoxic 6 hr and 24 hr X-ray time points which are obtained from only one shot each.
All the averaged values have the relevant control value (averaged over two to five samples)
of 1.85± 0.11, 1.84± 0.12, 1.89± 0.18 and 1.81± 0.09 for the oxic, hypoxic, DMSO and
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CoCl2 15 MeV proton values, and 1.81 ± 0.11, 2.16 ± 0.08, 1.96 ± 0.05 and 2.72 ± 0.04
for the oxic, hypoxic, DMSO and CoCl2 225 kVp X-ray values respectively.
Fig. 6.25 Kinetics of DNA DSB damage and repair visualised through 53BP1
immunostaining for oxic irradiation conditions, displayed as the average number of foci
per nucleus per Gy with respect to time post irradiation.
Fig. 6.26 Kinetics of DNA DSB damage and repair visualised through 53BP1
immunostaining for physically hypoxic irradiation conditions, displayed as the average
number of foci per nucleus per Gy with respect to time post irradiation.
Figures 6.25, 6.26, 6.27 and 6.28 all show promising features in the form of a peak in the
number of DSBs followed by a period of recovery. The 53BP1 foci are dephosphorylated
over time with kinetics which parallel the rate at which the DSBs are repaired. The kinetics
6.4 TAP 2015 Experiment 227
Fig. 6.27 Kinetics of DNA DSB damage and repair visualised through 53BP1
immunostaining for chemically hypoxic irradiation conditions, displayed as the average
number of foci per nucleus per Gy with respect to time post irradiation.
Fig. 6.28 Kinetics of DNA DSB damage and repair visualised through 53BP1
immunostaining for free radical scavenging irradiation conditions, displayed as the average
number of foci per nucleus per Gy with respect to time post irradiation.
which are measured as a mean number of foci per nucleus per Gy over time ( shown as the
average number of foci per cell per Gy on the left had plot of Figures 6.25, 6.26, 6.27 and
6.28 and as the percent foci remaining compared to 0.5 hours post irradiation on the right
hand plot) represent the fast and slow components of the DNA repair. The fast component
is apparent from the measured time points of 0.5 to 2 hours post irradiation with the slow
228 Biological Effects of Laser-Driven Ions
component extending from 2 to 24 hours post irradiation. The fast component of the kinet-
ics represent the repair of the simple DSBs by non-homologous end-joining (NHEJ), and
the slow component represents the repair of complex DSBs by homologous recombination
(HR). The error bars on the data are produced by combining the error in the manual foci
count itself, the dose obtained from the EBT-3 film, the subtracted background count and
the subtracted background dose. The error in the average number of foci per nucleus per Gy












where F is the average number of foci per nucleus ± δF , FC is the control average number
of foci per nucleus ± δFC, D is the dose ± δD and DB is the background dose ± δDB. An












where FGT ± δFGT is the average number of foci per nucleus per Gy at the time point of
interest and FG0.5± δFG0.5 is the average number of foci per cell per Gy at 0.5 hours post
irradiation.
The relative foci induction, RFI, was investigated for each of the irradiation conditions
across all the time points. The RFI is the ratio of the average number of foci induced per
Gy for the 15 MeV protons compared to the average number of foci induced per Gy by 225
kVp X-rays. This is an analogous measure to the relative biological effectiveness (RBE),
which is more commonly used for cell survival studies. The RFI values for each irradiation
condition were calculated for each time point and plotted along with the generally accepted
RBE value of 1.1 for proton irradiations in Figure 6.29, and are summarised in Table 6.7.
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Fig. 6.29 The relative foci induction for each of the irradiation conditions across all time
points.
The oxygen enhancement ratio, OER, or perhaps more correctly the hypoxia reduction
factor, HRF, was calculated for the physically and chemically induced hypoxic samples
compared to the oxic samples for both the 15 MeV protons and the 225 kVp X-rays. The
OER is the ratio of the radiation dose required for the same biological effect in the absence
versus the presence of oxygen, and the HRF is the same ratio in reduced oxygen conditions
compared to oxic conditions. As the hypoxic samples were kept in a hypoxic incubator at
1% O2 the term HFR applies here. The values are summarised in Table 6.7.
15 MeV protons 225 kVp X-rays
RFI HRF HRF
Oxic 1.00 ±0.09 - -
Hypoxic 1.78 ±0.94 1.36 ±0.55 1.95 ±0.33
CoCl2 2.07 ±0.84 0.94 ±0.26 1.78 ±0.31
DMSO 0.96 ±0.22 - -
Table 6.7 Summarised RFI and HRF values for the four different irradiation conditions for
15 MeV protons and 225 kVp X-rays.
For the oxic samples the 15 MeV protons and the 225 kVp X-rays exhibit almost identi-
cal foci kinetics. The protons induced marginally fewer foci at 0.5 and 6 hours post irradia-
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Fig. 6.30 HRF calculated for both 15 MeV protons and 225 kVp X-rays for the physically
hypoxic samples and the chemically hypoxic (CoCl2) samples for all time points. The
average values were 1.36 ± 0.55 and 1.95 ± 0.33 for the proton and X-ray hypoxic
samples respectively, and 0.94 ± 0.26 and 1.78 ± 0.31 for the proton and X-ray CoCl2
samples respectively.
tion, but marginally more at 1 and 2 hours post irradiation (Figure 6.25 left hand side). The
protons have a marginally slower response in the fast component of repair than the X-rays
(Figure 6.25 right hand side). The RFI was calculated as 1.00 ± 0.09, with all time points
being approximately the same value as shown in Figure 6.29, meaning that the cells have
approximately the same response to the proton and X-ray irradiations.
For the hypoxic samples, more initial damage is inflicted on the cells shown by a higher
number of foci at the 0.5 hour time point compared to X-rays, at 1 and 2 hours the foci
number is approximately equal for both radiation types, and at 6 and 24 hours there are
more residual foci for the protons as shown by Figure 6.26. The rate of repair is initially
much faster for the damage inflicted by the protons, but after 2 hours the rate slows down
significantly as shown by Figure 6.26. The RFI was calculated as 1.78 ± 0.94. The value
was close to 1.1 for the 0.5 to 6 hour time points, then the value shoots up to approximately
3.5 at the 24 hour time point (see Figure 6.29). The HRF for the protons was 1.36 ± 0.55,
and it was 1.95 ± 0.33 for the X-rays. The HRF was significantly lower for protons at 24
hours post irradiation as shown in Figure 6.30. This shows that irradiations performed with
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X-rays are more sensitive to changes in the oxygen concentration. In the hypoxic conditions
the protons were more lethal than the X-rays to the cell samples.
Analogous to the hypoxic samples, more damage was inflicted on the cells by the protons
for the CoCl2 samples at all time points as shown in Figure 6.27. There also many more
residual foci at 24 hours post irradiation for the proton irradiated samples. Initially the rate
of repair of this damage is faster for the proton irradiated samples, but after two hours the
rate slows down. The RFI was calculated to be 2.07 ± 0.84, with the four initial time points
with values around 1.5, but an increase to ∼ 3.5 at 24 hours post irradiation (see Figure
6.29). The HRF was calculated as 0.94 ± 0.26 for the proton irradiations and 1.78 ± 0.31
fr the X-ray irradiations. This value decreased with time post irradiation for the proton
irradiated samples as shown in Figure 6.30. Again this shows the samples irradiated by the
protons are less affected by the presence or reduction of oxygen in the environment. Overall
the 15 MeV protons appeared again to be more lethal than the X-rays.
The results for the DMSO irradiations were analogous to the oxic irradiations in that the
protons and X-rays produced approximately the same response. there were marginally more
foci at 0.5, 1 and 2 hours post irradiation in the proton irradiated samples, but marginally
more foci in the X-ray irradiated samples at 6 and 24 hours post irradiation (Figure 6.28).
Initially the repair of the damage was faster for the proton induced damage as shown in
Figure 6.28. The RFI was calculated to be 0.96± 0.22, with the values being approximately
1.1 for all time points apart from 24 hours post irradiation where the value drops to ∼ 0.5
(Figure 6.30). Again the samples have approximately the same response for the X-ray and
proton irradiations.
The shot to shot dose variation at the position of the 15 MeV line is shown in Figure 6.31
along with the target dose of 1 Gy. The average dose across all shots for 15 MeV protons
was 1.27 ± 0.58 Gy. The experimental aim was to have a reproducible dose of 1 Gy, which
was true on average within error, however there was a large spread of values as indicated
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by Figure 6.31, with a maximum and minimum value of 2.35 ± 0.01 and 0.16 ± 0.04 as
recorded in Table 6.8.
15 MeV protons
Average Dose (Gy) 1.27 ±0.58
Max Dose (Gy) 2.35 ±0.01
Min Dose (Gy) 0.16 ±0.04
Table 6.8 The average dose calculated across all shots, the maximum dose obtained and the
minimum dose obtained for the 15 MeV proton line.
Fig. 6.31 Shot to shot dose variation across all shots for the 15 MeV proton energy line.
The data used for calculating the RFI and HRF for X-rays was obtained in a set of
comparative X-ray experiments which are described in the next Section.
6.5 Comparative X-ray Experiments
Comparison experiments were carried out employing the 225 kVp XRAD225 X-ray cabinet
located in the Centre for Cancer Research and Cell Biology, Queen’s University Belfast.
6.5 Comparative X-ray Experiments 233
X-rays are the gold standard for current cancer therapy, thus any future treatment modality
must be compared to the already existing treatments available. Irradiations in the four dif-
ferent environments of hypoxic, oxic, CoCl2 and DMSO using the same dishes and hypoxia
chambers as employed by the previous three experiments were carried out. The results ob-
tained from these irradiations were used to calculate the RFI for the proton energies used in
each of the previous experiments, and the results were also used for visual comparisons of
the foci induced and the average number of foci per nucleus per Gy.
Sterilisation of the cell dishes was performed using the X-ray cabinets located in both
the CCRCB and the Public Health England Building on the Harwell Campus. Dosimetry
experiments using normal and customised EBT-3 were also carried out at the CCRCB to
create a calibration for updating the ImageJ Macro used for obtaining the dose from the
scanned films.
6.5.1 Experimental Arrangement
For cell dish sterilisations, the fully assembled cell dishes were placed in petri dishes cleaned
with 70% ethanol before being transported to the X-ray machine in a sealed container. The
lids of the petri dishes were removed and the dishes were placed on the shelf in the X-ray
cabinet at a distance of 50 cm from the source. The X-ray machine was operated at 13.3
mA and 225 kVp for 30 mins. The 2 mm copper filter in front of the source was removed to
allow as high a dose as possible to reach the dishes. Once the 30 mins were up, the lids of
the petri dishes were replaced (using sterilised gloved hands) and the dishes were placed in
the same sealed container as before once it had been cleaned with 70% ethanol. The dishes
were then transported back to the laminar flow hood and kept there under UV light until they
were required for seeding cells. When at the Rutherford Appleton Laboratory, a similar X-
ray cabinet in the Public Health England (PHE) building on the Harwell Campus was used
for sterilisation. Again, the copper filter was removed and the dishes were sterilised for 45
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mins with 225 kVp X-rays. A longer sterilisation time was used as the dishes were stacked
inside the PHE cabinet as a larger number of dishes were required at a faster turn around
rate for the TAP experiment. A dosimeter on the PHE cabinet confirmed the dishes were
receiving a dose of > 1000 Gy, which was more than adequate for sterilisation.
6.5.2 Irradiation Setup
For the dosimetry experiments, normal and customised EBT-3 films were exposed to known
doses of X-rays (0, 0.5, 1, 2, 4 and 8 Gy) by themselves, attached to the cell dishes using
the RCF mask from the TAP experiment and attached to the dish with the mask and placed
inside the hypoxia chamber, to ascertain if there was any increase or decrease in the dose
received by the sample owing to scatter from the dish or chamber. The films were scanned
with an Epson Perfection V75 Pro calibrated flat-bed transmission scanner with RGB 48 bit
and 300 dpi settings.
Cellular irradiations were only carried out using the CCRCB X-ray cabinet. The X-
ray cabinet was fitted with the 2 mm Copper filter to cut off the low energy part of the
X-ray spectrum and the delivery was controlled with an ISOVOLT Titan E. The cabinet
was operated at 13.3 mA and 225 kVp. The samples were irradiated at a source to sample
distance of 50 cm for 1 minute and 42 seconds at a dose rate of 0.591 Gy/min, equating to
a dose of 1 Gy. For these irradiations the medium was not removed from the dishes as the
samples were being irradiated in a horizontal position and the X-rays would not be affected
by the small layer of cell culture medium on the cells.
Oxic Environment
One set of samples were irradiated inside the hypoxia chambers, but with no gassing or
chemical additions before, during or post irradiations. These samples were plated on 3 µm
Mylar on the specially designed cell dishes 24 hours prior to the irradiations. A second
6.5 Comparative X-ray Experiments 235
half layer of Mylar was added to the second side of the dish, as for the TAP experiment.
Before the samples were placed inside the chamber, the cell culture media was removed and
replaced with 1 ml of fresh complete un-supplemented media. The samples were secured
inside the chamber with the aluminium bracket, and the gas ports were left open to allow
the air to circulate. After the irradiations the samples were removed from the chambers, the
second half layer of Mylar was removed and the samples were placed in the normal cell
culture incubator until they were required for fixation. The 0.5, 1 and 2 hour samples were
left with the media they were irradiated in, but the media was topped up with fresh medium
on the 6 and 24 hour samples before they were placed in the incubator.
Hypoxic Environment
The hypoxic samples were irradiated inside the hypoxia chambers after being gassed for 4
hours with a hypoxic gas mixture of 5% CO2 and 95% N2. The cells were plated on the 3
µm Mylar sterile dishes at least 28 hours prior to irradiation. This allowed the cells to attach
and grow for 24 hours before commencing the gassing. The cell dishes were placed inside
the hypoxia chamber which was tightly sealed, then connected to the gas supply for 4 hours.
This time of 4 hours is widely accepted as being sufficient to remove all the oxygen from the
cell samples. The oxygen concentration of the gas within the chamber was monitored using
a Rapidox 1100Z meter, however the concentration inside the cells and cell media could
not be monitored during the gassing or irradiations. The chambers were, however, verified
for inducing cellular hypoxia as described in section 6.5.3. After the 4 hours of gassing
the chamber valves were sealed and the chamber was placed in the X-ray cabinet. After
the irradiation the chamber was placed inside a normal incubator. The shorter time point
samples of 0.5 to 2 hours were not reconnected to the gas supply as the chambers could
maintain pathological for up to 5.5 hours on average, however the 6 and 24 hour samples
were reconnected to the supply to maintain pathological hypoxia. The longer time point
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samples were monitored to ensure the samples did not dry out from the gas flow. The gas
was passed through a flask of sterile water before reaching the samples to try and reduce the
drying effect, however if the medium level appeared to be becoming too low, the gas was
then turned off.
The samples were kept in a hypoxic environment as different biological effects would
occur as soon as the samples started to reoxygenate.
Cobalt Chloride Environment
For the CoCl2 irradiations, the samples were seeded on the 3 µm Mylar dishes 48 hours
prior to the irradiations. A stock 25 mMol CoCl2 solution was created by dissolving 0.237
g of CoCl2 in 40 ml of pure distilled water then filtered using a sterile syringe filter. After
24 hours, the media was removed from the samples and 3 ml of fresh complete medium
was added to each dish, then 18 µl of the stock CoCl2 was added to the dishes for a final
concentration of 150 µMol. The samples were incubated for a further 24 hours with this
media. Just before irradiation, the complete CoCl2 medium was removed from the samples
and 1 ml of fresh incomplete medium (10% FBS, 100 µgml−1 penicillin/streptomycin) was
added to the dish along with 6 µl of the stock CoCl2 solution. After irradiation the medium
was changed for fresh CoCl2 supplemented medium.
The samples were irradiated inside the hypoxia chambers to provide directly compara-
ble irradiation conditions to those of the oxic, hypoxic and DMSO samples, but once the
irradiations were complete, the samples were removed from the chambers and stored in the
normal tissue culture incubator until they were required for fixing.
Dimethyl Sulfoxide Environment
For the DMSO irradiations, the samples were seeded on the 3 µm Mylar dishes at least
28 hours prior to the irradiations. Several 50 ml tubes of stock 0.5% DMSO solution were
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created by adding 250 µl of DMSO to 50 ml of incomplete cell culture medium (10% FBS,
100 µgml−1 penicillin/streptomycin). After 24 hours, the normal cell media was removed
from the samples and 3 ml of fresh DMSO supplemented incomplete medium was added to
each sample. From this point DMSO supplemented media had to be used on the samples to
maintain the radical scavenging environment, otherwise scavengers could be re-introduced
into the cell media and affect the biological response. The samples were incubated for a
further 2-4 hours with this media. Just before irradiation, the excess medium was removed
from the samples leaving 1 ml of the DMSO supplemented medium on the cell sample.
After irradiation the medium was changed for 3 ml of fresh DMSO supplemented medium
on all samples.
The samples were irradiated inside the hypoxia chambers to provide directly compara-
ble irradiation conditions to those of the oxic, hypoxic and CoCl2 samples, but once the
irradiations were complete, the samples were removed from the chambers and stored in the
normal tissue culture incubator until they were required for fixing. Sham irradiations of con-
trol samples were carried out for each of the four irradiation conditions, with the samples
being prepared, mounted and transported in exactly the same way as the irradiated samples,
only they were not subject to any irradiation. Control samples were also kept inside the
incubator.
6.5.3 Data Analysis and Results
The samples were stained and mounted as described in Section 5.3.1. The hypoxic and
CoCl2 samples were stained for both the hypoxia induction marker HIF-1α and the DNA
DSB marker 53BP1. The oxic and DMSO samples were stained only for the DNA DSB
marker 53BP1. The 53BP1 assay was chosen for the superior staining it had produced in
conjunction with HIF-1α , as compared to HIF-1α and γ-H2AX. It was also the assay used
for the proton irradiations carried out on employing LULI and TAP, so would provide the
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CCRCB 225 kVp X-rays
Time Oxic Hypoxic DMSO CoCl2
Point (hrs) Replicates Replicates Replicates Replicates
Control 3 2 2 2
0.5 2 2 2 2
1 2 2 2 2
2 2 2 2 2
6 2 1 2 2
24 2 1 2 2
Table 6.9 Summary of the CCRCB replicates for each time point and irradiation
environment for 225 kVp X-rays. The values represent the number of samples successfully
stained with clearly discernible foci.
best comparison. The fluorescence microscopy was performed on the Carl Zeiss Axiovert
200M fluorescence microscope with CCD acquisition capabilities and Axiovision Rel. 4.6
software in the CCRCB. A x 63 magnification oil immersion objective was used to quantify
the 53BP1 foci induced by the X-rays and to visualise the hypoxia induction through the
nuclear staining of HIF-1α . As for the other experimental slides, a minimum of 50 and a
maximum of 150 cells were counted for each time point. As an approximately uniform dose
of 1 Gy was received by the entire cell monolayer, images could be taken and cells counted
at any position of the cell dish for each of the time points, unlike the proton irradiations
where the images had to be taken along a specific line chosen at the position of the 15 MeV
protons. The position of this line could not be altered to accommodate dose fluctuations
between shots, as the proton energy would no longer be consistent for all the shots to provide
a proper comparison. Table 6.9 summarises the number of replicates for each irradiation
environment and time point. All time point and environment combinations had at least two
replicates with clearly discernible foci after the staining process, apart from the hypoxic 6
hr and 24 hr combinations which only had one replicate each.
Owing to the nature of X-ray induced foci, it was possible to count the foci directly
through the eyepiece of the microscope, with the images being taken as a reference. How-
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ever the same counting constraints relating to overlapping cells, cells with high background
and cells in the S phase of the cell cycle were implemented.
The results of the X-ray experiments have been presented on the graphs in the previous
sections, and were used to calculate the RFI for the different energies of the protons used in
the previous sections.
The results of the dosimetry experiments were used to modify the ImageJ Macro to
include calibrations for X-rays. The pixel values of the images were obtained from ImageJ
for each of the RGB channels and plotted against dose in Excel. A six order polynomial
expression was fitted to the data then transferred to the ImageJ Macro. The Macro was then
used to determine the dose received by each of the films irradiated in each channel, with
particular interest in the red channel as it is most sensitive to low doses. The results were
used to test if there was any reduction or increase in the dose received inside the hypoxia
chamber compared to outside the chamber. The results showed that there was no reduction
or increase in the dose received by the sample, and were described in detail in section 6.5.2.
6.6 Discussion of Results
We report for the first time measurement of the DNA damage with laser accelerated pulsed
protons at ultra-high dose rates (109 - 1010 Gys−1) under physically and chemically hypoxic
and free radical scavenging conditions employing the TARANIS, LULI and Vulcan lasers at
QUB, Laser Lab Europe and the CLF respectively. The TARANIS experiment served as a
proof of principle experiment to establish the cell handling techniques required for the LULI
and TAP experiments as well as benchmarking the new compact hypoxia chamber designed
at QUB. The results from the laser irradiations have been compared to X-ray results and
show some promising features, and have also been compared to foci kinetic results from
conventionally accelerated protons.
Slight adaptations and improvements were made to the immunofluorescence protocol
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during the course of the investigations. The adaptations arose form poor staining results such
as very weak staining of HIF-1α and γ-H2AX in the TARANIS experiment, to pan staining
of the sample arising from too harsh a fixative and permeabiliastion buffer in some LULI
samples. The protocol was then adapted to use the 53BP1 antibody and the corresponding
HIF-1α antibody as these had produced better staining results in testing, with the primary
antibodies being left on the sample for 2 hours rather than one to increase the uptake of
the antibody and strengthen the staining. A 4% solution of PFA was used instead of a
1:1 solution of methanol and acetone to fix the samples and a permeabilisation buffer of
0.5% Triton X-100 in PBS instead of methanol was use to help reduce the pan staining that
occurred in some samples. The finalised version of this protocol which was used on the TAP
experiment is provided in Appendix B.
Fig. 6.32 Comparison of the 15 MeV proton DNA DSB kinetic profiles for the TAP and
LULI experiments.
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Fig. 6.33 The percentage of cells with 0 - 5 (blue), 6 - 10 (green), 11 - 20 (yellow), 21 - 30
(orange) and > 30 (red) foci per nucleus per Gy at 0.5 hours post irradiation for the four
different irradiation environments. The percentages for 225 kVp X-rays from the CCRCB,
15 MeV laser accelerated protons (LA protons, 3.3 keV/µm) from TAP and conventionally
accelerated protons from the 62 MeV beam at Istituto Nazionale di Fisica
Nucleare-Laboratori Nazionali del Sud (INFN-LNS), Catania, Italy (CA protons, 1.2
keV/µm low LET at the entrance of the Bragg peak) are shown. At Catania it was not
possible to perform hypoxic experiments using gassed samples at the time of the
experiment.
Figure 6.32 shows the response of AGO1522 human fibroblast cells irradiated with 15
MeV protons at both the LULI laser facility and at TAP. Marginally more initial foci were
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evident in the TAP samples, with similar numbers at 1, 2 and 6 hours post irradiation. At 24
hours post irradiation there is a difference in the shape of the curves as more residual foci
are present in the LULI samples. These differences are most likely a result of the relatively
low dose on the cell plane at the 15 MeV position during the LULI experiment and the fact
there were three replicates at the TAP experiment and only one for LULI at the 24 hr time
point, but there is reasonable agreement between the results. The individual values for each
time point of the average number of foci per nucleus for 15 MeV protons at LULI and TAP
are summarised in Table 6.10.
Time Post Irradiation (hrs) LULI 15 MeV protons TAP 15 MeV protons
0.5 19.29 ±0.54 24.21 ±3.38
1 15.74 ±1.36 16.50 ±1.91
2 12.20 ±2.04 12.85 ±1.09
6 6.86 ±0.18 5.37 ±0.54
24 7.70 ±0.74 1.74 ±0.21
Table 6.10 The average number of foci per nucleus for each time point for 15 MeV proton
irradiations at LULI and TAP. These values have had the control value of 1.87 ± 0.05 and
1.85 ± 0.08 for LULI and TAP respectively, subtracted.
Figures 6.33 and 6.34 show the percentage of nuclei with 0 - 5, 6 - 10, 11 - 20, 21 - 30
and > 30 foci per nucleus, in blue, green, yellow, orange and red respectively, for the TAP
samples irradiated with 15 MeV protons and the samples irradiated with 225 kVp X-rays.
Comparative data from irradiations carried out at the Istituto Nazionale di Fisica Nucleare-
Laboratori Nazionali del Sud (INFN-LNS), Catania, Italy employing their conventionally
accelerated 62 MeV proton beamline are also included. There is a pie chart for each ir-
radiation condition at 0.5 hrs and 24 hrs post irradiation. For the oxic samples, all nuclei
have at least 11 or 6 foci per Gy for both the conventionally and laser accelerated proton
samples and the X-ray samples respectively, and all nuclei have 10 foci or less at 24 hrs post
irradiation, although more nuclei have a greater number of foci for the X-ray samples. For
the hypoxic samples, all the nuclei have 20 or fewer foci per Gy at 0.5 hrs post irradiation
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Fig. 6.34 The percentage of cells with 0 - 5 (blue), 6 - 10 (green), 11 - 20 (yellow), 21 - 30
(orange) and > 30 (red) foci per nucleus per Gy at 24 hours post irradiation for the four
different irradiation environments. The percentages for 225 kVp X-rays from the CCRCB,
15 MeV laser accelerated protons (LA protons, 3.3 keV/µm) from TAP and conventionally
accelerated protons from the 62 MeV beam at the Istituto Nazionale di Fisica
Nucleare-Laboratori Nazionali del Sud (INFN-LNS), Catania, Italy (CA protons, 1.2
keV/µm low LET at the entrance of the Bragg peak) are shown. At Catania it was not
possible to perform hypoxic experiments using gassed samples at the time of the
experiment.
for protons although 10 % of the X-ray samples have between 21 and 30 foci. At 24 hrs the
X-ray samples have between 0 and 10 foci per nucleus per Gy, whereas some of the pro-
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ton irradiated nuclei have up to 20 foci per Gy. The facilities required for gaseous hypoxic
irradiations were not available at Catania when the experiment was performed, hence there
are no comparative pie charts for the hypoxic samples. For the DMSO samples, at 0.5 hrs
post irradiation all nuclei have between 6 and 30 foci per Gy, apart from 1% of the X-ray
samples which have > 30 foci per Gy. At 24 hrs post irradiation, all laser proton irradiated
samples have 0 to 5 foci per nucleus per Gy, as do the X-ray and conventional proton irra-
diated samples, apart from 5% and 2% of nuclei respectively which have 6 to 10 foci per
nucleus per Gy. Finally, for the CoCl2 samples, 18% of the laser proton irradiated nuclei
have > 30 foci per Gy, all other nuclei, including the X-ray and conventional proton samples,
have between 6 and 30 foci per Gy at 0.5 hrs post irradiation. At 24 hrs post irradiation,
3% of the proton irradiated samples have 11 to 20 foci per nucleus per Gy, with the rest
having 10 or less, including the X-ray and conventional proton samples. These results again
confirm the similarity between the X-ray and laser accelerated proton responses in oxic and
free radical scavenging conditions, but the differences in physically and chemically hypoxic
conditions. The data from Catania also shows similar responses for laser accelerated and
conventionally accelerated protons in oxic and free radical scavenging conditions, however
more of a difference is seen with the chemically hypoxic samples. More laser accelerated
proton irradiated samples have greater percentages of nuclei with a larger number of foci at
0.5 and 24 hrs post irradiation, implying more and more complex damage is induced by the
laser accelerated protons than the conventionally accelerated protons.
Figures 6.35 and 6.36 show the same data but with error bars to show the inherent error
in the measurements. Again data for the 15 MeV laser accelerated protons from TAP are
compared to X-ray irradiated samples from the CCRCB and conventionally accelerated laser
irradiated samples form the 62 MeV beamline at the Istituto Nazionale di Fisica Nucleare-
Laboratori Nazionali del Sud (INFN-LNS), Catania, Italy.
Figure 6.37 shows a comparison between oxic and hypoxic (physical and chemical) irra-
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Fig. 6.35 The percentage of cells with 0 - 5 (blue), 6 - 10 (green), 11 - 20 (yellow), 21 - 30
(orange) and > 30 (red) foci per nucleus per Gy at 0.5 and 24 hours post irradiation for the
Oxic and Hypoxic irradiation environments. Values are shown for 225 kVp X-rays, 15
MeV laser accelerated protons from TAP (3.3 keV/µm) and low LET conventionally
accelerated protons from the 62 MeV Catania beamline (1.2 keV/µm at the entrance of the
Bragg peak).
diations by 15 MeV protons at TAP, 225 kVp X-ray irradiations in oxic and hypoxic (phys-
ical and chemical) conditions at the CCRCB, and 15 MeV oxic proton irradiations carried
out at Clatterbridge Cancer Centre, UK. The proton beam generated at the Clatterbridge
Cancer Centre is accelerated using a cyclotron.
At the 0.5 hr time point, the largest number of initial foci are induced in the Clatterbridge
samples with 27.07 ± 1.2, followed by the X-ray samples with 24.87 ± 0.76, and then the
TAP samples with 24.21 ± 3.38 for the oxic conditions. At 24 hrs post irradiation this
situation is mirrored with 2.21 ± 1.1, 1.88 ± 0.16 and 1.74 ± 0.21 for the Clatterbridge,
X-ray and TAP samples respectively. For the samples irradiated after gaseously inducing
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Fig. 6.36 The percentage of cells with 0 - 5 (blue), 6 - 10 (green), 11 - 20 (yellow), 21 - 30
(orange) and > 30 (red) foci per nucleus per Gy at 0.5 and 24 hours post irradiation for the
CoCl2 and DMSO irradiation environments. Values are shown for 225 kVp X-rays, 15
MeV laser accelerated protons from TAP (3.3 keV/µm) and low LET conventionally
accelerated protons from the 62 MeV Catania beamline (1.2 keV/µm at the entrance of the
Bragg peak).
hypoxia, the laser accelerated proton irradiated samples had 14.16 ± 2.51 foci per nuclei
per Gy, while the X-ray samples had 9.67 ± 1.19. Again at 24 hrs post irradiation, the
TAP samples had more residual foci with 3.82 ± 1.26 compared to 1.07 ± 0.09 for the
X-ray samples. A similar situation is true for the samples treated with the hypoxia mimetic
agent CoCl2, where the TAP samples have 20.02 ± 2.00 and 2.97 ± 1.10 at 0.5 and 24
hrs post irradiation respectively, and the X-ray samples have 11.75 ± 0.41 and 0.80 ± 0.11
at 0.5 and 24 hrs respectively. This demonstrates that laser accelerated protons produce a
comparative result to conventionally accelerated protons and X-rays under oxic conditions,
and for chemically and physically induced hypoxia, laser accelerated protons produce more
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initial and residual damage than X-ray irradiations.
Fig. 6.37 Comparison of the 15 MeV proton DNA DSB kinetic profiles for the TAP and
LULI experiments.
Another significant point which can be raised is that the effect of hypoxia observed
in the TARANIS and TAP experiments are very different. In the TARANIS experiment
the response of the cells to irradiations under oxic and hypoxic conditions produced the
same results within error. The number of DNA DSBs induced in oxic conditions at 0.5
hrs post irradiation was marginally higher than for the hypoxic samples, and at 24 hrs the
oxic samples still had marginally more foci present. Conversely, for the TAP experiment
there was a significant difference in the number of foci at 0.5 hrs post irradiation for the
oxic and hypoxic samples (both physically and chemically induced hypoxia). The rates at
which the foci were repaired also differed, and at 24 hrs post irradiation there were more
residual foci present in the physically and chemically induced hypoxic samples than the
oxic samples. The main difference between these experimental approaches was that in the
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case of the TARANIS experiment, only one hypoxia chamber was available, thus once the
samples were irradiated they were stored inside a normal cell culture incubator and not
under hypoxia, thus they were allowed to fully reoxygenate during the 24 hr period of DNA
DSB kinetic study. In the TAP experiment, there were six new hypoxia chambers and a
dedicated hypoxic incubator, thus once the samples were irradiated they could be kept in
hypoxic conditions either inside the small hypoxia chamber or the hypoxic incubator for
the full 24 hr DNA DSB kinetic study period, with only minimal reoxygenation during
transfer between the chamber and the incubator and during the washing step before fixation.
This shows that effects observed in the TAP samples are a result of this continual hypoxic
environment during the DNA DS repair process, rather than the initial hypoxia at the time
of irradiation.
Other experiments carried out by different research groups may explain some of the
results obtained, although it should be noted that different irradiation qualities and cell lines
were employed in these experiments. These are discussed below.
Tinganelli et al [194] studied the effect of acute hypoxia and radiation quality on cell
survival. They employed CHO, Chinese Hamster Ovary, cells and RAT-1 prostate cancer
cells. They developed their own compact hypoxia chamber, consisting of a PEEK box with
an irradiation window of 1 mm corresponding to a water equivalent thickness 1.23 mm, a
transparent PMMA top cover and chamfer at the bottom of the chamber allow control over
the sample position. The cells were grown on sample rings made from polyvinyl-chloride
and a 25 µm gas permeable foil. The chamber was gassed for 2 hours with different gas
mixtures: 95% N2 and 5% CO2 for anoxic samples and 94.5% N2, 5% CO2 and 0.5% O2
for hypoxic samples. The normoxic samples were kept in 21% O2. All exposures were
performed through the irradiation window of the chamber. X-ray irradiations were carried
out employing an Isovolt DSI X-ray machine operated at 250 kVp and 16 mA with a 7 mm
beryllium, 1 mm aluminium and 1 mm copper filtering at a dose rate of 2 Gy/min. The GSI
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synchrotron (SIS) was employed for C-ion and N-ion irradiations and the Heidelberg Ion
Therapy (HIT) accelerator was used for O-ion irradiations. A Spread Out Bragg Peak of 1
cm was used for all ion exposures. The LET values were dose-average: 100 and 150 keV/m
for C-ions, 140 keV/m for O-ions, and 160 keV/m for N-ions [194]. The OER and RBE were
determined from clonogenic assays. They found the OER decreased with increasing LET,
and the RBE of CHO cells reached a plateau above 100 keVµm−1 for normoxic conditions
but increased under anoxia. The HRF obtained for the TAP 15 MeV proton irradiations
compared to the X-ray irradiations (summarised in Table 6.7), an analogous measurement
to the OER used for hypoxic exposures, also shows decreasing HRF for increasing LET as
the HRF of the hypoxic 15 MeV protons is 1.36± 0.55 compared to 1.95± 0.33 for X-rays,
and for the CoCl2 samples these figures are 0.94 ± 0.26 and 1.78 ± 0.31 for the proton and
X-ray irradiations respectively.
Raschke et al [291] used A549 human lung cancer cells to investigate whether ultra-short
laser accelerated proton pulses have similar DNA damaging effectiveness and their imme-
diate nitroxidative stress compared to conventional proton beams. The laser accelerated
protons (LAP) were generated using the 200 TW ARCTURUS laser system at the Univer-
sity of Düsseldorf in the single shot mode focused on titanium foil targets. Dose rates of 108
Gys−1 were employed. The cell samples were grown on cover-slips and exposed to 2.1 ±
0.25 MeV protons with an average LET of 23 keVµm−1. Distinct doses of between 0.25 and
2 Gy were created by accumulative application of several laser shots at 3 s intervals, (a min-
imum of eight shots) with a known dose per shot. The samples were irradiated on enclosed
ring shaped sample holders sealed on one side with 1.5 µm Mylar and on the other with a
glass slide on which the cells were grown. The conventionally accelerated protons (CAP)
were generated by a Van de Graaff accelerator at PTB Braunschweig. The primary proton
beam was scattered by a 0.5 µm gold foil in the center of the scattering chamber. A dose
rate of 0.01 Gys−1 was employed. The same sample dish was used as that for the LAP. The
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initial beam energy was 1.54 MeV, producing an energy spectrum with a peak of 0.4 MeV,
a width of 0.13 MeV (FWHM) and an LET of 45 keVµm−1. A second higher energy of
1.7 MeV was utilised with a peak around 0.7 MeV, width of 0.11 MeV (FWHM), resulting
in an average LET of 32 keVµm−1. Their comparison X-ray irradiations were carried out
employing a 320 kV Isovolt 320HS cathode generator at the University of Duisberg-Essen
Medical School, using a voltage of 320 kV with a 1.65 mm aluminium filter, delivering a
photon energy of approximately 90 keV. For the 0.2 to 2 Gy irradiations, no difference in the
DNA DSB foci kinetics measured by the γ-H2AX and 53BP1 immunofluorescence assays
were observed between the LAP, CAP and X-ray samples. For 0.64 to 1 Gy irradiations the
time course of decay of the foci was similar for all irradiation types. At 1 hour post irradi-
ation all samples regardless of irradiation type exhibited 19 - 27 foci, and at 12 - 16 hours
post irradiation 2 - 4 foci, which was similar to the control value. The RBE for CAP was 1.8
± 0.8 and for LAP it was found to be 1.4 ± 1.0. The mode of irradiation does not seem to
affect the response in the energy range employed here, similar to the results obtained from
the oxic irradiations at TAP, LULI, Clatterbridge and the CCRCB as described earlier.
Ionising radiation, as well as producing free radicals, induces delayed response involv-
ing enhanced nitroxidative stress, which is thought to contribute to late and non-targeted
effects. The half life of the primary radicals produced is in the ns range. The LAP are de-
livered at a dose rate of 108 Gys−1, whereas the CAP are delivered at around 0.01 Gys−1,
about 11 orders of magnitude lower than the lifetime of the primary radicals. Consequently,
LAP could possibly have a different radical generating potential and characteristics than
CAP, despite having a similar DNA damaging potential. The X-ray irradiations had a 5 fold
lower nitroxidative stress and the LAP had a 2 - 3 fold lower nitroxidative stress than CAP.
The salient finding of this experiment was that laser accelerated beams have a similar
DNA damage potential as conventional beams but produce less immediate nitroxidative
stress, which provides a distinctive therapeutic potential.
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Kumareswaran et al [292] studied the effect of chronic hypoxia on DNA DSB repair, and
the compromising effect it has on genetic stability. The human fibroblast cell line GMO5757
was employed. The anoxic samples were exposed to 0% O2, the hypoxic samples to 0.2%
O2 and the oxic samples to 21% O2 for 16 hours prior to the irradiations using an Invivo2
400 chamber. To induce the exogenous DNA damage, the samples were irradiated using a
137Cs irradiator from MDS Nordion. The samples were then gassed post irradiation for 0.5,
4 or 24 hours at 37◦ and assayed for residual DNA damage.
The γ-H2AX and 53BP1 assays were employed to quantify the residual foci in the hy-
poxic sample 24 hrs post irradiation. DNA repair under continued hypoxia lead to a de-
creased repair of G1 associated DNA DSBs resulting in chromosomal instability. Aberrant
DNA DSB repair under hypoxia is a potential factor in hypoxia mediated genetic instabil-
ity. The decrease in repair of foci was attributed to a defective NHEL pathway for hypoxic
cells, which then leads to the hypoxic samples acquiring increased numbers of residual
DNA DSBs under continued hypoxia. The OER obtained for hypoxic samples was 1.81
± 0.31 and 2.02 ± 0.13 for anoxic samples, which is consistent with the range of 1.6 to
2.6 for normal human fibroblasts [292]. The γ-H2AX induction was O2 dependent with
the induced foci number decreasing significantly under hypoxia and anoxia. The number
of γ-H2AX foci in oxic samples fell to background levels after 24 hours, but although the
hypoxic and anoxic samples had reduced initial number of foci, the number was elevated
at 24 hours compared to the oxic samples. The rate at which the foci were lost fell from
1.11 ± 0.37 foci per hour for the oxic samples to 0.11 ± 0.09 foci per hour for the hypoxic
samples. The same initial decrease in foci numbers for hypoxic compared to oxic samples
was also observed for 53BP1 foci, and the hypoxic samples also retained increased resid-
ual foci numbers at 24 hours post irradiation. This is similar to the results obtained for
the physically induced hypoxic samples and the CoCl2 samples from the TAP experiment
which were kept in reduced oxygen conditions post irradiation, where there are fewer initial
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foci but more residual foci compared to the oxic samples, however they exhibit more initial
and residual foci compared to the hypoxic and CoCl2 X-ray samples. This is also supported
by the TARANIS results which did not exhibit this effect in the hypoxic samples at 24 hrs.
These samples had not been kept in hypoxic conditions post irradiation, thus this repair
pathway would not have been affected. Therefore the DNA repair is compromised under
continual hypoxic exposure leading to increased retention of γ-H2AX and 53BP1 foci. Ku-
mareswaran showed this effect to be specific to the induction and repair of DNA damage
and not a non-specific effect of hypoxia.
Chapter 7
Conclusions and Future Directions
7.1 Conclusions
This was the first time radiobiological experiments had been carried out on both the LULI
and TAP beamlines. Reported for the first time are measurements of DNA DSB damage with
pulsed protons at ultra-high dose rates of 109 to 1010 Gys−1 under physical and chemical
hypoxia and free radical scavenging conditions. These results were compared with con-
ventionally accelerated protons and standard X-ray irradiations. A close similarity was ob-
served between the foci kinetics of laser and cyclotron accelerated protons under normoxic
and free radical scavenging conditions, however differences were observed in the cellular
response under physical and chemical hypoxia. No significant difference was observed in
the initial damage inflicted, however at 24 hours post irradiation there was an increase in
the residual damage in the laser accelerated samples compared to the X-ray samples and the
cyclotron accelerated samples, indicating the efficiency of ultra-high dose rate exposures in
damage induction under radioresistant conditions. This enhanced number of residual foci
could be a result of a deficient NHEJ repair pathway for hypoxic cells which leads to an
increase in the number of retained foci 24 hours post irradiation if the samples are kept in
continual hypoxia, as suggested by Kumareswaran [292]. The HRF of the laser accelerated
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protons was lower than that for X-rays which is agreement with the findings of Tinganelli
[194]. As with Raschke [291], it was found that there was a similar DNA damage potential
for laser accelerated protons, conventionally accelerated protons and X-rays. The RFI for
15 MeV protons versus 225 kVp X-rays for oxic, hypoxic, CoCl2 and DMSO samples was
found to be 1.00 ± 0.09, 1.78 ± 0.94, 2.07 ± 0.84 and 0.96 ± 0.22 for the TAP experiment
and 1.20 ± 0.18, 1.32 ± 0.29 and 1.62 ± 0.55 for the 10, 13 and 15 MeV LULI proton
irradiations respectively. The HRF for the 15 MeV protons at TAP was calculated to be 1.36
± 0.55 for the hypoxic samples and 0.94 ± 0.26 for the CoCl2 samples, with the respective
values of 1.95 ± 0.33 and 1.78 ± 0.31 for the X-ray irradiations.
Fourkal’s theory of the linear response described in Section 4.4.1, predicted that when
the distance between protons in a cluster becomes less than its velocity divided by the char-
acteristic frequency of the collective excitations supported by the medium it is traversing,
the cluster’s LET starts increasing so that the stopping power of the individual proton in the
cluster increases compared to a single moving particle. Unfortunately the collective effects
predicted by this theory were not observed during the laser proton irradiations of AG01522
normal human fibroblast cells as the samples were placed beyond the distance at which the
effect can be observed. The conditions required to observe these effects are only observable
within cm distances of the target, which would require the samples to be placed inside the
vacuum which they would not survive. It was planned to observe these effects using plasmid
DNA instead.
Owing to time constraints and unforeseen circumstances, other planned investigations
into cell survival and the effect of laser accelerated protons on plasmid DNA at cm distances
(the distance at which Fourkal’s [228] linear response theory becomes observable) from the
target were not possible. Two shots for clonogenic assays were attempted, but abandoned
as the laser flux was too low and the cells were not the best quality at the end of the run.
Two shots were also carried out with plasmid DNA, as plasmid DNA is more resilient than
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AGO1522 cells and could be placed at cm distances from the target in a cell dish sealed
with 1 cm thick aluminium plates to investigate the overlapping of the ion tracks in space
and time, as these conditions were only possible at cm distances from the target. These
samples have been kept for future reference in the CCRCB.
7.1.1 Thesis Aims
The main aims of this thesis were set out in Section 1.2. These were to:
• Demonstrate laser accelerated proton induced DNA DSB under physically induced
hypoxia, chemically induced hypoxia and free radical scavenging environments for
the first time
The results reported here are the first time laser accelerated protons have been used to induce
DNA DSB damage under physically induced hypoxia, chemically induced hypoxia and a
free radical scavenging environment in AG01522 normal human fibroblast cells. These
results have been compared to data from X-ray irradiations under the same conditions as a
comparison, with similar results for laser accelerated protons and X-ray irradiated samples
in free radical scavenging conditions, and favourable results for laser accelerated protons
under physical and chemical hypoxia, which is encouraging with the view to using laser
accelerated protons sources for hypoxic tumour treatment in the future.
• Develop and characterise a new compact hypoxia chamber for use with laser driven
sources
To study the radiobiological effects of laser driven ion beams under hypoxic conditions, a
new compact hypoxia chamber was designed for low energy laser ion radiobiology applica-
tions. The chamber is suitable for characterising the biological effects of laser accelerated
beams under a range of different oxygen concentrations. The chamber design was char-
acterised physically and biologically. It proved capable of maintaining a radiobiologically
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hypoxic environment (<0.4% O2) for up to 3 hours and an acutely hypoxic environment (<
3% O2) for 24 hours, with no dose enhancement inside the chamber compared to outside
the chamber. This chamber was then implemented during the TARANIS, TAP and CCRCB
experiments, with results showing that hypoxia was indeed induced in the cell samples as
well as DNA damage. This chamber will be a valuable tool in the study of the biological
effects of laser-driven ions under hypoxia.
• Develop the cell handling procedure and irradiation methods associated with the new
hypoxia chamber
The new chamber was implemented in the TARANIS experiment as a proof of principle to
develop the cell handling and procedure and irradiation methods associated with this new
chamber. It was previously thought that EBT-3 normal film would not be able to survive
on the inside of the hypoxia chamber next to the cell dish for extended periods of time,
but it was discovered this was not the case during this experiment. It was also discovered
the original design of the hypoxia chamber would not be compatible with the insertion
pipe used for the TAP experiment so the design was adjusted accordingly. This experiment
was also only carried out with one chamber, thus the samples were allowed to reoxygenate
between irradiation an fixation, something which was seen initially as a mistake, but in the
end proved as a useful comparison for the effects produced. Issues with staining were also
highlighted during this experiment, such as the poor staining produced by γ-H2AX and the
corresponding HIF-1α antibody, thus 53BP1 was used in future experiments. By the time
the chamber was implemented on the TAP experiment, a clear technique had been developed
for the cell handling and irradiation, thanks to the initial TARANIS experiment.
• Repeat laser accelerated proton experiments in an oxic environment for comparison
Previously, the effectiveness of laser accelerated protons and carbon ions in inducing DNA
DSBs in AG01522 normal human fibroblast cells has already been shown, as described in
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Section 6.1.1. It was possible to replicate these results in both the LULI and TAP campaigns
where the RFI for the 10 MeV, 13 MeV and 15 MeV protons at LULI were found to be 1.20
± 0.18, 1.32 ± 0.29 and 1.62 ± 0.55, and 1.00 ± 0.09 for the 15 MeV protons at TAP
compared to 225 kVp X-rays. These results are a step closer to showing the potential stabil-
ity of this mode of radiation delivery as a possible alternative to conventionally accelerated
protons.
When compared to conventionally accelerated proton data such as that from Clatter-
bridge Cancer Centre and INFN-LNS Catania, the average number of foci per cell per Gy
and the proportion of nuclei with certain numbers of foci both compare favourably.
• Discover if there are different biological effects produced under the four irradiation
environments as compared to X-ray and conventionally accelerated proton irradiations
where data exists
A close similarity was observed between the foci kinetics of laser and conventionally accel-
erated protons under normoxic and free radical scavenging conditions, however there were
observed differences under physical and chemical hypoxia in the cellular response. At 24
hours post irradiation there was an increase in the residual damage in the laser accelerated
samples compared to the conventionally accelerated samples and the X-ray samples. This
indicates the efficiency of ultra-high dose rate exposures in damage induction under chem-
ically and physically induced hypoxia. The RFI for the oxic, hypoxic, CoCl2 and DMSO
samples were 1.00 ± 0.09, 1.78 ± 0.94, 2.07 ± 0.84 and 0.96 ± 0.22 respectively, and the
HRF was 1.36± 0.55 and 0.94± 0.26 for the hypoxic and CoCl2 proton samples, compared
to 1.95± 0.33 and 1.78± 0.31 for the x-ray samples. This indicates the presence of oxygen
has less effect on the laser accelerated samples than the X-ray samples. This is promising in
terms of the potential for laser driven ions to be used as an effective treatment for hypoxic
tumours.
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The effect of hypoxia observed in the TARANIS and TAP experiments was very differ-
ent. In the TARANIS experiment the response of the cells to irradiations under oxic and
hypoxic conditions produced the same result within error. For the TAP experiment there
was a significant difference in the number of foci present at 0.5 hrs and 24 hrs post irradia-
tion. At 24 hrs there were more residual foci present in the laser irradiated hypoxic samples
as compared to the X-ray irradiated samples. The main difference between these experi-
mental approaches was that in the TAP experiment the samples were not kept in a hypoxic
environment after they were irradiated, whereas the TAP samples were kept in a hypoxic
environment right up until fixation. This shows that the effects observed in the TAP samples
are a result of this prolonged hypoxic environment during the DNA DSB repair process,
rather than the initial hypoxia at the time of irradiation.
• Develop a robust immunofluorescence protocol
At the start of the work in this thesis there was a standard immunofluorescence protocol
which had been used on previous radiobiological experiments such as those described in
Section 6.1.1. During the course of the three experiments described in Sections 6.2, 6.3
and 6.4 slight adaptations were made to this protocol to produce a robust protocol which
delivers excellent staining results in the form of clearly discernible 53BP1 DNA DSB foci
and bright staining of the HIF-1α hypoxia bio-marker. A copy of this enhanced protocol is
included in Appendix B. This protocol can be used with confidence on future experiments.
7.2 Future Work
Future work will be directed towards optimisation of higher energies and development of
more robust cell based assays for screening the effectiveness of laser accelerated protons in
cancer pre-clinical models. Below is a brief description of the techniques that will be used
on future experiments;
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7.2.1 Dose and LET Dependent Cell Survival Studies
The next radiobiology experiment will be carried out at LULI and will attempt to replicate
the results presented here. The DNA damage results gathered at the experiment will also be
correlated to cell survival, which is the golden standard assay for radiobiology and repre-
sents the basis for radiation therapy treatment planning. The Laserlab Europe’s LULI2000
laser would allow these studies to be carried out at significantly higher dose rates and doses
than in previous experiments. Employing the CLF’s Vulcan or Gemini laser would also
allow the effects on cell survival of single pulses of carbon ions to be investigated for the
first time, allowing the relevance of high-LET doses delivered in nanosecond time-scales to
be addressed. Clonogenic assays performed under the same four irradiation conditions as
those used at the TAP experiment would allow correlation of these results to cell survival
and a calculation of the RBE rather than the RFI.
7.2.2 Plasmid DNA Studies
The conditions required to produce collective non-linear effects, predicted to take place
when there is spatio-temporal overlap of the tracks formed by single particles in the irra-
diated biological sample, are dependent on beam density and duration and the energy and
LET of the particles in the beam. During the TAP experiment these conditions were only
produced within cm distances of the target. To investigate these effects, plasmid DNA will
need to be used rather than cell samples as the cell samples would not survive the incredibly
high doses this close to the target. Plasmid DNA samples do not need to be in air, so can be
irradiated in sealed aluminium cell dishes inside the interaction chamber.
The overlap of tracks leads to modifications in the effective LET of a dense beam of
ions, compared to the LET of a single particle, resulting in a different biological response
to the radiation, which can be quantifiably measured by the RBE.

Glossary
ADC - Analogue to digital converter. 66
AG01522 - A human non-cancerous skin fibroblast cell line from the Coriell Institute for
Medical Research. 9, 40
ANRT - Aryl hydrocarbon receptor nuclear translocator, the alternative name for the β
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NER - Nucleotide excision repair. 108, 112
NHEJ - Nonhomologous end joining, a form of cellular repair. 109, 110, 111
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OER - Oxygen enhancement ratio. 116, 117, 118, 120
OPCPA - Optical parametric chirped pulse amplification. 43, 48
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PSL - Photo-stimulated luminescence. xi, 66, 67, 68
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SSA - Single strand annealing. 109, 111
SSB - Single strand break. 95, 114, 115, 118
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TA2 - Target area 2 of the TARANIS laser system at Queen’s University Belfast. 53
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TARANIS - Terawatt Apparatus for Relativistic And Non-linear Interdisciplinary Science.
The laser apparatus located at the Centre for Plasma Physics, Queen’s University
Belfast.. ix, 6, 7, 8, 9, 40, 47, 51, 52
TAW - Target Area West of the Vulcan laser system at Rutherford Appleton Laboratory,
Didcot, Oxford, UK. 47
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V(D)J - Variable diversity joining recombination. 109, 111
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• ((no. of dishes x 2) + 1) ml if using 4% PFA solution
• ((no. of dishes x 2) + 1) ml of permeabilisation buffer (0.5% Triton X-100 in PBS)
• ((no. of dishes x 5 x 10) + 1) ml of PBS
• ((no. of dishes x 2) + 1) ml of blocking buffer (10% Goat Serum, 0.1-0.25% Triton
X-100 in PBS)
• ((no. of dishes) +1) ml of blocking buffer with correct concentration of primary anti-
body/antibodies
• ((no. of dishes) +1) ml of blocking buffer with correct concentration of secondary
antibody/antibodies
• ((no. of dishes x 3 x 5) + 1) ml of washing buffer (0.1% Triton X-100 in PBS)
• (no. of dishes x 2) drops of DAPI
• Superglue
292 Immunofluorescence Protocol
• Clear nail varnish
• 50 ml centrifuge tubes for mixing the fixative, permeabilisation and washing buffers
• 15 ml centrifuge tubes for mixing the blocking buffer and preparing the antibody
solutions
• Aluminium foil
• Coverslips (22 x 40 mm are best for the cell dishes used)




1. Seed the cells at least 12-24 hours prior to irradiation and store in the incubator.
Fixation
2. Remove all media from the dish.
3. Wash twice with 5 ml of PBS.
4. Remove all the remaining PBS from the samples.
5. Fix the cells by adding 2 ml per dish of 4% PFA solution to each sample for 10 to 12
minutes at room temperature.
6. Remove the fixing solution and wash three times with 5 ml of PBS.
7. Store the samples in the fridge covered with at least 5 ml of PBS until after the 24
hour time point has been fixed.
293
8. Never let the sample dry out at any point; top up the PBS if necessary.
Permeabilisation
9. Remove any remaining PBS.
10. Permeabilise the cells with 2 ml per dish of the permealisation buffer (Triton X-100
in PBS) for 10 minutes at room temperature.
11. Remove any remaining buffer and wash three times for 5 minutes with 5 ml of PBS.
Blocking
12. Discard PBS and add 2 ml per dish of blocking buffer (10% Goat Serum, 0.1% Triton
X-100 in PBS) and incubate at 37◦C or room temperature for 1 to 2 hours.
13. Remove blocking buffer. No need to wash the samples after this step.
Primary Antibody Reaction
14. Add 1 ml per dish of the primary antibody/antibodies at the correct dilutions in block-
ing buffer, 3BP1(rabbit) primary antibody at 1:1000 and HIF-1(mouse) at 1:500, and
incubate at 37◦C for 2 hours.
15. Wash the dishes thrice with 3 ml of washing buffer (0.1% Triton X-100 in PBS), then
once with PBS.
16. Remove all remaining solution.
Secondary Antibody Reaction
17. Add 1 ml per dish of the secondary antibody/antibodies at the correct dilutions in
blocking buffer, GAR488 for 53BP1 secondary and GAM594 for HIF-1 secondary,
both 1:1000 and incubate at 37◦C for 1 hour.
294 Immunofluorescence Protocol
18. Wash the dishes twice with 3 ml of washing buffer (0.1% Triton X-100 in PBS), then
once with PBS.
19. Remove all remaining solution.
Mounting Samples
20. Remove the DAPI from the freezer 30 minutes before mounting.
21. Ensure the samples are as dry as possible.
22. Mark the back of the sample with any relevant information (such as the position of an
energy line) using a marker and seal with clear nail varnish.
23. Add 2 drops of DAPI to each sample and attach a coverslip.
24. Remove the excess with a tissue and leave to dry for 24 hours in the dark.
25. Seal the edges of the coverslip with clear nail varnish once dry.
26. Attach a glass slide to the other side of the sample using Superglue. Once the glue
is dry, cut the sample from the dish using a scalpel and label with any more relevant
information (time point, cell line etc.).
27. Store at 4◦C in the fridge or -20◦C in the freezer until you wish to count the foci.
